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PREFACE
Scope of the thesis
The work for th is thesis was ca rried  out m the Regional 
Haemophilia Centre and the University Department of Medicine, 
Glasgow Royal Infirm ary over the past si% years. It consists of 
both clinical and laboratory studies into the haom orrliagic problems 
of patients with haemophilia and Christmas disease. In diseases 
with so many facets it is  not possible to eseamine every aspect b o  
Î have focussed my attention on some outstanding clinical and 
laboratory problem s. In the clinical section I have investigated 
methods of m easuring the early pathological changes in the 
synovium of the joints, the biochemical methods of diagnosing 
muscle bleeding, the localisation of muscle haeniatom ata with 
ultrasonography, the effect of fibrinolytic inhibitors in the reduction 
of bleeding after dental extraction, the incidence of and aetiology 
of gastro-in testinal bleeding and evaluated electroencephalography 
as a te s t of previous cerebral bleeding. In the laboratory section 
I look at some of the complications of therapy with plasm a products, 
both of human and animal origin. In particular the incidence of 
transfusion hepatitis, the incidence of blood group antibodies, the 
effect of elevation of plasm a fibrinogen and the effects of animal 
antihaemophilic factor on human blood platelets*
a.
Some of tills work lias already been published and the thesis 
contains ex tracts from  the following:
1) C hristm as disease and haemophilia in Kenya
Forbes, C .B ., MacKay, N ., Elian, A. A.
Transactions of the Royal Society of Tropical 
Medicine and Hygiene (1966), 60, TZ7
2) Cryoprecipitate therapy in haemophilia
Forbes, C .B ., Hunter, J . , B a rr , R .D ., Davidson, J . F . ,
Short, D.W.,  McDonald, G . A . , McNicoi, G.P . ,
W allace, J . , Douglas, A. S.
Scottish Medical Journal (1969), 14, 1
3) Radioactive joint scanning in haemophilia and Christm as
disease
Forbes, C .B ., Greig, W .R ., Prentice, C .B .M ., 
McNicol, G.P.
Journal of Bone and Joint Surgery (1973), in p ress
4) Tranexam ic acid in control of haem orrhage after dental 
extraction in haemophilia and C hristm as disease
Forbes, C .D ., B a rr, R . D . , Reid, G ., Thomson, C . , 
Prentice, C . R . M . , McNicol, G .P . ,  Douglas, A. 8.
B ritish  Medical Journal (1972), 1, 311
5) Aggregation of human platelets by commercial preparations
of bovine and porcine antihaemophllic globulin 
Forbes, C .D. ,  Barr, R.D.", McNicol, G .P . ,
Douglas, A. 8.
Journal of Clinical Pathology (1872), 35, 210
6) Duplication of LDE-1 In a patient receiving multiple
transfusions
Forbes, C.D. ,  King, I ., McNicol, G.P.
Clinical Chem istry (1971), 17, 948
7) Rupture of the u re te r  due to crushing injury in a patient 
with severe haemophilia
Forbes, C .D ., Craig, J. A ., Prentice, G .H .M .,
McNicol, G .P . , Levack, J ,H . , Ireland, J . T , ,
Adame, J , F . , Sutherland, G.R.
B ritish  Journal of Surgery (1971), 58, 9S1
8) Acute W ravaecu lar haem olysis associated with cephalexin 
therapy
Forbes, C. D . , Craig, J .A . , M itchell, E . ,
McNicol, G .P .
Postgraduate Medical Journal (1972), 48, 180
9) Aggregation of human platelets by purified porcine and 
bovine antihaemophllic factor
Forbes, C .D ., Prentice, C.E.M.
Nature (Lond. ), (1972) in press.
The detailed planning of the work, its day to day evolution 
and its  execution w ere m y  individual responsibility, and, except 
where indicated in the acknowledgements, the work was entirely 
personally perform ed.
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"Strange it is  that our bloods 
of colour, weight and heat, pour'd all together 
Would Quite confound distinction, yet stand off 
In differences so mighty"
Alls Well That Ends Well 
Act 2, Scene 3
CHAPTER 1 HAEMOPHILIA - AN OVERVIEW
CHAPTER 2 DEVELOPMENT OF KNOWLEDGE
IN BLEEDING DISORDERS
CHAPTER 1 
HAEMOPHILIA - AN OVERVIEW
The word haemophilia is  derived from  two Greek words 
'haima* - blood and *philein' ~ to love and despite being sense­
less in the description of excess bleeding it rem ains in general 
use. In the older lite ra tu re  various names have been used eg. 
haemorrhaphilia, haematophilia, haemorrhoea, haemorrhagophilia, 
idiosyncrasia haemorrhagica and morbus haem aticus. The f irs t 
use of the word "haemophilia^  ^ is attributed to Schbnlein (Virchow, 
1854) but the f irs t  w ritten use was by Hopf, a student of Schbnlein, 
who gave a dissertation entitled "Die Hémophilie" at Wurzburg in 
1838.
The disease is now called haemophilia A or classic  
haemophilia and is due to deficient activity of antihaemophllic 
factor (AHF, AEG or Factor VIII). A variety has been described 
which is called Christmas disease in Britain but in Europe is  often 
called haemophilia B and in the U. S. A ., plasma thromboplastin 
component deficiency (PTC). This is due to deficient activity of 
Christmas factor (CF, PTC or Factor DC).
The clinical m anifestations of these two diseases are 
essentially sim ilar and in th is thesis no differentiation is  made
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between them with regard  to bleeding tendency. It has been 
suggested that the bleeding tendency of Christm as d isease is often 
milder than classic haemophilia (Ratnoff, I960; iWcKnsick, 1962(a)) 
but this has been disputed (Wilkinson et a l . , 1961; Lewis et a l . , 
1968).
Haemophilia is  often thought to be a ra re  or eso teric 
condition but th is is not so. P ro jecting  an estim ate of its frequency 
to the current population, we would expect in B ritain  about 5, 500 
patients with c lassic  haemophilia and about 550 with C hristm as 
d isease. In the United States there a re  between twenty to th irty  
thousand sufferers and it is probable that in all countries there 
a re  equal num bers of undiagnosed patients with mild form s of 
disease.
The medical and social consequencies of haemophilia 
begin to m anifest them selves in early childhood and continue 
throughout the lifetim e of the sufferer. The high m ortality in 
th is population in the ir e a rlie r  years can be inferred  from  the survey 
by Katz (1970); of the 1,055 haemophiliacs surveyed, only twenty- 
seven men, aged sixty years and over, w ere found. This was 2, 6 
p er cent of the haemopMlic group compared with 20 per cent of
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the general population. With improvements in management and 
the availability of potent concentrates of plasm a which can co rrec t 
the clotting defect the m ortality  from  bleeding continues to fall and 
it is  predicted that the life expectancy of the haemophiliac may 
soon approach that of the general population.
The popular concept of the haemophiliac as somebody who 
bleeds at the slightest touch has placed him in a special category 
in society in which he is thought to be incapable of leading a 
norm al existence and perform ing the usual social ro les  in the 
socially expected fashion. Social problem s involve the patient’s 
m other, father, b ro thers and s is te rs , and stra in  and d istort the 
usual family relationships, but the person most affected is , of 
course, the patient in whom psychiatric symptoms and signs are  
well documented (Early, 1959; Agle, 1964; M attson and G ross, 
1966 (a) and (b)). F rom  the medical point of view excess bruising 
may be noticed from  the tim e the infant s ta r ts  to craw l and bleeding 
occurs into the Joints when he s ta rts  to walk. The severity  of 
the d isease dictates the number and frequency of bleeds and in 
this thesis the clinical classification of severity  a s  described by 
Biggs and M acfarlane (1963) is  used.
Severe grade: patient suffers severe recu rren t joint
bleeds, and m uscle and subcutaneous liaematomata with little  or 
no provocation. This usually re su lts  in serious crippling.
M oderate grade: patient suffers few haem arthroses or
m uscle bleeds. These only occur after definite injury.
Mild grade: patient usually suffers no Joint bleeds and
does not bleed spontaneously. Abnormal bleeding usually only 
occurs after definite injury or after surgery.
These clinical grades correspond approximately to the level of AHF 
or CF in the plasm a (Nilsson et a l . , 1961),
le ss  than 1 per cent - severe
1 to 4 per cent - m oderate
5 to 30 per cent - mild
The severe haemophiliac may suffer excess bleeding from, 
or into any p art of the body and each site p resen ts a different 
type of complication or diagnostic problem. The mild haemophiliac 
may not p resen t until he has a surgical operation in middle-age; 
because of th is, it has been suggested that the mildly affected patient 
now runs a g rea ter r isk  than the severe patient (Ratnoff, 1963; Pappas 
et a l . , 1964).
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Treatment of bleeding episodes consists of replacem ent 
of the m issing factor by transfusion of plasm a or plasm a con­
centrates, This may add the additional hazards of transm ission  
of serum  hepatitis or development of inhibitors.
6.
CHAPTER 3 
DEVELOPMENT OF EJXTOWLEDGE
BLEEDING DISORDERS
(a) E arly  history of bleeding d isorders
It is  probable that genetically determ ined bleeding d is­
o rders a re  as  old as tim e but they seem  to have been neglected 
by the Egyptian, Roman and Greek physicians. The ea rlie s t 
documented cases of a  fam ilial bleeding disorder occur in the 
fifth century Talmud and in Rabbinic writings thereafter. The 
Babylonian Talmud in the trac ta te  Yevamoth 64b sta tes
"For it was taught: II she circum cised her f irs t
child and he died (as a resu lt of bleeding from  the 
operation), and a second one also died, she m ust 
not circum cise her th ird  child. "
This decree of Rabbi Judah (redactor of the Mishneh) recog­
nised the fam ilial and sex-linked nature of this bleeding defect and 
variations of his edict have been incorporated into Rabbinic Law 
through the centuries and commented on by others eg. Alfasi (1013- 
1108), Maimonidea (twelftli century).
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A part from  this legal debate no cases suggestive of a 
bleeding d isorder w ere described in mediaeval tim es except 
for a reference by Abiil E l ICassam (Albucasis), an Arabic author 
who lived in Cordova in the eleventh or twelfth century A. D. He 
described that In a certain  village there  w ere men, who, when 
wounded or phlebotomised, suffered an uncontrollable haem orrhage 
which ended only in the death of the patient.
T hereafter sporadic case repods of patients with excess 
bleeding may be found in the scientific lite ra tu re . Philip 
libchste tter, a physician practising  in Aughsburgh at the beginning 
of the 17th Century, speaks of a boy who haem orrhaged from  the 
navel at birth; la te r  in life he had repeated epistaxis, bloody 
stools and spontaneous ecehymosia. Banyer (1743) described 
the case of a  24 year old gardener from  Wisbech, in the Isle of Ely, 
who bled profusely from  a puncture wound of his foot and then 
nearly exsanguinated from  the site  of a phlebotomy perform ed by 
his physician. This boy had epistæ ds, recu rren t m elaena and haemat- 
uria and eventually died in 1738, aged 33 years, following a triv ia l 
wound of the leg. In neither of these cases was the re  a  documented 
family history.
The f irs t  probable case of haemophilia in A m erica was 
recorded m an obituary in the Salem (Mass. ) Gazette of March 
22nd, 1791 and described the case of Isaac îSoll who died in F red ­
erick  County, Virginia, at the ago of nineteen from
"a  sllglit cut in one of h is feet, with an axe. From  
the tim e of his receiving the wound, til l  he expired, 
no method could be devised to stop the bleeding. "
This obituary goes on to describe the deceased’s five 
b ro thers who had all died of exsanguination following minor traum a, 
"one received a prick with a thorn - another, a  scratch  
with a comb - a th ird , a prick  with a needle - a fourth, 
bru ised  his cheek against a  stove - and a fifth, received 
a  cut in one of h is thumbs. "
It is  of great in terest that this boy’s father, Henry Soil, 
was twice m arried  and only the children of the f ir s t  wife were 
affected by th is bleeding tendency.
In 1803, John C. Otto of Philadelphia described a family 
of b leeders by the name of Smith who had settled in the vicinity of 
Plymouth, Mew Hampshire about 1720. Otto recorded that only 
the m ales w ere subject to th is strange affliction and the fem ales
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w ere exempt, although they w ere s till capable of transm itting  it 
to the ir male children. Unfortunately Otto never sav/ or e^mmined 
the patients but learned of them  from  Samuel L iverm ore, a lawyer 
who represen ted  Hew Hampshire in the Continental Congress.
The f irs t  pedigree of haemophilia was published by Hay (1813), 
who followed the d isease in the Appleton-Swain family through 
sm  generations spanning 172 y ears and containing twenty haemophilic 
m ales. This family has been reinvestigated by several authors 
since then (Osier, 1885; McICusick, 1962 (b)) and has now been 
traced  over four hundred years and thirteen generations. The 
disease was identified originally in a male born in B risto l, England, 
in 1630 who came to Newbury, M assachusetts in 1639.
The f irs t  European notices of the disease a re  case reports 
by the Editor of Sammlimg aiiaerissener Abhandlungen (1805) and 
by Consbruck (1810), followed by careful clinical and post-m ortem  
observations by Blagden (1817) and Wilson (1019). It is  of in terest 
that Meckel (1816) postulated a coagulation defect in haemophilic 
blood but his suggestion was ignored for eiglity y ears .
The next publication m arks the transition  from isolated 
case rep o rts  to an attem pt at scientific description of the disease.
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ÏE 1820, N asse published a collection of the cases available at 
that tim e and gave a general review of the disease. He was of 
the opinion that the Mood was of "imtisual fluidity" and th is was due 
to "hyperoxidation". F rom  study of the family h isto ries came 
"N asse’s Law" which stated that haemophilia occurs only in m ales 
and is  transm itted  by unaffected fem ales.
After 1820, the history of haemophilia is  alm ost totally 
contained in the German lite ra tu re  and between 1830 and 1860 
complete descriptions of the disease a re  met within the text books 
of Bchbnlein., Ganstatt, Neumann, and Fuchs, At th is tim e there 
was no re a l clue to the aetiology of the disease but it was thought 
by Bchbnlein to be due to "cyanosis and malformation of the heart" 
and by others to be due to "anomalous gout" or "scrofu la", this 
despite the adequate post-m ortem  examinations reported by 
Virchow (1854),
Grandidier (1855) collected all cases published up to 
that tim e of abnorm al bleeding and found that there  were 452 m ales 
and 32 fem ales. These numbers are difficult to evaluate as they 
contain cases of umbilical haemorrhage? m enorrhagia and haem orrhage 
after circum cision as well as cases of haem orrhagic d isease 
suggestive of haemophilia.
In 1872 Legg wrote an excellent ’T reatise  on Haemophilia’ 
describing the genetic transm ission  of the disease,
"The d au g h te rs ............... possess in a very high degree
the faculty of transm itting haemophilia to th e ir sons.
The women may appear perfectly healthy; they may 
m arry  perfectly healthy husbands; and yet bear a family, 
à ll the boys of which shall be b leed ers ."
He also described in detail the bleeding problem s associated 
with the disease, the causes of m ortality, the psychiatric aspects, 
the episodic bleeding and the curren t treatm ent. All th is  seem s 
to have been neglected till it was rediscovered by la te r  authors.
In 1893 Wright discovered that the clotting tim e of the 
patient’s  blood was prolonged and in 1811 Addis and Minot and Lee 
(1910) observed that the addition of normal blood could correct the 
clotting defect in the haemophilic blood.
In the ir classical monograph Bulloch and FiM es (1912) 
surveyed the disease in 235 patients and their re la tives . They 
re-em phasised  the lim itation of the disease to m ales but gave no 
credence to e a rlie r  descriptions of haemophilia in the fem ale 
despite case reports strongly suggestive of a bleeding tendency. 
Indeed the female patient described by T reves m 1886 has sub­
sequently been shown to belong to a family afflicted with classic
haemophilia (Merekey, 1951).
M the f irs t few years  of th is century the diagnosis of 
haemophilia depended on the clinical and family h istory  plus the 
finding of prolongation of the whole Mood clotting tim e (Liston,
1839; Wright, 1893) in patients with norm al levels of prothrom bin 
(Howell and Cekada, 1926),
Treatment of the bleeding episodes up to th is point varied 
from  the b izarre  to the lethal despite the dem onstration by Lane 
(1840) of the beneficial value of blood transfusion. This was 
rediscovered by Weil (1906) and Minot and Lee in the Ü. B. A, (1910). 
The Vise of plasma was then shown to be superior to whole blood 
by F eissiy  (1924) and Payne and Steen (1929) and th is treatm ent 
became standard practice for th irty  years.
The first m ajor biochemical advance occurred in 1935 
when Bendien and van Greveid, then Patek and Taylor (1937) found 
that platelet free  plasma, precipitated with w ater at a pH of 5. 3 - 
5. 8, yielded a substance which was capable of correcting the 
clotting abnormality. This was confirmed by Lewis et al. (1940) 
and Brinlchous (1947) and the protein further characterised .
Until 1947, haemophilia was considered to  foe a single disease 
entity, then Pavlovsky observed that Mood from  one haemophiliac
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could co rrec t the clotting defect In another. This phenomenon 
was dem onstrable both in vivo and in v itro (Schnlman and Smith, 
1952; R oller et a l . , 1950). Coincidental with these clinical 
findings the development of te s ts  of throm boplastin generation 
(Biggs and Douglas, 1053) confirmed that there  w ere two separate 
groups of patients. This observation was confirmed clinically 
by the finding of a group of "haemophilic” patients whose defect 
could foe corrected  by the infusion of haemophilic blood plasm a 
(Biggs et a i . , 1952; Aggeler et a l . , 1952), This new disease 
was called C hristm as disease and is associated with lack of a 
factor found in serum  called C hristm as factor (C. F., factor DC or 
p lasm a throm boplastin component (P. T. C. )).
As knowledge increased and new clotting te s ts  w ere devised 
it became apparent that there  w ere other bleeding d iso rders besides 
the haem ophilias. In 1947, a clotting deficiency was described by 
Owren in a patient with normal prothrom bin and fibrinogen levels. 
This p lasm a would not clot readily with tissue ex tract and calcium  
ions and the defect was called Factor ¥  deficiency. In the course 
of tim e it becam e apparent that th is factor was identical with the 
"labile” factor described by Quick (1943) and to the accelerato r 
globulin (Ac-globulin) of W are andSeegers (1948).
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Further investigations have shown the need for two 
additional factors participating in clotting with tissue  thromboplastin, 
Factor VII (De V ries et a l . , 1948; Alexander et a l . , 1951) and Factor 
X (Teller et a l , , 1956; Hougie et a l . , 1957). All these defects 
present with bleeding which is clinically indistinguishable from  
that of haemophilia and it is  probable that early case reco rds 
included patients with these defects.
As the pathways of blood coagulation have become better 
understood it is  apparent that defects can be found in the laboratory 
which a re  not manifested clinically eg. Hageinan factor deficiency 
(Hatnoff and Colopy, 1955) is  not usually associated with bleeding 
and deficiency of plasm a thromboplastin antecedent (Rosenthal et 
a l . , 1953) is  associated with bleeding in only about tw o-thirds of 
cases. Deficiency of fibrinogen may be associated with only a mild 
bleeding defect.
(b) ' Distribution of haemophilia and C hristm as disease
C lassical haemophilia probably exists in about 3 - 4 per 
100,000 of the population in B ritain  (Biggs and M acfarlane, 1966).
A sim ilar figure is found in Europe (Hardisty and Ingram, 1965) 
and in the United States (Ratnoff, 1960; Lewis et a l . , 1963). It
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Î8 important to rem em ber tlie dictum of Legg (1872), 
the number of cases in a given country 
depends upon the previous education of the 
m edical men, and the in terest which they take 
in the disease.
He points out that in 1872 Germany had 50 per cent of cases,
England le ss  than 20 per cent, France, U.S.A . and Switzerland 
10 p er cent each.
The disease has now been described in every rac ia l group 
(Prentice and Katnoff, 1067) but is said to be uncommon in the 
Am erican Negro (Lewis et a l , , 1963), the Japanese (YosMda, 1061) 
and the Bantu (Merskey, 1958), This last statement is probably 
co rrec t and may apply to other negroid stock. In a recent study 
of E ast African negroes from  various Kenyan tr ib e s  we found only 
th ree fam ilies with C hristm as disease and five fam ilies with 
haemophilia (Forbes et a l , , 1966). This observation has been 
confirmed by other investigators working in Uganda (Lotlie, 1968).
As laboratory facilities are  extremely deficient in both these 
countries it is  difficult to draw definite conclusions but if the incidence 
of these d iseases was sim ilar to that in Europe and A m erica one 
would have expected about 270 patients In Kenya clone. It is
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possible that the number of adult haemophillaes Is in fact low due 
to the high m ortality which would be expected following ritua l 
circum cision ca rried  out a t puberty.
There a re  also wide variations in the incidence of bleeders 
within certa in  countries, eg. in the Tenna Valley in Switzerland 
(Moor-Jankowski et a l , , 1957) and in the Amish communities in 
Ohio and Pennsylvania (Wall et a l . , 1964) the incidence of C hrist­
m as d isease is high due to inbreeding,
(c) The inheritance of haemophilia and C hristm as disease
Only about tw o-thirds of patients with these d iso rders 
have a family history  of excess bleeding (Aggeler et a l , , 1661; 
^chulman, 1962; Macfarlane, 1962). The in terpretation  of this 
figure is difficult as few people know the m edical h istory of their 
fo rebears beyond two generations and many of the cases could 
have been transm itted  through successive generations of fem ale 
c a rr ie rs . When extremely active attem pts a re  made to  trace  back 
family h isto ries , a higher incidence (80 per cent) of positive h isto ries 
is found (Bamgren, 1962 (a); Quick, 1966). Occasionally 
patient’s d iso rder must be due to a fresh  gene mutation.
17.
Genetic defect in haemophilia
The form ation of defective molecules of antihaemophilic 
factor is  probably due to the presence of an abnormal recessive 
allele at the gene locus on the X  chromosome controlling synthesis 
of th is factor. This locus is close to those determ ining deutan 
colour blindness (Whittaker et a l . , 1962) and glucose 6-phosphate 
dehydrogenase synthesis (IVicKusick, 1962 (a)). M ales, p o ssess­
ing th is one abnorm al X  chromosome produce a  protein, anti- 
genicaily sim ila r and in an equal amount to norm al AHF but 
with deficient activity (Denson et al*, 1968; Eoyer and Breckeoridge, 
1968; Beimet et a l . , 1970; Zimmerman and Batnoff, 1971 (a)). 
Fem ales possessing an additional norm al X chromosome a re  thought 
to produce twice as much protein antigenically sim ila r to norm al 
A1ÎF but with an activity of half that which one might expect 
(Zimmerman and Ratnoff, 1971 (fo)). The suggestion of Zimmerman 
and Batnoff is that the abnorm al X chromosome produces an abnormal 
protein with no activity and the norm al X chromosome produces 
protein with activity. They suggest that this will provide a method 
of identification of c a rr ie r  fem ales. The sons of a haemophilic 
male do not inherit his X  chromosome and a re  unaffected, but all
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the haemophüic daughters w ill foe c a rr ie rs , since they inherit 
the affected X chromosome. In the ra re  instance of m arriage 
between a liaemophilic male and a c a rr ie r  female, the daughters 
have an even chance of being haemophilic, inheriting the abnormal 
allele from  each parent. At least four authentic cases of 
haemophilia in the human female have been reported  (Israels et a l . , 
1951; M erskey, 1951), fout examination of the chrom osom es of 
one such fem ale showed her to foe genetically m ale (Nilsson et a l . , 
1959). In canine haemophilia the mating of a haemophilic dog to 
a c a rr ie r  fem ale re su lts  in the b irth  of haemophilic fem ales (Brink- 
houB and Graimm, 1950).
Genetic defect in C hristmas disease
The loci for C hristm as factor and haemophilia are  apparently 
far apart on the X chromosome, and only a linltage with the newly 
described serum  protein designated as Xm has been found (Berg 
and Bearn, I960). It is  thought that in C hristm as d isease there 
a re  two varie ties , one in which there seem s to foe a complete 
absence of protein and another, much r a re r  type in which the 
plasm a contains a factor antigenically indistinguishable from  normal 
C hristm as factor (Bougie and Twomey, 1967).
The concentration of C hristm as factor in the plasm a of 
fem ales who a re  heterozygous c a rr ie rs  of C hristm as d isease is
about half that of norm al indivMuals (Barrow et a l . , 1960; Bolton 
and Clark, 1969; Simpson and Biggs, 1962). These c a rr ie rs  
a re  usually asymptomatic but In a few cases the concentration of 
C hristm as factor is  so low that a bleeding tendency exists (Hardlsty, 
1957; Nilehn and Nilsson, 1962).
C ases have been recorded in which classic  haemophilia 
and C hristm as disease are thought to co-exist (Soulier and L arrieu , 
1953; Hill and Speer, 1955; Graham, 1957; Nilsson et a i . , 1961). 
D iseases with sim ilar features to haemophilia and C hristm as 
disease have been described in dogs (Graham et a l . , 1949;
M ustard et a l . , 1960) and in a horse (Nossel et a l . , 1962).
(d) C urrent thoughts on the ro le  of AHF and C hristm as 
factor in blood coagulation
The end stage of the coagulation process is  the production 
of an insoluble fibrin clot. Numerous theories to explain the p re ­
ceding se rie s  of reactions have been proposed (Davie and Batnoff,
1965; Seegers, 1965; Quick, 1966 (a)). In 1964, two essentially 
identical system s term ed a "waterfall*' and a "cascade" were suggested 
to explain the enzymatic nature of blood clotting (Davie and Batnoff, 
1964; M acfariane, 1964), In these system s inactive protein 
p recu rso rs  in the plasm a w ere activated in a stepwise manner, one 
protein acting as an enzyme the other as a substrate. A current 
theoretical concept is  shown in fig. 1.
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în the presence of activated plasm a throm boplastin ante­
cedent (PTA) and divalent calcium ions, C hristm as factor is converted 
to an activated form  (Waaler, 1956; Eatnoff and Davie, 1962;
Noasel, 1964). Activation involves minor proteolysis as there is  
a change in electrophoretic mobility of Christm as factor on starch  
block electrophoresis (Schiffman et a l . , 1664). Activated PTA 
may function as an enzyme by virtue of its es te rase  activity (Kingdon 
et a l . , 1664). Recent work, using purified facto rs, suggests that 
AHF is not activated but form s a  complex with CF (a), phospholipid 
and calcium ions (Hougie et a l . , 1967; Barton, 1667). It is  thought 
that this complex then activates the Btuart-Frow er factor (Factor X).
It is  probable that there  exists a feed back activation of 
AHF by thrombin (Hapaport et a l . , 1963 and 1665) and it has been 
shown that thrombin-modified AHF formed factor X activator at 
a ra te  nearly twenty tim es faste r than a control sam ple but the 
final amount of factor X activator was unaltered (Lundblad et a l . , 
1671).
These schem es of coagulation rem ain the essential theore t­
ical basis of blood coagulation despite our clinical knowledge that 
patients with Hageman factor deficiency ra re ly  bleed excessively 
(Katnoff and Colopy, 1955).
SECTION 2
CLINICAL AND LABORATORY INVESTIGATIONS
nH you prick us, do we not bleed?"
The Merchant of Venice, 
Act III, Scene 1
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JOINT DISEASE IN HAEMOPHILIA
Î/IÎJSCLE BLEEDING IN HAEMOPHILIA
DENTAL EXTRACTION EN HAEMOPHILIA
GASTROINTESTINAL BLEEDING M  
HAEMOPHILIA
ELECTROENCEPHALOGRAPHY' IN 
HAEMOPHILIA
C m P T E R  3 
INVESTIGATION OF JOINT CHANGES IN RAEMOPHILm
(a) Introduction
The clinical features of acute haem arthrosis in haemo­
philia were well described in early  clinical case rep o rts  (Davis,
1826) but it was not initially appreciated that the acutely swollen 
joint contained blood. This was f irs t suggested by Dubois (1838) 
but the suggestion was met with great resistance until R©inert 
(1869) described a  patient with a bleeding tendency who developed 
an acute swelling of the shoulder Joint which ’suppurated’ and 
liberated a great quantity of Mood. This observation was confirmed 
by Assman (1866) when he punctured the knee joint of a haemo­
philiac with an acute swelling and allowed a considerable quantity of 
fluid blood to escape. The ea rlies t post m ortem  examination of 
the chronic Joint changes in haemophilia was that of Lemp (1857) 
who described pigmentation and hypertrophy of the synovium associated 
with dissolution of the a rticu lar cartilage. P r io r  to th is J . Felt 
(1834) a local New England (non-medical) h istorian , wrote about 
the Appleton - Swain family (vide supra) and stated that these bleeders 
were "subject to severe and prem ature rheum atism ". îConig (1862) 
published a detailed account of the pathological changes in a  large
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se rie s  oî haemophilic joints and suggested that th is resu lted  from  
recu rren t bleeding into the joint space. Histology of both the 
acute am! chronic joints chmiges has now been well documented 
by numerous investigators (Freund, 1925; Key, 1932; Collins,
1949; De Palm a and Cotier, 1956; Marion, 1965) and observations 
have also been made in haemophilic dogs with Joint d isease 
(Swanton, 1957 and 1959).
In experimental studies, injection of whole blood into 
the joints of anim als produced an inflammatory response with 
hypertrophy of the synovial villi (Key, 1929; Young and Hudacek,
1904; T rusta , 1966). The effect of a single injection was short 
lived but more pronounced effects were found with multiple injections 
which produced histological appearances sim ilar to those found m 
human haemophilic joints (Key, 1,932). It is  probable that in 
haemophilia a vicious circle is set up m which crushing of the hyper­
trophied villi occurs as a resu lt of normal Joint movements and 
this leads to further joint bleeding, which in turn leads to hypertrophy 
and liyperaemia of the synovium. It has been suggested that 
prophylactic therapy with plasm a or plasm a concentrates may be 
of value in preventing acute Joint bleeding and so might break this
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vicions c irc le  (Alilberg, 1965; Kaspar et a l . , 1970; Brinkhous 
et a l . , 1970; Hirsclimao et a l . , 1970; van Creveld, 1971).
However, there  le some evidence that deterioration contimies, 
as judged radiologieally, if prophylactic therapy is  attempted 
when bone disease is established (van Creveld et a l . , 1971),
Joint disease is probably the greatest single cause of 
morbidity in haemophilia. After repeated bleeding episodes 
the Joints become disorganised with obvious external deformity, 
loss of function, pain and lim itation of movement. The adjacent 
m uscle cuff undergoes atrophy and support of the joint is further 
weakened. ïn the severely affected haemophilic child it has been 
shown that by the age of ten years, eighty per cent have chronic 
a r th r itis  of the knee joints (K err, 1963),
Prevention of this chronic joint p rocess would therefore 
seem  to be important in the overall management of haemophilia.
Despite many approaches, such as the use of plasm a and plasm a 
concentrates, fibrinolytic inhibitors and stero ids there  is little  
evidence that the basic pathological process is substantially altered, 
although there  are dram atic clinical changes in the signs and symptoms 
of the acute joint when plasm a products a re  infused in adequate amounts.
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P roper assessm ent of the effects of new therapeutic 
agents is difficult due to the lack of objective te s ts  which can foe 
easily repeated and which reflect changes within the joint over a 
period of tim e. Radiology is unfortunately of little  value in the 
detection of early  changes in the soft tissues of the Joint, By the 
tim e cartilage and bone changes are  apparent the arth ritic  process 
is  probably irrev ersib le  (van Creveld et a l . , 1971) and the radiological 
changes which do occur (Jordan, 1958; De Palm a, 1967) probably 
reflect some long forgotten bleed into the joint.
In th is chapter is described an attempt to  quantitate the 
early joint abnorm alities in haemophilia and C hristm as disease 
using radioactive joint scanning and thermography, A  clinical 
scoring system  has also been devised to compare with these 
objective te s ts .
(fo) Radioactive joint scans
Introduction
99mIntravenous technetium ( Te), half-life am hours, is 
an ideal isotope for joint scanning and has been used to study other 
joint d iseases (Anon, 1968). The radiation dose to the foody of 0.1 
rads is  extrem ely small (Belcher and V etter, 1971). The scans, 
which consist of a p ic torial image of isotope localisation in and
around the Joint, show changes in regional Mood flow at the tim e 
of study and a re  abnormal during acute inflammation (McCarty 
et al. s 1970 (a); W eiss et a l . , 1965; Weiss et a l . , 1966;
Whaley et a l . , 1968). While visualisation of the isotope in an 
inflamed joint reflec ts, mainly, increased vascularity of the 
synovial membrane and other joint tissues (Alargon-8egovia et 
a i . , 1967; Whaley et a l . , 1968), part oî the localisation of the 
radioactivity may foe due directly to the synovium binding the 
technetium (Green and Hays, 1969; McCarty et a l . , 1970 (fo); 
Mowat et a l . , 1971).
For these reasons joint scans are  abnormal in a variety 
of inflammatory joint diseases, such as rheumatoid arthritis, gout, 
psoriatic arthritis, acute pseudo-gout and experim ental synovitis, 
but are not characteristically specific for one type of inflammatory 
change. Nevertheless, as McCarty et al. (1970 (fo)) have shown, 
the Joint scan may be much more abnormal than the degree of 
symptoms and signs would suggest and since they can be repeated 
at intervals and do give an index of blood flow in a joint it was 
thought this technique might be helpful as a measure of the extent
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oî the synovial lesion in the joints of haemophiliacs. The present 
study was confined to the knee joints where scanning is optimum 
for clarity  and comparative work.
Method
Five m illieuries of technetium (^^^Tc) as sodium per- 
technetate (HaTc04) w ere given as a single bolus intravenously 
to each patient and the imee joint scans commenced 20 minutes 
later as suggested by Whalley et a l . , (1968). The image of the 
radioactivity distribution in the joint was obtained using a rectilinear 
scintiscanner (Selo Model DS4/4) which has two 5 inch detectors.
Beans were perform ed of both knees f irs t in the antero-posterior 
and then in the la te ra l positions. The display was in colour; line 
spacing and scan speed being adjusted for each patient, joint, and 
position. The time taken to scan the knees of each person was 
approximately 15 minutes.
Various classification approaches were considered but it 
was ultim ately decided that the m ost practical method of categorisation 
of the im ages should be sim ple and visual. Accordingly the scans 
from  each knee Joint w ere examined and then said to be norm al, if 
they w ere obviously sim ila r to knee Joint scans from controls in 
other studies (Group 0). In the norm al knee the re  is  very little
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Isotope uptake. E the eeaus were obviously abnormal in width, 
depth and degree of isotope uptake, with or without irregular 
localisation they were said to be group 8. This group showed 
a very high isotope uptalte. Scans which were obviously abnormal 
but not grossly so were given grade 2. Bliglitly abnormal scans 
were grade 1 (see figs. 2, 8, 4, 5),
Thirty-five patients were included in this study, ranging 
in age from 1 1 - 6 0  years, and informed consent was obtained 
from  all subjects or parents. Twenty-eight patients had classical 
haemophilia and seven had Christmas disease. There was no 
blinical evidence of any other variety of joint disease and the 
anti-nuclear factor and Rose-Waaler tests were negative.
Classification of the clinical severity of haemophilia was 
described by Biggs and Macfariane (1963). Patients were graded 
as ’severe’ if they had suffered repeated haemarthroses with serious 
crippling and deep tissue haemorrhages with little or no provocation, 
as ’moderate’ if they had sustained few haemarthroses with no 
serious crippling or occasional muscle haematomas and ’mild’ if 
they had no haemartlirosis or other spontaneous bleeding, and merely 
gave a history of abnormal bleeding after definite injury. 18 of our
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patients were ’severe’, 6 were ’moderate’ and 11 were ’mild’.
Each of the following clinical features were arbitrarily 
graded from 0 - 3 ;  these features were pain, effusion, temperature, 
cr^ itu s and degree of contracture. This we have called the 
’signs score’. The number of previous bleeding episodes into the 
knee joints were also graded from 0 - 3, a score of 0 being no 
previous haemarthrosis, 1 being one haemarthroeis, 2 being less  
than one haemarthrosis per year and 3 being more than one haem- 
arthrosis per year; this we have called the ’incidence score’.
81% patients were seen with acute haemarthroses on a 
background of previous episodes of joint bleeding and IS with chronic 
joint disease of varying degrees of severity. Two patients had 
subacute disease at the time of examination. This category was 
defined as a swollen, non-tender joint with a normal range of move­
ment, in which there was no history of an acute bleed in the previous 
six months. 12 patients gave no previous history of joint bleeds 
and had normal knee joints on clinical examination. In 6 of the 
patients clinical examination and scanning was repeated.
Results
Acute haemarthros is  (Table 1) Six patients (1 - 6) aged from 14 - 
60 years were studied in this group. All had a severe defect and 
had sustained frequent bleeding episodes into botli knees. Every
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joint had an incidence of bleeding score of 3. The ’signs’ score 
reflected the clinical changes at the time of examination and in 
the acutely affected Joint these scores ranged from  8 ~ 11. The 
other knee Joint in ail patients had a low score (0 - 4). This 
was probably the resu lt of chronic changes in the joint. Radio­
active joint scans in all the acutely affected joints w ere grossly 
abnormal (grade 3),
All patients in this group w ere energetically treated  with 
plasm a concentrate (cryoprecipitate or Christm as factor concentrate) 
with rapid resolution of the clinical signs and a fall in the signs 
score which usually reached the baseline for the joint in 48 - 72 
hours.
Two of the patients (4, 6) have had se ria l joint scans follow­
ing the acute episode. The scans rem ained abnormal (grade 3) for 
at least four weeks and in one patient the scan was s till grade 2 at 
twelve weeks. Unfortunately he sustained another acute haem- 
arth rosis  in the same Joint and the signs score rose dramatically 
and the scan became grossly abnormal (Table 2).
Two patients (2, 3) with chronic joint disease w ere seen at 
a la ter tim e after they developed acute bleeding into a knee joint.
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Table 3 shows the changes in the ’signs’ score and in the scans in 
these patients.
L ateral scanning of the knees failed to localise the 
isotope to  any particu lar part of the joint.
In acute joint disease there is a good correlation between 
the ’signs’ score and the abnormality of the scan (fig. 6).
Bufoacut© joint disease
Both patients (7, 8) in this group had painless swelling 
of one joint which had been present for at least eight weeks.
There had been no history suggestive of an acute bleeding episode 
in the previous size months. One patient was a moderately affected 
haemophiliac and the other had severe Christm as disease. The 
resu lts  a re  shown in Table 4. In both patients the affected joint 
had an abnormal incidence of bleeding score (grade 3) and the ’signs* 
score was elevated although not so abnormal as in the acute joint 
se rie s .
Both patients received adequate haemostatic doses of 
plasma products and clinical resolution of the Joint swelling took 
place over the period of a few days. The ’signs’ score fell m 
patient 7 from 0 ; 9 to 0 ; 1 and: in patient 8 from  6 : 1 to 1 : 1. ïn 
patient 8 the scan was repeated at 6 weeks and showed a change
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from  grade 9 to grade 1. This may rep resen t a baseline for tMs 
joint as the patient has chronic arthropathy as judged raclioiogiealiy. 
Chronic joint d isease
The details of the fifteen patients (9 - 23) a re  shown k  
Table 5. Four had a moderate defect and eleven w ere severely 
affected. Two patients (18, 29) had Christm as disease and the 
re s t  had haemophilia.
All patients had an abnormal ’signs’ sco re  and abnormal 
scan in one or both knees. As shown in figure 7 there  is  a poor 
correlation between the clinical signs and the radioactive scan.
There a re  joints in which the scan is grade 2 or 3 and in which 
there was a zero  or low ’sign* score (Patient 9, 11, 12, 13, 23). 
Sim ilarly there  seem ed to be no good correlation between the scans 
and the incidence of bleeding score , there  being patients with no 
history of bleeding into one joint who had abnormal scans (patients 
11, 23) and patients with a history of bleeding into a joint who had 
norm al scans (patient 21).
No detectable joint disease
The details of the twelve patients (24 - 35) with no detectable 
joint disease a re  shown in Table 6. They w ere aged from  1 1 -5 2  
years .
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Eleven of the twelve patients had a mild degree of haemo­
philia, One patient (31) with a moderate degree had been afflicted 
with severe paralytic polio as a  child and had never borne weight 
on the Joints of the lower limbs; however, he had sustained 
multiple other bleeding problems consistent with th is degree of 
defect. As can be seen none of these patients had sustained 
bleeding into the joints and none had any clinical joint abnormality. 
However, four of the patients had b ila teral abnormal scans (grade 2 
or 3).
(c)  Thermography
Introduction
Thermography is the p ictorial representation  of in fra -red  
em ission from the foody surface and has been used before in the 
investigation of inflammatory joint diseases such as rheumatoid 
a rth ritis  (Boos, 1964; Cosh, 1966; Cosh and Ring, 1967; Hafoerman 
et a i , , 1968; Goldie, 1969; Viitanen and Laalcsonen, 1970), T ietze’s 
d isease (Aarts, 1969), spondylitis (Agarwal et a l . , 1970), Osgood- 
Schlatters disease and osteom yelitis (Aarts, 1969) and simple 
’sp ra in s’ (Albert et a l . , 1964),
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ïn inflammatory joint disease the surface pattern  of 
ra ised  skin tem perature can be easily demonstrated. In the 
knee Joint the skin tem perature over the patella is  thought to 
foe an approximate guide to in tra -articu la r tem perature although 
2 - 3^C lower (Lloyd-W illiams, 1969), It was felt that therm ­
ography might be helpful in investigation of haemophilic joints 
to m easure the extent of increased synovial vascularity . We have 
also compared the resu lts  of the therm ographs taken in acute and 
chronic haemophilic Joint d isease with the number of previous 
bleeding episodes and the clinical assessm ent of the Joint 
abnormality, and have compared this method with radioactive knee 
joint scanning using technetium.
Methods and patients studied
Fourteen patients with haemophilia or C hristm as disease 
w ere studied. Their ages ranged from  ten to stety years , th irteen 
had haemophilia and one had Christm as disease. There was no 
clinical or laboratory evidence of any other type of joint disease 
being present in the se rie s  and the Rose-Waaler and anti-nuclear 
factor tests w ere negative. Five patients had acute haem arthroses 
on a background of chronic joint disease, six had chronic joint disease
oî varions severity  with no recent episodes of acute haem artlirosis 
and th ree patient with mild haemophilia had no apparent joint 
d isease.
The equipment used for thermography was the Bofors 
I .E . cam era and display unit. This has an indium-antimonide
detector cooled by liquid nitrogen; it will distinguish tem perature 
variations of the order of 0 .2^C and has the facility for demon­
strating  isotherm al bands.
The therm ographic examinations w ere ca rried  out with 
the subject sitting in a chair with the knees several inches apart 
and flexed approximately 30^ in order to provide a  standard 
position which could he adopted by the arth ritic  patients. The 
tem perature of the room was kept as constant as possible (21^C to 24^C), 
Lloyd-W illiams et al. (1961) recommended a constant level of le ss  
than 20^C, In order to achieve equilibrium before starting the 
recording, the unclothed lower lim bs were exposed for a period 
of 15 minutes whilst a  fan was directed towards them. Photographs 
of the therm ographic pattern and of a series of isotherms as displayed 
on the oscilloscope were taken with an attached 35 mm. camera,
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according to a technique previously described by Feaeey et al.
(1070). This provided a perm anent record  of the examination.
The 35 mm. therm ograph records w ere examined by an 
observer experienced in th is technique and from  observations of 
the film s and the isotherm s a crude scoring system  was devised. 
Therm ographs that were normal w ere given a score of 0, if 
slightly abnormal a score of 1, markedly abnormal a score of 2 
and for grossly abnorm al a score of 3. Examples of such therm o­
gram s a re  shown in figs. 8, 9, 10, 11. An example of the use 
of isotherm s is  shown m fig. 12.
Results
The results of thermography in the th ree groups of patients 
a re  shown in fig. 13 and Table 7.
Acute haemartlirosis
Each of the five patients in this group was severely  affected 
and in each instance the therm ograph was grossly abnormal (score 
3) in the joint with the acute haemartlirosis* ïn no Joint was there 
any localised a rea  of heat em ission. By use of iso therm s it is 
possible to m easure the tem perature difference between the affected 
and unaffected joint. F igs. 11, 12 show a r is e  in tem perature of
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8^C m a Joint with an acute haem artlirosis. There is a good 
correlation between the abnormality of the therm ograph and the 
signs score . T here is  no correlation  with the number of previous 
bleeding episodes.
Chronic joint d isease
The details of these six patients a re  shown in Table 7.
All six had a severe degree of haemophilia and had sustained 
frequent bleeds into both knee joints. All six had abnormal 
therm ographs of one or other knee joint but the abnorm ality of the 
therm ographs did not correspond well with either the number of 
previous bleeding episodes of the ’signs’ score, the re  being 
patients with grossly abnorm al joints on clinical excamination with 
only a slight abnormality on the therm ograph (patient 9).
No detectable Joint d isease
Three patients with no detectable joint disease who had 
mild haemophilia w ere also examined. All th ree  had abnormal 
therm ographs (score 1). There was no history of previous bleeding 
into the joints in any patient. These joints w ere radiologically 
norm al.
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Comparison of thermography and radioactive scans
In acute joint d isease (fig. 14) there  is  a crude positive 
correlation between the scans and therm ographs, a ll are abnormal. 
The five scans a re  grade 3 and four of the five therm ographs are  
grade 3, the other being grade 2.
In chronic joint d isease (fig. 15) there  is  poor correlation 
between the scans and the thermographs with wide discrepancies 
in individual joints eg. some joints appearing to have a normal 
therm ograph and others having a grade 3 scan. The scans are  
more often abnormal than the thermograph.
The num bers in the th ird  group are  too sm all for comment,
(d) Discussion 
One of the ea rlie s t, most frequent and most disabling 
m anifestations of haemophilia is  acute haernarthrosis. Symptoms 
of joint bleeding may occur as soon as the child starts to walic 
(Hamgren, 1062 (b)) and by the age of ten years , eighty p er cent 
of severe haemophiliacs have abnormal knee joints (K err, 1963), 
T here is , as yet, no s atisfactory objective method of 
m easuring the changes which occur in the haemophilic joint over 
a. period of tim e. Obviously clinical examination can give a crude
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assessm ent of pain and lim itation of function and sim ilarly  radiology 
of the joint shows changes which may have resu lts  from  some 
long forgotten haem arthroBis.
In th is present study we have used two new techniques in 
the investigation of haemophilic joint disease. From work ea rrM  
out in rheum atoid a r th ritis  it has been shown that the radioactive 
scans reflec t Mood flow in the synovium (Weiss et a i . , 1965), 
Abnormality of the scans indicates hyperaemia of the synovium 
and other joint tissues. Thermography provides a p icture of 
heat em ission from  the joint and th is is  also thought to reflec t 
synovial blood flow (Goldie, 1969).
The aetiology of the signs of inflammation in the joint in 
acute haemophilic haem arthrosls is not imown but it has been suggested 
that pain is partly  due to capsular distension and that intra-articular 
bleeding will continue until the intra»synovial p re ssu re  exceeds 
that of the cap illaries and a rte rio les  of the bleeding site . The signs 
of inflammation may also be associated with the generation of 
kinm«lik0 m ateria l from  components in the extravasated blood 
(Hatnoff, 1966; Moskowltz et a l , , 1970),
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In acute liaem arthrosis the clinical signs can be correlated  
with the degree o! abnormality of the radioactive scans and with 
the therm ographs, the abnorm alities of which reflec t changes in 
the synovial blood flow. This hyperaemla of the synovium can 
be seen histologically in the joints of haemophilic patients after 
bleeding (Key, 1932) and in experim ental anim als after injection 
of blood (Key, 1929; Young and Hudacek, 1954; T rueta, 1966;
Roy and Ghadially, 1966). The histological abnormality in 
escperimental anim als is short lived after a single injection of blood 
but m ore pronounced effects can be produced by multiple injections 
of blood. After a  single injection the synovium may re tu rn  to 
normal but permanent changes are produced by multiple injections. 
The slow resolution of the synovial changes a lte r acute bleeding is  
well shown in our patients in which the scans took up to  th ree 
months to re tu rn  to the baseline, indicating that tem porary  synovial 
hypertrophy is partly involved in the pathological process.
The subacute classification represents a variation of the 
p rocesses seen in the acute joint. In both our patients there had 
been no clinical evidence of recent acute bleeding and the joints 
had been swollen, hot and painless for over eight weeks. However, 
the scans w ere identical with those seen in acute bleeding. Repeat
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scanning in patient 8 six weeks la te r showed only slight im prove­
ment despite total clinical resolution with adequate haem ostatic 
therapy.
Ail the patients with chronic Joint d isease had abnormal 
scans and therm ographs of one or both knees. None of the patients 
in th is group had a history of recent acute haem arthrosis so the 
abnormal scans presum ably rep resen t a chronic state in which 
there  is increased vascularity  in the synovium. This is  in keeping 
with many previous descriptions of the histology of these chronic 
Joints (Bokelman, 1881; Konig, 1892; Freund, 1925; Collins, 1949; 
Hodnan et a l . , 1959; De Palm a and Cotier, 1956; Marion, 1966; 
T rueta, 1966), in which the synovium was found to be markedly 
thickened, hyperplastic and endowed richly with vascular channels, 
Storti (1969) has described a  hypertrophic-angiom atous type of 
synovium with thin-walled varicose veins on the surface which bled 
even when touched with a gauze swab.
In the group of patients with no clinically detectable joint 
d isease and no previous history of bleedmg into the knee joints, four 
patients had b ila te ra l abnorm al scans and th ree  had abnormal 
therm ographs. The abnorm alities presumably are a reflection of
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subcliMcal bleeding into the joints, a condition which is  analogous 
to the asymptomatic bleeding from  the renal cap illaries which we 
have previously described in mild haemophilia (Prentice et a l . ,
1971X
When the two methods are  compared there  is  agreement
only in the acute haem arthrosis. Both methods a re  m ore sensitive 
than clinical examination and th is confirms the findings of Cosh et 
a l.(1970) and MaxfieM et ai. (1972), These authors suggest 
that therm ography shows a m ore superficial pattern , while the 
scans dem onstrate the deep synovial area.
Recently synovectomy has been ca rried  out in patients 
which chronic haemophilic joint d isease (Storti et a l . , 1969, 1970). 
The prelim inary re su lts  seem  encouraging but as yet no long term  
follow up is  available. These two objective te s ts  should prove 
of value in the selection of patients for th is operation and in the 
assessm ent of the short and long term resu lts  of the synovectomy. 
They may also prove of value in the assessm ent of stero ids and 
antifibrinolytic agents in the treatment of acute joint bleeds.
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(a) Introduction
Bleedmg into m uscles has been recognised from  early 
tim es as a frequent cause of morbidity in haemophilia. Usually 
th is occurs after traum a (Lafargue, 1838) but can occur spon­
taneously or after emotional s tre s s  (Fournier, 1861). The 
swelling may reach  enormous proportions (Vieli, 1863) and has 
caused death, on occasion, from  exsanguination. It was not 
until 1839 that Hopf, on opening one of these swellings with a 
caustic, showed that they contained altered  blood; the re su lt on 
this occasion for the patient was exsanguination from  the wound 
and death. In two modern surveys m uscle liaematomata were 
shown to  foe the th ird  commonest type of bleeding, the incidence 
varying from  68 « 82 p er cent (Hartman and Diamond, 1957; 
Wilkinson et a l . , 1961),
L arge m uscle liaematomata may produce com pression of 
adjacent nerves, blood vesse ls  or other s truc tu res. In the muscle 
itself there is  large scale destruction of muscle fib res, partly  as a
resu lt of mechanical disruption and partly  due to isciiaemia, as 
the venous circulation, then the a r te ria l supply is  interrupted by 
the rising  p ressu re  within the haematoma. It is  thought that, 
as the healing p rocess proceeds, muscle fib res a re  replaced by 
fibrous tissue, which may produce contractures, particu larly  in 
the calf and forearm  muscles (Trueta, 1966). A ra th e r unusual 
feature of an untreated m uscle haematoma is the development of 
a chronic haematoma (pseudotumour) which may grow to large 
proportions and produce erosion of adjacent bones and other tissues.
'Muscle haematomata do not usually p resen t a diagnostic 
problem as they often develop in a peripheral situation but if they 
occur within the abdomen the diagnosis is m ore difficult. In 
the f irs t section of th is chapter we describe changes in serum  
enzyme activ ities after muscle bleedmg. This we believe can be 
used as the basis of a te s t to prove the presence of intram uscular 
bleeding. In the second section the use of ultrasonography is 
described in the measurement and localisation of muscle haem ato­
m ata and in the th ird  section is described the diagnosis and investi­
gation of a patient which chronic haematomata (pseudotumour) in the 
pelvis resulting from untreated bleeding into the iliacus m uscles.
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(fo) Serum enzyme changes after intram iiscular
bleeding
Introduction
Creatine kinase (adenosine triphosphate: creatine
phosphotransferase; CK) catalyses the reversib le  tran sfe r of 
phosphate accorcimg to the equations:
creatine phosphate 4* adenosine 5*-diphosphate creatine
IgHU. 0
-i- adenosine 5’-triphosphate.
This enzyme is  found in abundance in both skeletal muscle 
(Oliver, 1955; Tanzer and Gllvarg, 1950) and cardiac muscle 
(Colombo et a l . , 1862). Estim ation of the serum activity is 
widely used as a diagnostic aid in human disease (Ebashi et a l . ,
1959; Okinaim et a l . , 1961; Dreyfus, I960 (a); Dreyfus, i960 (b)) 
particu larly  with regard  to  diagnosis of prim ary skeletal m uscle 
d isorders and in m yocardial muscle damage after occlusion of the 
coronary a r te rie s . D iseases of skeletal muscle which may 
produce elevation of serum  creatine kinase a re  thyrotoxic myopathy, 
myasthenia gravis, endocrine and electrolyte disturbances (Hess, 
1964) and also poisoning with hypnotic drugs (Wright et a l . , 1971). 
Serum CK levels may also be of value in the diagnosis of p ro - 
clinical m uscular dystrophy and detection of the fem ale c a rr ie rs
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of the Duchenne type of m uscular dystrophy (Okinaka et a i . , 1961; 
Dreyfus, 1960 (a)). High levels of CK have also been reported  
in patients who have suffered extensive injuries in road or industrial 
accidents and also following m ajor surgical procedures (King, 1970).
A transien t r is e  ilrthe level of serum  CK may occur after 
recent strenuous m uscular exercise (Colombo et a l . , 1962; Graig 
and R oss, 1963; Schneider and Heise, 1963) and after severe 
epileptic se izu res (Wilson, 1971). Sim ilarly, elevation of 
lactate dehydrogenase (DDE) and aldolase has been reported  after 
prolonged m uscular exercise (Baumann et a l . , 1962; R em m ers 
and Kaljot, 1963),
Relatively sm all amounts of creatine kinase a re  also found 
in brain , smooth m uscle, kidney and liver (Colombo et a l . , 1062) 
but diseases of these tissu es do not usually give r is e  to diagnostic 
levels of enzyme activity in the serum.
Changes in serum  levels of creatine kinase, lactate dehydro­
genase, aldolase, aspartate  and alanine amino -transferases (GOT, 
OPT) were determ ined in patients with haemophilia and Christm as 
disease who had suffered haem orrhage into m uscles either spon­
taneously or as a resu lt of traum a.
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Methods and materials
Ail enzymes w ere assayed by initial reaction  ra te  procedures 
at 37*^0, The transaminases and lactate dehydrogenase assays 
were ca rried  out on the LKB 8600 reaction ra te  analyser using 
Boehringer te s t combination reagents, Boehringer k its  w ere 
also employed for estimating aldolase and creatine kinase activities 
inlially on a Unicam SP8ÛÔ, and la tterly  on a Unicam SP1800 
recording spectrophotom eter with tem perature control by a circulating 
Heto w ater-bath. Enzyme activ ities are  expressed m  International 
Units (international Union of Biochem istry, 1961 and 1965). An 
addendum on the nomenclature of enzymes is found in Table 8.
Normal ranges of activities established in a hospital 
patient population by tnm cated probit analysis (Neuman, 1968) were 
as follows; asparta te  am inotransferase (GOT) 9 - 3 5  IÜ/litr e , 
alanine am inotransferase (GPT) 5 - 26 lU /li tre , lactate dehydrogenase 
(LDH) 115 “ 465 ÏÜ/ l i t r e ,  aldolase 0 - 6  ïü / l i t r e  and creatine 
kinase (CK) 0 - 100 ïü / l i t r e  at a reaction tem perature of 37^C.
Higher norm al ranges (98 p er cent confidence lim its) have been 
obtained with the same assay procedures in a norm al healthy non- 
hospital population giving values of 10 ™ 37 lU /  litre  for aspartate
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am inotransferase, 6 ™ 37 IÜ /litre for alanine am inotransferase 
and 0 ™ ISO IÜ /litre for creatine kinase (McQueen et a l . , 1972).
Electrophoretic separation of lactate dehydrogenase isoenzymes 
was performed as previously described (Forbes et a l . , 1971).
A ssays of antihaemophilic factor were performed by the 
method as described by M argolis (1958) and modified by Brocken- 
ridge and Hatnoff (1962). Clinical grading of the severity  of the 
defect was as described by Biggs and Macfarlane (1963).
Estim ation of the serum  levels of enzymes was under­
taken in a se rie s  of forty-one control patients with haemophilia 
or Christm as d isease. They were all in-patients in hospital and 
had been rested  in bed for at least twenty-four hours. All had 
some clinical bleeding problem , eg. haem aturia, haemoptysis, 
haem arthrosis, haem atem esis and melaena or epistaxis. None 
had clinical evidence of m uscle bleeding or of m uscle disease.
Ten patients with haemophilia or C hristm as disease with 
obvious or suspected m uscle haematomata w ere investigated and 
daily estim ations of the enzymes were ca rried  out; clinical 
details a re  shown in Table 10. Serial blood sam ples w ere taken 
from  the tim e of adm ission until the enzyme levels had returned to 
baseline values.
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Results
Normal levels of serum  enzymes in haemophiliac patients without 
muscle liaematomata:
The re su lts  a re  shown in Table 9. The mean level of 
creatine kinase is  32.7 ÎCJ/ l i t r e  with a standard deviation of 
-t-20,2 ÏÜ/ litr e . When the results are shown on a histogram (fig.
16) there  is  a skew to the left. The upper limit of normal of CK 
for healthy rested  volunteers in our laboratory is  100 ÎÜ/ l i t r e .
The mean value in haemophilia for LDH was 271 lU /li tre  with a 
standard deviation of +102-4 ID /litre . The normal upper lim it in 
healthy volunteers in 460 ÎÜ / l i t r e .  There is  no significant 
difference in these results from the normal population.
The mean levels for GOT and OFT a re  shown. Five patients 
of the forty-one showed biochemical evidence suggestive of hex^atitis 
and the ir values were eliminated from the study.
Enzyme levels in haemophilic patients with m uscle haematomas 
There w ere significant r is e s  in creatine kinase in all ten 
patients. The tim e taken to reach the peak CK activ ities varied 
from 36 hours to 96 hours with a mean of 86 hours after onset of 
the haematoma. All patients showed a significant r is e  of CK above 
the baseline level within 24 hours of the onset of clin ical symptoms.
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Fig. 17 shows se ria l estim ations of CK and LDH in one rep resen t­
ative patient; the peak levels of the enzymes attained in all the 
patients a re  shown in Table 11. In three of the patients with 
very sm all m uscle haeraatornas, the peak level of CK is  relatively 
low and only a little  above the upper lim it of normal, but all s tarted  
with low levels of CK activity and showed the same pattern  of 
elevation after injury as the others. LDH was elevated above 
the norm al range in only th ree  patients despite se ria l estim ations. 
E lectrophoresis consistently showed the pattern 1 ) 2 ) 3 ) 5 ) 4 .
One of these patients (patient 2) had evidence of duplication of LDH. 
and th is case has already been reported (S'orbea et a l . , 1971).
Serial estim ations in a ll ten patients showed a r is e  in LDH activity 
above the baseline for that individual patient. One patient had 
transient elevation of GOT (patient 1) and two had transien t elevation 
of GPT (patients 1 and 9). Aldolase was slightly elevated in patient 3. 
Discussion
In th is study the only enzyme in which a consistent r ise  
was found after m uscle haematoma formation is creatine kinase.
The *’normaT^ activity in serum is  probably derived from  muscle 
and In a healthy population the levels are  influenced by the degree 
of m uscular activity (Griffiths, 1966). The low levels found in the
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general haemophilic x^opulation, as evidenced by the skew to the 
left in the histogram  (fig. 16) may perhaps reflect the inactivity of 
these patients due to the fear of inducing bleeding and to the ir 
sedentary occupations.
Within a few hours of the occurrence of m uscle bleeding, 
there was a r is e  in level of creatine kinase which reached a peak 
at a  mean of 56 hours after onset of symptoms and persis ted  for a 
further forty-eight hours before falling to norm al values by the 
fourth day after injury. The extent of haematoma formation in 
muscle was difficult to a ssess  clinicaEy but there appeared to be 
a crude positive correlation between the size of haematoma and 
the peak level of CK activity. LDH, GOT, GPT and aldolase showed 
no consistent r is e  after muscle bleeding.
Determ ination of the isoenzymes of LDH by electrophoresis 
was generally unhelpful. One patient (patient 1) had duplication of 
LDH. which was probably due to the large amount of plasm a concen­
tra te  (cryoglobulin precipitate) infused during and immediately after 
surgery to rep a ir a  ruptured u re te r (Forbes et a l . , 1971). The 
other five patients on whom LDH isoenzymes w ere estim ated showed 
a pattern  1 ) 2 ) 3 )  5 ) 4 .  This probably rep resen ts  re lease  of LDH 
from red  ceils in the haematoma; however, the pattern  5 ) 4  may
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possibly rep resen t leakage of m uscle LDH.
The cause of the r is e  ia CK levels after exercise  and in 
disease sta tes of m uscle is not known. It has been suggested that 
it is clue to leakage of the enzyme through the sarcolem m a and it 
has been further suggested (Aefoi et a l . ,  1962) that GÏC is more 
likely to pass to the e^dracellular compartment than the other 
m uscle enzymes, because of its  high concentration and low mole­
cular weight (Schmidt and Schmidt, 1967). In m uscle haematomata 
the cause of the r is e  in GIC is not known. It is  uncertain whether 
actual cell death must occur to liberate CK but it has been shown 
in vitro that changes in cellu lar perm eability may perm it the 
escape of other in tracellu lar enzymes (Schmidt et a l . , 1983),
The m ajority of patients in th is se rie s  had m uscle haem at­
omata which w ere clinically obvious and presented no diagnostic 
problem s. Estim ation of CK, however, shows such a consistent 
elevation following m uscle bleedmg that it may be of value in the 
haemophiliac who presen ts with abdominal pain of obscure aetiology. 
Case 10 illu stra tes  the potential usefulness of CK estim ation as a 
diagnostic te s t. This patient presented with severe loin pain which 
was initially diagnosed as being due to pyelonephritis. However, 
the urine was s te rile  and both an isotope renogram  and an in tra -
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venous pyelogram w ere norm al. A lter infusion of plasm a, 
pain stopped and the patient was sent home. Similar symptoms 
recu rred  two weeks la te r and a pattern  of enzyme change sim ilar 
to that seen in association with muscle haematoma form ation was 
found (fig. 18), The diagnosis would seem  to have been bleeding 
into the sacrospm alis muscle.
It is suggested that estim ation of creatine .kinase may be 
of value in the diagnosis of occult muscle haem orrhage in patients 
with bleeding d isorders and it is possible that it may be of value 
in the differentiation of acute appendicitis from  haem orrhage into 
the ileo-psoas muscle, a recu rren t clinical problem  in haemophilia,
(c) U ltrasonic investigation of haematomata 
Introduction
Ultrasound techniques have been used in diagnosis since 
1945 when Dussik tried to m easure the transm ission  of ultrasonic 
energy through the intact brain. The sound used has a frequency 
in the order of 1 - 10 million cycles per second. It is produced in 
pulses of a few m icroseconds from a transducer and is  then passed 
into the tissue under investigation as a narrow beam. Different 
tissu es transmit and reflect ultrasound differently according to
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their physical p roperties , so that when the interfaces between 
the constituent elem ents of the medium are  concerned, a sm all 
proportion of the sound is reflected. On returning to the trans­
ducer, the reflected energy produces an electronic pulse which 
can be displayed on a cathode ray  oscilloscope. Simultaneous 
display of many such echoes as finite spots enables a correctly  
relationed two-dimensional image to foe displayed and th is is 
recorded on Polaroid film. The image is produced by reflection 
of sound from  interfaces within the tissues. By moving the probe 
with an angular rocking movement around the a rea  under investi­
gation a tissue may foe examined from  a variety  of directions to 
produce the compound "B" scan.
Ultrasound has been used as a diagnostic aid in a variety 
of clinical situations eg. differentiation of gynaecological tum ours 
(Donald et a l . , 1958), diagnosis of in tracerebral lesions (Jefferson, 
1959), obste trics (Willocke et a l , , 1967; Wiliocks and Dunsmore, 
1971) and in d iseases of the kidney and bladder ('Mountford et a l . , 
1971; Barnett and Morley, 1971). The present study was under­
taken to evaluate the use of ultrasonography in the diagnosis and
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localisation of haematomata in patients with bleedmg d isorders. 
M aterials
Seven patients w ere examined with clinical haematomata 
of m uscle. All had haemophilia or Christm as d isease of a severe 
grade and on© patient had a circulating anticoagulant. The clinical 
details a re  shown in Table 12.
The machine used in th is study was a "Diasonograph” 
scanner with a swept gain facility such that echoes arising  from 
deep s tru c tu res  w ere amplified to compensate for the absorption 
of acoustic energy in tissue.
The skin was liberally  coated with arach is oil to  provide 
acoustic coupling and compound "B" scans were perform ed in 
the longitudinal and tran sv erse  planes. The scans w ere perform ed 
in parallel to imaginary lines drawn through fixed anatomical 
landm arks, usually bony prom inences.
The machine sensitivity was adjustable and machine settings 
w ere recorded on the back of each scan.
R esults
A selection of Polaroid photographs from  the patients is 
shown in figs. 19 (a) (b), 20 (a) (b). All u ltrasonogram s showed 
that the haematomata w ere poorly transonic i. e. behaved as cystic
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lesions and were of varying consistency. The extent of the lesion  
was clearly defined both longltndinaily and transversely and as 
the reduction factor is 1 : 5 on the Polaroid picture this allows 
actual measurements of the haematoma size. All haematomata 
contained reflecting speckles.
Discussion
Pulsed ultrasound provides a reasonably simple, safe 
and repeatable diagnostic technique but it has not been used before 
in the investigation of haematomata. In our hands it has allowed 
accurate localisation and measurement of haematoma size and 
provided an objective method of following resolution with therapy.
It seem s probable that the interface of muscle and haema­
toma consists of compressed muscle fibres and it may be that the 
"speckles" within the haematoma consist of degenerating muscle 
fibres, nerves and blood vessels. B is apparent that in some cases 
(fig. 21) the haematoma remains localised and does not expand to 
fill the muscle belly. This may be a result of clotting of the 
extravasated blood by liberated tissue thromboplastin.
With therapy all these haematomata rapidly resolved and 
left no apparent residual damage. Repeat ultrasonography showed 
muscle echoes which w ere diminished in volume compared to the 
normal side.
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The fate of the blood clot is not known. Presum ably 
the red  blood cells are  digested by local tissue and white cell 
enzymes and the haemoglobin denatured to bilirubin which is 
then excreted by the liver. The fibrin clot is presum ably also 
digested in this manner as in no patient was there a significant 
elevation of fibrinogen degradation products (FDPs, FR-antigen) 
in the serum  (Forbes and Prentice, 1972).
Ultrasonography, therefore, offers a rapid effective 
method in the delineation of muscle haematomata and in a s se s s ­
ment' of the ir resolution.
(d) B ilateral pseudotumours of the pelvis in a 
patient with Christmas disease; with notes on 
localisation by radioactive scanning and ultrasonography.
Introduction
P seudotimiours in patienta with coagulation defects are 
ra re , the incidence in several large se ries  of haemophilic patients 
varies from  0. 5 to 2 per cent (Ahlberg, 1965; W essler and Avioii, 
1968; Gunning, 1966; Bayer et a l . , 1969). The m ost common 
sites are  the thigh and the pelvis but a sm all number of cases 
have been reported in the calves, feet, arms and hands. Bi-
87.
lateral pseudotumours have been recorded in only two patients; 
theme involved the cuboid bones of the feet (Chen, 1968) and the 
pelvis (Fraenltel et a l . , 2089).
Peeudotmnours are found in both haemophilia and Christ­
mas disease (Ahlberg, 1068; Revol, 1968; 8ilber and Chrieteneen,
1989; Bayer et a l . , 1969) despite the euggestion that Christmas 
disease patients tend to have a less  serious defect (Ratnoff, 1960; 
Ramgren, 1962). It is  of great interest that a pseudotumour has 
also been reported in a patient with a mild bleeding history and 
an Euitihaemophilic factor assay of 29 per cent (Pappas et a l . ,
1964).
In several of the case reports, including the original, 
there has been doubt about the diagnosis, the suspicion being that 
the destructive lesion might be osteogenic sarcoma (Starker, 1918; 
Becker, 1942; Nelson and Mitchell, 1962; Pappas et a l . , 1964).
In many of the cases where biopsy was undertalsen serious complications 
ensued including death from infection introduced at the time of the 
diagnostic aspiration or uncontrollable haemorrhage from the 
needle track (Starker, 1918; Abell and Bailey, 1960; Nelson and 
Mitchell, 1962; Silber and Cliristensen, 1989). Osteogenic
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sarcom a has been described in a haemophilic patient (Fraenkel 
et a l . , 1959) and should always enter into the differential diagnosis 
despite its ra re  occurrence.
We describe here the ease of a boy with severe C hrist­
mas d isease with b ila tera l pseiidotumours in the pelvis. We 
have used radiological techniques and ultrasonography to localise 
the tum ours. In addition scmtiscanning was ca rried  out using 
87m strontium , a  bone seeking radionuclide and 99m technetium 
which localises in tissu es  with large or abnormal vasculature. 
Scintiscan p ic tu res of known osteogenic sarcom a w ere compared 
with the appearances of the pseudotumours.
Methods
F or scintiscanning 87m strontium  (2 mCi) was given 
intravenously and 55 minutes la ter the lov/er abdomen, pelvis 
and upper fem ora w ere scanned in that order using a dual headed 
scintiscanner. A colour dot and photo scan was obtained. On a 
separate occasion a sim ilar procedure was ca rried  out 20 minutes 
after 99m technetium (10 mCi) had been given mtravenousiy.
Ultrasonography was perform ed using a Nuclear E n ter­
p rise s  Diasonograph.
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Cas© Report The patient is  now aged twenty-five years and 
has a severe degree of C hristm as disease with a zero  p er cent 
assay  of C hristm as factor. M his youth he experienced multiple 
bleeding episodes, involving especially the Joints, renal tra c t 
and after dental extraction. When aged nine years  he developed 
a painful tense swelling in the left groin associated with numb» 
ness down the front of the left thigh. He was seen in hospital 
at this tim e and the presence of an iliacus haematoma with 
com pression of the fem oral nerve was confirmed. X -ray of the 
pelvis showed a homogeneous soft tissue m ass m easuring 9 cms 
in diam eter overlying the left iliac cres t, encroaching the upper 
p a rt of the sacro -iliac  joint as well as the distal th ird  of the left 
psoas m uscle with no bone erosion. Treatm ent with plasm a was 
given for a week with some slight resolution of the m ass but the 
patient then defaulted from  further attendance.
In 1963 he developed a sim ilar pain and swelling in the 
right groin with a fem oral nerve palsy which was trea ted  in his 
home without p lasm a infusions. In 1964 he had a recu rrence  of 
pain in the sam e site  and thereafter was reasonably well except 
for recu rren t episodes of haem aturia and acute haem arthroses of
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loiees, ankles and shoulders. The patient was readmitted to 
hospital in 1971 having fallen and sustained a  frac tu re  of the 
right tib ia and the left patella.
Examination of the abdomen showed two large swellings 
arising  out of each side of the pelvis. Both w ere hard, non- 
tender and non-fluctuant. The swelling of the left w as la rgest, 
extending to just above the nmbilicits. There w ere b ila tera l 
fem oral nerve lesions with absent Imee Jerks and g ross wasting 
of both quadriceps.
P lain  X -ray  film s of the pelvis showed erosion of the 
Made of the ilium on the left side. Continuous with th is area  
of bone destruction there  was a soft-tissue m ass within which 
w ere a rea s  of calcification. O steosclerotic a rea s  were also seen  
in the ilium (fig. 22). On intravenous pyelography it was seen 
that the bladder and left u re te r  w ere displaced to the right.
The appearance of the low© r  end of the left u re te r  suggested 
further that it was held in fixed dilatation as a resu lt of its  involve- 
ment by the pseudotumour (fig. 23(a)). A barium  m eal and follow 
through confirmed the appearances previously noted, namely that 
both sm all and large bowel were displaced by the large left-sided
pseudotumour and also by a sm aller but presum ably sim ilar 
lesion on the right side (fig. 23(b)).
At th is Stage ultrasonography was performed with a 
view to confirming that there  were in fact two separate  m asses.
It was also considered that u ltrasonic ecamiing would constitute 
a sim ple and safe method of assessing  the effects of therapy on 
the size of the lesions. As expected, two d iscre te  lesions were 
shown (fig. 24).
Examination of the ultrasonographs showed that these 
lesions w ere poorly trans-son ic  i. e, were fairly solid s tructu res, 
and w ere of varying consistency. This together with the ir 
rather indistinct m argins, makes them indistinguishable from  
malignant tum ours such as an osteogenic sarcom a.
The scan pictures after 87m strontium and 99m technetium 
w ere sim ila r and only the 87m strontium  photo-scan of pelvis is 
shown (fig. 25). This shows a large round volume of abnormal 
uptalce in the right pelvis and an elongated volume of abnormal 
uptake extending la terally  and superiorly in the left pelvis. Both 
regions correspond to the sides of the pseudotumours. The general 
appearances a re  sim ilar to those we have found in known fem oral 
osteogenic sarcom a.
Discussion
At least forty-nine cases of pseudotumour in haemophilia 
have been recorded since the original case rep o rt of S tarker 
(1918) and of these twenty have involved the ilium (Forfota, 1931; 
P eterson , 1947; P ark s , 1956; Horowitz et a i . , 1959; Fraenkel 
et a l . , 1959; Silber and Christenson, 1069; Birk, 1960; Schwarz, 
1060; Nelson and Mitchell, 1062; Hall et a l . ,  1062; Kerr, 1968;
Caen et a l . ,  1064; Ahlberg, 1965; Goulston and McGovern, 1065;
Eibl et a l . , 1965; Revol, 1965; W essler and Avioii, 1968).
As suggested by VaMerama and Matthews (1066) haemo­
philic haem atom as may a rise  in muscle where they a re  confirmed 
by the tendinous attachm ents (simple cyst), or in a m uscle with a 
large periosteal attachm ent and produce cortical thinning by in te r­
ference with bone nutrition; alternatively they may a r ise  from  a 
haematoma which s trip s  the periostium  from  the cortex until lim ited 
by an aponeurotic or tendinous attachment. It is  difficult, in 
re trospect, to determ ine the site  of origin of this patient’s  pseudo- 
tum ours but the initial episodes of pain and fem oral nerve com pression 
suggest strongly that they started  as haematomata in the iliacus 
m uscle (Goodfellow et a l . , 1967). The lesion on the left has
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probably been presen t for sixteen years and the lesion on the 
right for eight y ears . As judged both clinically and radio- 
logically the left psendotiitmour has grown over the y ea rs  but it 
is  not possible to say whether th is has occurred gradually or 
whether it is  s till enlarging, Serum enzymes levels w ere norm al. 
It seem s probably from the history that the two tum ours have 
arisen  from  separate s ites  and both the ultrasonic and photo 
scans suggest that they are  d iscre te  entities.
Although renal function, as judged by the blood u rea  
of 25 m g /100 ml and the creatinine clearance of 127 m l/m in  is 
excellent, there  is evidence both from  the I. V .P . and the isotope 
renogram  of obstruction to the u re te rs . Similarly there  is  as 
yet no in terference with bowel function but the barium  meal and 
follow through shows distortion of the norm al anatomy of the large 
and sm all bowel in the pelvis. There is one case report of 
pseudomembraneous colitis in a haemophiliac associated with 
pseudotumour of the pelvis producing obstruction to the rectum  
(Goulston and McGovern, 1965) and one of rupture into the sigmoid 
colon (Hall, 1961). There has been no case, to  date, of renal 
failure resulting from  com pression of the u re te rs .
T reatm ent of the peendotimioiir can foe either medical 
or surgical. Medical management has been advocated foy several 
authors (McMahon and Blackburn, 1969; van Creveld and King- 
ma, 1961; Caen et aL , 1964; Favre-GiHy et a l . , 1965). Correct- 
ion of the coagulation defect with long te rm  prophylaxis resulted  in 
resolution of the haematoma in one case (McMahon and Blackburn, 
1959) and prevented enlargem ent in another (Kerr, 1963). Success 
of th is treatm ent probably depends on the size of the haematoma 
as well as how long it has been present (Fraenkel, 195?). Long 
term plasm a or plasm a concentrate therapy ca rr ie s  its own 
hazards of transmission serum hepatitis or production of inhibitors 
to antihaemophilic or Christmas factor. Irradiation of these 
tum ours has fallen into disrepute (Horowitz et a l . , 1959) despite 
the initial encouraging reports of M uller (1942) and Chen (1965), 
When the lesion is  peripheral then surgery has a better 
chance of success (Britten and Salsman, 1966) particu larly  when 
amputation of the limb is ca rried  out. Surgery has been success­
fully performed on peeudotumours of the pelvic region (Hall et 
a l . , 1962; Bailey et a i . , 1965; W essler and Avioli, 1968), but 
because of th e ir size, position and proximity to v ita l struc tu res
the resu lts  have been poor. Steel et al. (1969) however advocate 
rad ical surgery for iliac pseudotumours but we feel the only hope 
of trea ting  th is  patient is with long term infusions of C hristm as 
factor concentrate. This has now been given for four months 
but no change in size of the tumour has been noted either clinically 
or on ultrasonography.
F rom  studies of the operative case notes of the patients 
undergoing excision of these tum ours they appear to foe extremely 
vascular and p resen t m ajor technical problem s of haem ostasis. 
M acroscopic and histological examination confirm s the presence 
of large vessels in the outer fibrous zona of the capsule (Fraenkel 
et ai. p 1959; de V alderram a et a l . , 1965) and th is would escplain 
the localisation of both 87m strontium  and 99m technetium in and, 
especially around, the tumour in the pelvis.
Both ultrasonography and radioisotope scanning have 
failed to differentiate the pseudotumour from an osteogenic sarcom a 
but they offer methods of p rec ise  localisation and m easurem ent of 
the size of the tum ours and should provide an objective assessm ent 
of the efficacy of plasm a therapy.
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CHAPTER 5 
I)EBr&AL I&KTRj&CTICMK liAEIWCWPJBrLlA
(a) Introduction
Dental extraction is  a necessary  evil in the life of every 
haemophiliac patient and early  case reports in the lite ra tu re  a re  
spiced with dram atic ta les  of exsanguination and death after 
extraction of a single tooth (Davies, 1826; Craig, 1826); for 
example, the medical student whose case was recorded by Coates 
(1828) had a single tooth esdracted and lost half a gallon of blood 
in twenty-four hours; the bleeding lasted ten days and the entire 
quantity of blood lost was estim ated at "not le ss  than th ree  gallons". 
Because of these problem s dental extraction was specifically 
contraindicated (Legg, 1872). Exsanguinating haem orrhage from  
such a sm all site  obviously tried the patience and ingenuity of 
generations of physicians who used many preparations of chemicals 
(mercury, silver n itra te , alum, gallic acid, turpentine, strychnine, 
tannin, per chloride of iron) and many surgical procedures (phlebo­
tomy, the red  hot iron, suturing of the socket, p re ssu re  from  a 
cork or a  bullet, a r te ria l compression) with little  success. Unfor­
tunately all these methods were doomed to failure and indeed some
exaggerated the problem; death is  recorded after therapeutic 
phlebotomy and m assive haem orrhage always occurred when 
the sloughs separated after use of "the red-hot iron".
The f irs t m ajor advance came with the introduction of 
blood transfusion (Weil, 1906). Unfortunately, blood used for 
transfusion purposes contained only sm all amounts of an ti­
haemophilic factor and it was not unusual for a  patient to rem ain 
in hospital for 6 - 8  weeks and require twenty pints of blood 
after extraction of a single tooth. With the advent of plasm a 
therapy ('Feissley, 1924) dental extraction became le ss  dram atic 
but s till extractions of many teeth simultaneously lead to excess 
bleeding. Many types of splints w ere devised to pro tect the 
healing socket and prevent damage to the friable blood clot (Wishart 
et a l , , 1957). These probably provided some advantage but w ere 
uncomfortable to w ear and, if ill-fitting, produced ulceration and 
haem orrhage at the alveolar margin.
With the advent of potent concentrates of both human 
and animal antihaemophilic factor tooth esdraction became a 
routine, trouble-free event, even in patients with circulating anti­
coagulants (Biggs and Macfarlane, 1966), Awareness has since
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increased of the problem s of serum  hepatitis and circulating 
anticoagulants to AHF induced by the infusion of plasma products 
and a search  has been made for agents which might reduce tra n s ­
fusion requirem ents.
It is thought that, in haemophilia, bleeding from the 
tooth socket is  due, in part, to an imbalance between the deposition 
of fibrin clot and digestion of th is clot by the enzymes of the 
fibrinolytic system . Attempts have therefore been made to 
prom ote haem ostasis by inhibition of fibrinolysis using the anti­
fibrinolytic drug aminocaproic acid (EACA, E p s to p ro n  (Reid et 
a l . , 1964; Cooksey et a l . , 1966; Tavenner, 1968; Walsh, et a l . , 
1971X
These tr ia ls  of EACA have, however, been largely un­
controlled and the c r ite r ia  of efficacy of th is drug have also varied 
from  tr ia l  to tr ia l , eg. Cooksey et ai. (1966) and Tavenner (1968) 
used transfusion requirements and days spent in hospital; others 
(Alagille at a l , , 1965; M arini at a l . , 1966; Giordano et a l , ,
1967; Paddon, 1967) compared visible Mood loss and some 
(Reid et a l . , 1964) used the fall in the haemoglobin level. Walsh 
et ai. (1971) in th e ir w ell-controlled, double blind trial used the 
amount of plasm a concentrates given as the index of benefit. We
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describe here a double blind tr ia l  of tranexam ic acid in dental 
extraction in patients with haemophilia and C hristm as disease 
in which m easurem ent of the Mood loss was ca rried  out using 
labelled red Mood cells. Observations w ere made at the 
sam e tim e of possible toxic effects of tranexam ic acid.
(b) Methods and material 
Design of the trial.
Twenty-eight patients aged from  thirteen y ears to sixty- 
five years were studied during thirty-tw o separate episodes of 
dental extraction. Twenty patients had classical haemophilia 
and eight had Christmas disease.
W orm ed consent was obtained from all the patients or 
from the parents before they were included in the tr ia l . A history 
of haem aturla in the previous four weeks, or the presence of red  
cells in a fresh  sample of urine, w ere absolute contraindications 
to inclusion in the tr ia l.
Using a  double blind technique and random allocation to 
the tr ia l  the patients received either tranexam ic acid (1 gm th ree 
tim es per day) o r placebo tablets. Therapy was sta rted  two 
hours before extraction and continued for a five day period.
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Blood loss was m easured using ' Cr labelled red  blood 
cells as described by Watson and Dickson (1964). This entailed 
separate collections of o ral secretions and faeces over 24 hour 
periods for five days. On day 4 the patient received a  purgative.
Each patient received the factor VIE or DC equivalent 
of 1000 ml of human plasm a intravenously one hour before extraction 
and also tetracycline (280 mg four tim es p er day). Infection 
at the site  of e^ctraction is thought to be a contributing factor to 
contribution of bleeding. All extractions w ere ca rried  out under 
local anaesthetic. In the event of excess bleeding from  the 
sockets in the five day period, a clinical decision was made to 
infuse further blood products. Sufficient plasm a or plasm a 
concentrate was given only to stop the bleeding. The clinician 
was not aware which tablet the patient was receiving, nor the 
re su lts  of the laboratory assays.
F acto rs VIII and DC were assayed using the method of 
M argolis (1958) as modified by Breckenridge and Hatnoff (.1962).
T ests of fibrinolysis were performed as previously described by 
McNicol end Douglas (1964) and assessm ent of param eters  of 
liver and renal function, w ere perform ed by standard Autoanalyser 
techniques. Haematological indices w ere m easured on the Coulter-8
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coimter and erythrocyte sédimentation ra te  by the method of 
Westergren (1020). Inhibitors of factor V ni and DE w ere 
sought using the method of Biggs and Bidwell (1959), Standard 
12 lead electrocardiographs were made in all patients before 
and at the end of the tr ia l. All patients in this se rie s  had the 
extractions perform ed under local anaesthesia, including where 
appropriate, inferior dental block. ' No side effects resulting 
from  th is procedure w ere observed in any patient. Details of 
the patients in both groups a re  shown in Table 18.
Results
The data concerning blood loss is shown in Table 14, 
Teeth extracted;
As the amount of bleeding is partly  a reflection of the 
extent of the wound area , the number of roots rem oved is con­
sidered rather than the number of teeth removed. The number 
of roots extracted in the tranexamic acid group (mean 5. 5) was 
not significantly different from  the placebo group (mean 6. 9). 
Blood lo ss:
The mean volume of blood lost per patient in the placebo 
group was 85 mi and in the tranexam ic acid treated group 61 ml.
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There was a wide range in the total loss per patient. The blood 
loss per root extracted was IS. 3 m l/ro o t in the placebo group 
and 8 ,9  ml in the tranexam ic acid group. This corresponded to 
a mean fall of 1.4 gm per 100 ml in the haemoglobin level and 
5 per cent fall in haem atocrit in the placebo group and a fall of 
0. 3 gm per 100 ml in the haemoglobin and a 0. 9 p er cent fall 
in haem atocrit in the tranexam ic acid group. Using a rani^ sum 
teat (Mann-Whitney U teat) there  is a statistically  significant 
difference between the blood loss in the placebo group and the 
AMCA group (0.01 ( p ( 0* 025).
Replacement therapy:
The resu lts  a re  shown in fig. 26. In only two patients 
was it clinically necessary  to transfuse plasm a or plasm a con­
centrate in the tranexamic acid group a lter the initial dose. One 
of these patients had e^draction of twenty-two roots, the la rgest 
number in th is se rie s . In the placebo group eleven patients 
required multiple infusions during the five day tr ia l  period and five 
patients required no replacem ent therapy; all these had a mild or 
m oderate degree of defect. The patient requiring the greatest 
amount of replacem ent therapy was in the m oderate degree of
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haemophilia and had six  roots extracted. He was in the placebo 
group.
P lasm a fibrinogen levels and erythrocyte sedimentation ra te :
The re su lts  a re  shown in fig. 27. Significant elevation 
of fibrinogen is found in the placebo group on day 5 after e^ctraction. 
This finding is  m irro red  in the erythrocyte sedimentation ra te  
which is also significantly increased (p = 0.05).
Urokinase sensitivity and euglobulin lysis tim e;
The re su lts  a re  shown in fig, 28, As would be predicted, 
significant depression of ly sis  Is shown in the urokinase sen­
sitivity te s t after treatm ent with tranexam ic acid (p = 0.05),
Both trea ted  and untreated groups show a fall in the euglobulin 
lysis tim es indicating increased levels of circulating activator.
The inter group resu lts  are, however, not significantly different 
(p = 0.1); the tranexam ic acid is discarded in the supernatant 
during preparation of the euglobulin precipitate.
Renal and liver function tests;
Estim ations included serum  urea, bilirubin, alimline 
phosphatase, B. G. O. T . , 8, G .’P . T . , total pro teins, albumin 
and globulin. No significant differences w ere found between
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the tranexam ic acid trea ted  group compared with placebo.
Both groups showed a significant r is e  in the Mood u rea  after 
extraction (p = 0 ,05).
Electrocardiograph:
No changes are found after therapy in either group.
Side effects:
No side effects were reported in either group.
(c) Discussion 
It has been shown by many authors that surgery can be 
safely undertaken in haemophilia and Christm as disease if 
adequate replacem ent therapy with plasm a products is  provided. 
The c r ite r ia  for success of a new therapeutic agent in dental 
extraction must include a reduction in Mood loss from  the ex trac t­
ion site and also a reduction in the total requirement for plasm a 
replacement therapy. The use of tranexamic acid as an adjunct 
to conventional therapy in th is series of dental extraction ful­
filled both c rite ria ; post-operative bleeding and also the total 
volume of plasma product required, were both reduced.
Tranexam ic acid is the active trans-stereoisom er of 
aminomethyl cyclohexane carboxylic acid and it has been shown
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by M eiander et al. (1964) and Okamoto et al. (1964) to have 
powerful anti-fibrinolytic properties. The molecule has a 
coofiguratioii sim ilar to aminocaproic acid and liïœ amino­
caproic acid is a competitive inhibitor of plasminogen activation 
at concentrations in plasm a greater than 10 “M and a non­
competitive inhibitor of plasmin at concentrations greater than 
10" '1\4. These concentrations may be readily achieved in vivo 
(Dubber et a i . , 1965).
Tranexam ic acid had the advantage over aminocaproic 
acid of being about ten tim es m ore potent (Dubber et a l . , 1965; 
Meiander et a l . , 1965; Deiitseli and Fischer, 1968) and having 
minimal side effects. All Inhibitors of fibrinolysis when used 
m  patients with liaem orrhagic d isease have the potential danger 
of precipitating obstruction of the renal tra c t with unlysable 
clots (McNicol et a l . , 1961; Gobbi, 1967; Van Itterbeek et a l . , 
1968) however no patients in this study, who w ere all screened 
p rio r to therapy for the presence of haematuria,, showed evidence 
of th is complication.
Although the cause of post-extraction bleeding from  the 
tooth socket in the haemophiliac is not clear, it presumably
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rep resen ts  an imbalance between defective fibrin form ation 
to the abnormality in the in trinsic thromboplastin system  and 
the norm al rem oval of deposited fibrin by fibrinolytic enzymes 
produced by plasminogen activators locally and in the saliva 
(Albrechtson et a l . , 1958). It was noted that all patients In 
th is  se rie s  showed a fall in the euglobulin lysis tim es, indicating 
increased levels of circulating plasminogen activator. This 
has been recorded foy several authors in people under stress  
(Macfarlane, 1937; Biggs et a l . , 1947) and may be important 
in the light of the repo rt by Lucas et al. (1962) that extraction 
of teeth may foe safely ca rried  out in haemophiliacs under hypnosis 
without plasm a therapy. However, in the im m ediate post-extraction 
period the most im portant aspect of haem ostasis is probably 
defective fibrin form ation. In a recent study (Walsh et a l . , 1971), 
haemophilic patients who had the ir level of clotting factor ra ised  
to 50 per cent of normal by a single haem ostatic infusion before 
extraction ra re ly  bled before the th ird  post-operative day. This 
suggests that despite the transien t nature of the r is e  in the plasm a 
level of these factors the haem ostatic effect is  prolonged. Bleed­
ing after three days (up to six days) was commonly seen in our 
group of control patients and presumably represented digestion of
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the haem ostatic fibrin plug by fibrinolytic enzymes. Inhibition 
of these lytic enzymes by tranexam ic acid, as was manifested 
in the prolongation of the urokinase sensitivity te s ts , allowed 
fibrin  to rem ain in situ and presum ably expédited healing of the 
sockets. This greatly reduced the necessity to infuse plasm a 
products into our patients.
51We consider that m easurem ent of blood loss using Cr 
labelled red  blood cells offers a m ore accurate assessm ent of 
the effectiveness of therapy than fall in haemoglobin or days in 
hospital. However, in all patients, when bleeding was noted 
clinically, plasm a or plasm a products were immediately given 
and the effectiveness of tranexam ic acid must be judged against 
a combination of to tal blood lost and the amount of plasm a products 
infused.
There was no evidence of any toxic action of tranexam ic 
acid ill th is series of patients. There was however a significant 
r is e  in the mean blood u rea  levels in both groups after tooth 
e^dractlon. This probably resu lts  from  digestion of blood in the 
gut.
T'he complications of multiple transfusions are  well, 
known (de Gruchy, 1962). In haemophilia these may include 
production of inhibitors of antihaemophilic factor and serum  
hepatitis. It is a reasonable assumption that reduction of 
p lasm a requirem ents foy the use of tranexam ic acid will reduce 
the incidence of inliifoltorB and serum  hepatitis as well as 
reducing blood loss.
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CHAPTER 0
GASTROmTESTMAL BLEEDING IN HAEMOPHILm
(a) Introduction
M Mb review of 256 cases of bleeding d iso rders G ran- 
didier (1855) found gastrointestinal haem orrhage to be the second 
commonest cause of spontaneous bleeding and th is observation 
has been confirmed by Wilkinson et al. (1961) and Stuart et al, 
(1966). Many isolated case rep o rts  have appeared of the surgical 
management of bleeding associated with proven peptic u lc e r­
ation in haemophilia but no large se rie s  of cases of gastrointestinal 
haem orrhage was published until 1965 (Carron et a l . , 1965).
At that tim e about one third of deaths in the haemophilic population 
resulted from uncontrolled intestinal haem orrhage or its  sequellae 
(Nour-Eldin, 1961; Wilkinson et a l . , 1961).
In many cases no local source of bleeding was found 
(Britton, 1963) but in some the cause of bleeding was peptic 
ulceration (Desmond, 1955; Walker, 1955; van Creveld, 1957; 
Macfarlane et a l , , 1957; Handley et a l . , 1961; Ingram, 1962; 
Kerr, 1964(a)). In all of these case reports operative inter­
vention was necessary  because of m assive haem orrhage and all
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required  some variety  of gastrectom y.
The incidence, clinical features and sequellae of gastro ­
intestinal haemorrhage in haemophilia have been well documented 
by C arr on at al. (1965). They made a retrospective study of 
the case reco rds of eighty reg iste red  adult haemophilic patients in 
Newcastle and found fourteen out of eighty had suffered gastro ­
intestinal haem orrhage, twelve of these had a duodenal u lcer.
SbE of the patients with duodenal u lcer required  gastrectom y and 
one pyloroplasty and vagotomy. It was the conclusion of these 
authors that if a patient with haemophilia is found to have peptic 
ulceration he should have elective surgery after the f irs t gastro ­
intestinal bleed.
In the la st few years there  have been dram atic changes 
in the availability of potent concentrates of p lasm a to tre a t haemo­
philia and C hristm as d isease so it seemed worthwhile to re a sse ss  
the prognosis of gastrointestinal haem orrhage in these bleeding 
d isorders,
( b )  Patien ts and methods
All patients with haemophilia or C hristm as disease in the 
region who have had haem atem esia or meiaena in the past ten years
have been included in the survey. Clinical grading of severity 
of the bleeding defect was that described by Biggs and Mac­
farlane (1963) and assay of the antihaemophilic factor or C hrist­
m as factor was perform ed by the method of M argolis (1958) as 
modified toy Breckenridge and Hatnoff (1962), All patients 
underwent barium  m eal examination in an attem pt to determ ine 
the site  of bleeding. Duodenal or gastric u lcer w ere diagnosed 
only when an u lcer c ra te r  was visualised on the barium  meal 
and confirmed in the patients who underwent surgery .
Results
Thirty-two patients with 107 separate episodes of gastro ­
intestinal bleeding were found. This represents an incidence of 
25 per cent in the adult haemophilic population. Twenty-seven 
of the patients had classical haemophilia and five had C hristm as 
disease, Fifteen had a severe defect, twelve w ere m oderately 
affected and five w ere mildly affected. At the tim e th is survey 
was undertaken the mean age of the patients was 40.1 years the 
youngest being twenty-two years and the oldest six ty-six  years .
The average age of onset of the f irs t gastrointestinal 
haem orrhage was 3 1 ,6 years but there was a wide range, the
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youngest patient bleeding at age 6 years and the oldest at 63 
years . Wlien the age of onset of the f irs t symptoms of gastro - 
intestinal d isease is considered (dyspepsia or bleeding) the mean 
age was 30.6 y ears . This difference was not significant. In 
patients with dyspeptic symptoms alone the average ago of onset 
was 30. 8 years .
The patients w ere then classified into two main groups 
according to whether they had symptoms of dyspepsia suggesting 
a clinical diagnosis of peptic ulceration. The f irs t  group con­
sisted  of seventeen patients who had a history of dyspepsia and the 
second group of fifteen patients had no history of dyspepsia. This 
is  obviously an artific ia l division but from  the clinical point of view 
it serves to separate  the patients. The relevant clinical details 
of the two groups a re  shown in Tables 15 and 16.
Age
There is  no significant difference between the ages of 
these two groups, the mean age in the eupeptic group being 38. 5 
y ea rs  (range 22 - 66) and the mean age in the dyspeptic group 
40.9 years (range 17 - 60).
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Severity of haem ostatic defect
There is a significant difference between the two groups 
when the severity  of the haem ostatic defect is considered. As 
seen in Table 3 the eupeptic group contains eleven patients with 
a severe defect, th ree  with a m oderate defect and one mild defect, 
hi the dyspeptic group there  a re  four with a severe defect and nine 
with a m oderate defect and four mild cases. The differences 
in numbers of the severe and moderate patients are highly signi™ 
iicaat (X  ^ = 4, 5, p < 0.05 > 0. 02).
Blood group
In the thirty-tw o patients there a re  eighteen with blood 
group O (56.25 per cent), nine with blood group A (28.2 per cent), 
th ree in gi*oup B (9.4 p er cent) and two in group AB (6.15 p er cent). 
When the seventeen patients with radiologically proven peptic 
u lcer a re  considered there  a re  eight in group O (47 p er cent), sbi 
in group A (85, 8 per cent), two in group B (11. 8 per cent) and one 
in group AB (5 .9 per cent). These resu lts  a re  not significantly 
different from  the incidence of blood groups in the West of Scot­
land.
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Age at which f irs t  bleeding occurred
There was no significant difference between the groups 
in the age at which bleeding occurred. This was 31.4 years 
(range 6 - 50) in the eupeptic group and 31. 6 years in the dys­
peptic group.
In the dyspeptic group clinical symptoms suggestive of 
peptic ulcer preceded bleeding in eleven patients and in th ree 
symptoms sta rted  at the tim e of the f irs t bleeding episode. In 
th ree  other patients symptoms did not appear til l afte r the f irs t 
gastrointestinal haem orrhage. In the eleven patients with dys­
pepsia preceding bleeding there was an average period of 4. 6 
years  (range 1 - 13 years) with ulcer type symptoms before 
haem orrhage.
Number and type of bleeding episodes
In the thirty-tw o patients studied, a to tal of 107 episodes 
of gastrointestinal bleeding w ere recorded. Eighty episodes 
of bleeding sta rted  with haematemesia and twenty-seven with 
meiaena. In the seventeen patients in the dyspeptic group there 
w ere fifty-eight episodes of bleeding (mean 3.4, range 1 » 15) 
and in the eupeptic group of fifteen patients a to tal of forty-nine
bleeding episodes (mean 3. 3, range 1 - 14). In patients with 
proven peptic u lcer the mean (4. 5) number of bleeds is  higher 
than the mean for the re s t of the patients (2,1). This resu lt is 
significant (t -  2. 61, p ( 0.01).
Association of bleeding with salicylates or alcohol
Fourteen of the 107 episodes of bleeding w ere associated 
with p rio r ingestion of salicylate or alcohol. In both groups there 
w ere four episodes associated with salicylate ingestion and three 
with alcohol ingestion. Patient 3 was admitted with haem atem esis 
on two occasions after drinlûng heavily and on th ree  occasions 
after taking salicylates.
Time between onset of bleeding and diagnosis
In the dyspeptic group four patients w ere shown on barium  
meal examination to have peptic ulceration before the f irs t Meed 
but nine had no radiological proof of u lcer until some years  after 
the f irs t bleed (mean length of tim e = 5.4 years , range 6 months - 
12 years) despite having u lcer symptoms. Two had positive 
barium  m eals at the tim e of bleeding and in two others no bleeding 
source has been found. In only nine of the thirty-tw o patients
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was the probable source of bleeding shown radiologically at the 
tim e of the f irs t  episode of haem atem esis or meiaena.
Diagnosis
In the dyspeptic group, fifteen of seventeen patients 
had peptic ulceration; twelve had duodenal ulceration, two gastric  
ulceration and one both duodenal and gastric u lcers .
In the eupeptic group, eleven patients had norm al barium  
m eals, two had radiological evidence of active duodenal ulceration, 
one had a haematoma of the duodenal wall end one had intestinal 
obstruction with volvulus of the ileum as a resu lt of an ileal 
haematoma. Patient 6 had chronic myeloid leukaem ia and was 
on busulphan treatm ent at the tim e of bleeding but was not throm bo­
cytopenic. One patient (number 11) exsanguinated from  alim ent­
ary bleeding despite m assive infusions of blood (150 pints), plasm a, 
cryoprecipitate and porcine antihaemophilic factor. No rad io ­
logical lesion was dem onstrated. He was shown to have a potent 
antihaemophilic factor inliibitor and at post m ortem  was found to 
have multiple erosions throughout the length of the gastrointestinal 
trac t.
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&%r gical management
Seven patients have undergone surgery. Only one patient 
required an emergency procedure. The details a re  shown in 
Table 4, Four patients (7, 12, 20 and 28) had pyloroplasty and 
vagotomy for duodenal ulceration and two (patients 10 and 31) 
underwent partia l gastrectom y for gastric  u lcers . Only one 
patient has done badly after surgery (patient 7), He has had 
eight haem atem eses post-operatively all of which have been 
trea ted  conservatively. Insulin te st meal has shown that vago­
tomy is incomplete the pH of the gastric  secretion falling to pHl. 
Two other patients (20, 31) have symptoms of mild dumping which 
have responded to conservative management. Patien t 30 developed 
a  potent antihaemophilic factor inhibitor which was demonstrated 
on the seventh post-operative day and patient 12 developed serum  
hepatitis as a resu lt of cryoprecipitate therapy given during the 
operative period.
Discussion
G astrointestinal bleeding is a common feature of haemo­
philia and C hristm as disease tout it may be extrem ely difficult in 
the individual patient to dem onstrate the basic pathological lesion.
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în th is survey we have shown that 25 per cent of our adult haemo- 
phiiic patients have had gastrom testinal bleeding. Of these 53 
p er cent have peptic ulceration, gastric  or duodenal. The 
incidence of proven duodenal u lcer is  13.2 per cent of the adult 
haemophilic population, an incidence which is  significantly higher 
than that found by Doll and Avery-Jones (1951) and ïllingwortîi 
(1953) in the general population. It is  well established that th is 
group of patients a re  subjected to abnormal s tre s s  (Early, 1959; 
Agle, 1964) and th is may precipitate a bleeding episode (Legg,
1872; Browne, Mally and Kane, 1960; M attsson and G ross, 1960). 
It is also possible that the delayed healing in haemophilia, such 
as is  seen with a tooth socket, may also play a part in the con­
tinuation of bleeding.
There is a significant difference in incidence of severely 
affected patients in the eupeptic and dyspeptic groups. In the 
eupeptic group, where there is a preponderance of severely affected 
patients, it is  possible that bleeding occurs readily when the 
mucosal injury is  minimal, w hereas in the dyspeptic group, where 
the majority of patients a re  only moderately affected, the mucosal 
lesion m ust be more advanced before bleeding occurs.
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The absence of symptoms in the presence of active 
duodenal u lcers  is well known. Dunn and S tte r  (1962) found 
evidence of duodenal ulceration radiologlcally in 31 p er cent of 
206 patients who had no ulcer symptoms. Duodenal ulceration 
was shown radiologlcally in two of our patients (7, 16) who have 
had no symptoms.
The average age at which the f irs t gastrointestinal 
bleed occurred was 31. 6 years in the whole group and 29 years  
in the patients who w ere eventually shown to have duodenal u lcer. 
This is slightly older than found by Carron^ Boon and Walker 
(1965) in haemophilia and also by Doll and Avery^Jones (1951) 
in the general population. In the patients with dyspeptic symptoms 
the finding of an average of 4. 6 years history before the first 
haem orrhage is  s im ila r to that found in patients with peptic ulcer 
in the general population by Goghill and Willcox (I960).
There is  a preponderance of blood group O in th is se rie s  
of patients (56. 5 p er cent) but th is is not significantly different 
from the frequencies of ABO groups in the West of Scotland 
(Wallace, 1954), There is  no relationship between ABO blood 
groups and haemophilia (Chaudhuri, 1960; Wilkinson et a i . , 1961)
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but there is a positive correlation between peptic u lcer (especially 
duodenal u lcer) and blood group O (Aird et a l . , 1954) and also 
between liability to haem orrhage and blood group O (Langman 
and Doll, 1965). A predominance of blood group O in haemo- 
philic patients with gastrointestinal bleeding has been reported 
previously by C arron et al. (1965).
Ingestion of aspirin and aspirin containing components 
produces a defect in aggregation of p latelets (Zucker and Peterson, 
1968) and in patients with coagulation defects may produce severe 
haem orrhage (Kaneshiro et a l . , 1970). All our patients with 
coagulation defects have been warned about the effects of s a li­
cylates and th is probably accounts for the low incidence of sa li­
cylate induced bleeding in th is se rie s  compared with patients with 
non-haemophilic haem atem esis (Alvarez and Summer skill, 1958).
The recurrence ra te  of gastrointestinal haem orrhage is 
high; tw enty-three of the patients have had m ore than one episode 
and one has had fifteen separate episodes. All of these recu rrences 
have been trea ted  conservatively with plasm a concentrate and 
Mood if necessary . No patient has required emergency surgery 
for intestinal bleeding per se; patient 30 required  emergency surgery
for intestinal obstruction due to volvulus of the ileum. Only 
one patient died of haem orrhage and he had been shown to have 
a potent antihaemopiiilic factor inhibitor. This low m ortality 
is in keeping with the figures of Fraenkel and Truelove (1955) 
for non-haemophilic haem atem esis in which the prognosis was 
shown to foe dependent on the age of the patient. This low 
m ortality shows an improvement from  the 33 p er cent m ortality 
in haemophilic gastrointestinal bleeding quoted by Hour-Eldin 
(1961) and it would seem  likely that this is due entirely  to the 
availability of potent concentrates of the appropriate coagulation 
factor.
The decision to advocate surgery is  extrem ely difficult 
and on balance we s till tend to take a conservative approach.
The criteria for surgery in non-haemophilic patients with peptic 
u lcer (Hunt, 1952) do not apply to the haemophiliac. In the sm all 
se rie s  trea ted  surgically th ree  patients have had an excellent resu lt, 
two have mild dumping syndrome and two have had further gastro ­
intestinal bleeding. Against th is must foe balanced the production 
of serum  hepatitis and antiliaemophilic factor inhibitors from  
multiple infusions of plasm a products If the patients a re  trea ted  
conservatively.
CHAPTER
ELECTROENCEPHALOGRAPHY IN HAEMOPHILIA 
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In tracranial bleeding is  one of the commonest causes 
of death in patients with haemophilia, the m ortality  ra te  being 
over 70 per cent (Singer and Schneider, 1962; Alagille and 
Charles, 1964; P o tte r, 1965); most episodes of bleeding are 
spontaneous the re  being no history of traum a (Byring et a l . ,
1965X
It has been suggested by Denton and Goiirdeau (1970) 
that in haemophilia subclinieal bleeding into the central nervous 
system  occurs frequently and might eaqplain the high incidence of 
emotional instability and psychiatric d isorders documented by 
Agle (1964). Evidence presented by these authors using e lec tro ­
encephalography suggested that abnormal tracings w ere present 
in about SO per cent of haemophilic children who had no clinical 
evidence of previous in tracereb ra l bleeding.
As th is suggestion was out of keeping with our own 
clinical experience of a  large adult haemophilic population we 
undertook a survey of th irty  consecutive adm issions to the Haemo­
philia Centre.
93.
Methods and m aterials
T hirty patients with an age range from  eleven to fifty- 
four years of age w ere studied. Twenty-five patients had 
c lassical haemophilia and five had Christm as disease. Using 
the clinical grading system  of severity  of the d isease as  des­
cribed by Biggs and M acfarlane (1963), fifteen of our patients 
w ere severely affected, eight w ere moderately affected and seven 
had a mild defect. All patients had a neurological examination 
and a standard electroencephalograph (International Federation 
10/20 system ). T racings w ere interpreted by two independent 
experts as norm al, m inor abnormality or g ross abnorm ality.
Results
The resu lts  a re  shown in Table 19, G ross abnorm alities 
w ere found in only two tracings. One of these patients had su s­
tained a subarachnoid haem orrhage and the other had overt epilepsy. 
Three other patients had minor abnorm alities in the ir tracings.
The only patient with clinical abnormality in the central nervous 
system  was the patient with the subarachnoid haem orrhage. 
Following treatm ent with plasm a concentrates the clinical and 
E, E, G. abnorm alities in this patient resolved.
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Discussion
With modern therapy, control of haem orrhage from  
sites  other than the brain  has improved dram atically (K err,
1963), In tracran ial haem orrhage therefore rem ains the m ajor 
b a rr ie r  to the severe haemophiliac achieving a life expectancy 
comparable to the general male population.
In th is imselected se rie s  only three patients w ere un­
expectedly found to have an E .E .G . abnormality. This figure 
(10 per cent) is within the norm al expected in a hospital population 
(Walshe, 1958), In none of these patients was there associated 
clinical abnormality, history of traum a or family history  of 
epilepsy. Our figures therefore differ markedly from  these of 
Denton and Gourdeau (1970) who found that 50 per cent of the ir 
haemophilic patients had an E, E, G. abnormality and those of 
L ittle and Hammack (1971) who found E.E.G. abnorm alities in 
all of six haemophilic patients examined. The reason for the 
discrepancy is not c lear. These patients w ere of the sam e range 
of severity  but w ere of different age groups. These authors 
surveyed a paediatric population in which the in terpretation of 
the E .E .G . is extrem ely difficult. The finding of an abnormal
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E .E .G , does not necessarily  indicate previous intracerebral 
bleeding as idiopathic epilepsy lias been previously recorded in 
haemophilia (Silverstein, 1964).
The severely affected haemophiliac is  subject to in tracranial 
haem orrhage throughout life but in individuals with disease of 
le s se r  severity , the peak incidence of bleeding appears to be 
in the later decades of life (K err, 1964(b)). The expectation 
therefore would foe that adult patients would have a higher incidence 
of E. E. G, abnormality than children, if the E, E. G. abnormality 
was due to previous bleeding. This we have not found.
Our figures suggest that abnorm alities in the elec tro ­
encephalograph a re  no commoner in haemophilia than in any 
other chronic d isease state.
SECTION 3
COMPLICATIONS OF TREATMENT
"When sorrows come they corns not 
single spies but in battalions. "
Hamlet, Act 4, 
Scene B.
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CHAPTER 8
SERUM HEPATITIS W  HAEMOPHILIA AND 
CHRISTMAS DISEASE
(a) Introduction
Virus hepatitis is an acute inflammation of the liver 
and in general the definition excludes infection due to recognised 
v iruses such as cytomegalovirus, coxsackie A and B, Herpes 
simplex, yellow fever and adenovirus. Two clinically sim ilar 
infections a re  described; infectious hepatitis (epidemic jaundice) 
caused by v irus A and serum  hepatitis (homologous serum  
jaundice, transfusion hepatitis, inoculation jaundice) caused by 
v irus B.
Serum hepatitis was f irs t described in 1885 by Lürman 
following an outbreak of jaundice amongst a group of shipyard 
w orkers vaccinated against smallpox with glycerinated "lymph" 
of human origin. It was then appreciated that jaundice could be 
transm itted  in cen tres where multiple injections w ere given such 
as venereal disease and diabetic clinics (MacCallum, 1943),
The introduction of blood transfusion and the use of plasm a products 
was followed by episodes of jaundice which had a long incubation
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period of up to sb: months. This type of hepatitis could be 
transm itted  by any procedure in which the skin or a mucous 
membrane was punctured by instrum ents contaminated with the 
blood of a c a rr ie r  of the virus eg. needles, lancetsf tattoo 
needles, ra zo rs , dental and surgical instruments, dialysis 
equipment and tissue  and organ transplants. V irus hepatitis 
is now the most important complication of Mood transfusion 
(Mosley, 1966; Zuckerman, 1970(a) and (b)) and in 1963 in the 
United States out of 1.8 million transfusions given it was 
estim ated that the incidence of clinical hepatitis was 30,000 
cases with nearly 3, 600 deaths.
A m ajor advance in the study of v ira l hepatitis occurred 
in 1964 with the discovery of the A ustralia (Au) antigen by Blum- 
berg. The antigen was detected when the serum  of a haemo­
philic patient who had received multiple transfusions was tested 
by immunodiffusion against that of an A ustralian aborigine, and 
was originally considered to be an example of an iiiiierited tra it  
(Blumfoerg et a l , , 1965 and 1967). The antigen has been found 
only ra re ly  in healthy North American and European communities
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and has not been found in the serum  of patients suffering from  
various liver diseases other than hepatitis. The antigen has 
been shown to occur frequently in the blood of patients receiving 
multiple transfusions, in 20 per cent of patients with v irus hepatitis 
and in 10 - 14 p er cent of patients with leukaemia. It is also 
found in 1 - 20 per cent of norm al people living in the tropics 
and in South-East Asia (Blumberg et a l , , 1968).
Prince (1968(a)) described the appearance of an antigen 
which he term ed the SH antigen, in the blood of a patient during 
the early  incubation period of post-transfusioxi hepatitis and this 
was confirmed by Okochi and Murakami (1968) who found a strong 
association between the Australia antigen and post-transfusion 
hepatitis in Japan. The SH antigen has since been shown to foe 
identical to the Au antigen (Prince, 1968(b)). Some patients 
transfused blood containing AuSH antigen subsequently developed 
hepatitis with the antigen in the ir blood, while o thers developed 
antibody to it, with no evidence of hepatitis. It is Imown that the 
antigen may persist in the blood after recovery from the acute 
phase of hepatitis and it has been recorded over a twenty year 
period in an apparently healthy volunteer blood donor (Zuckerman
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and Taylor, 1969) and also in the blood of half the volunteers 
inoculated with iVlS-2 s tra in  of serum  hepatitis (Giles et a l . ,
1960).
Au-8H antigen has now been identified in all the plasm a 
fractions used therapeutically in the treatm ent of haemophilia 
and Christm as d isease (Schroeder and Mozen, 1970) and thus 
confirm s the clinical evidence of transm ission  of the v irus in 
the various fractions; eg. in fibrinogen (Anderson et a l . , 1960; 
Cronberg et a l . , 1863; Newcomb and Watson, 1063), in Cohn F I-0  
(Murder and Schulman, 1966), in cryoprecipitate (Del Duca et a l . , 
1006; B esselaar et a l . , 1966; Forbes et a i . , 1969; W hittaker 
et a l . , 1969; F itzpatrick  et a l . , 1969), in glycine precipitated  AHF 
(Brinîdîous et a l . , 1068) and in C hristm as factor concentrates 
(Kingdon, 1970).
As out-patient and home treatm ent of haemophilia becomes 
readily available m ore and m ore patients a re  receiving rep lace­
ment therapy with plasm a infusions with a resulting increase in 
exposure to hepatitis v irus. This survey of an adult haemophilic 
population has been ca rried  out to establish the incidence of
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clinical jaundice, an icteric hepatitis and the association of the 
episodes with the incidence of positive reactions for A ustralia 
(SH) antigen and antibody.
P atients and methods
To obtain figures for the incidence of clinical jaundice 
178 consecutive adm issions to the Haemophilia Centre were 
questioned about jaundice and its  relationship to transfusion of 
blood or blood products.
To determ ine the incidence of AiiSH (HAA) antigen in 
the haemophilic population blood was tested by immunodiffusion 
techniques each tim e a patient was seen with a new bleeding episode 
and on follow up after an episode of bleeding which required  blood 
or plasm a transfusion. A ssays of AuSH antigen and antibody were 
perform ed in the Regional Blood Transfusion Centre by immuno- 
electrophoresis. L iver function te s ts  were also perform ed on 
these occasions. These included serum  bilirubin, alkaline 
phosphatase, glutamic oxalo-acetlc transam inase (GOT) and 
glutamic pyruvate transam inase (OPT) all of which w ere estim ated 
by standard autoanalyser techniques. Total protein and albumin
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and globulins w ere estim ated as necessary. Bromsuiphthalein 
retention te s t (45 minutes) was perform ed by the method of 
Fleck and M orrison (1970). Seventy-eight patients with haemo­
philia or C hristm as disease w ere seen in this p a rt of the survey. 
Out of the haemophilic population these were the patients at 
rnasdmum risk  as they w ere receiving multiple transfusions of 
plasm a concentrates for therapeutic purposes.
Results
(b) Incidence of clinical jaundice 
Twelve patients out of 128 questioned (10.1 p er cent) had 
a past history of clinical Jaundice and all the episodes had been 
rela ted  to transfusion of blood or plasm a products in the previous 
ste  months. One patient had two episodes of jaundice within the 
space of one year. Seven patients w ere trea ted  at home by their 
own practitioners and five w ere admitted to hospital. The main 
biochemical findings of th is group of five are  shown in Table 20. 
Only two of the five patients had positive AuSH antigen, none 
developed positive AuSH antibodies. Patient 2 has had persistence 
of antigen in his blood for two years now and has clinical and bio­
chemical evidence of continuing liver cell damage.
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(e) Incidence of anicteric hepatitis 
In a four year period eleven out of seventy»eight patients 
who w ere repeatedly tested  w ere found to have an icteric  hepatitis. 
Of these eight w ere found on routine biochemical testing of blood 
sam ples and th ree  had minimal symptoms. Relevant data from  
these patients is shown in Table 21. Two of these patients 
have had two separate  episodes of biochemical hepatitis having 
totally recovered from  the f irs t attack. In only one patient 
was the A ustralia antigen found and he then developed a positive 
AuSH antibody. In one other patient AuSH antibody developed 
during the course of the hepatitis althougli AuSH antigen had not 
been found. All the patients had exposure to plasm a products in 
the previous six months. These varied from  6 units of fresh  
frozen plasm a to 380 units of cryoprecipitate.
(d) Incidence of AuSH antigen and antibody 
In seventy-eight adult haemophiliacs who have received 
multiple transfusions four patients have been found with positive 
AuSH antigen. Two of these had clinical jaundice, one had 
anicteric hepatitis and one patient was found by chance to foe a 
AuSH antigen c a rr ie r , with no previous history of hepatitis.
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Ten patients (13. 8 per cent) were found to  have AuSH 
antibody when f irs t tested. In only th ree of these was there 
evidence of previous hepatitis but all had severe haemophilia 
and had received multiple infusions of blood, plasm a and plasm a 
products in the past* In one patient the antibody te s t became 
negative after four months. In the other nine patients the 
antibody is s till p resen t. The follow up period v aries  from  
two months to two years .
Follow up of patients with evidence of hepatitis or positive Au 
antigen or antibody
Only th irteen  patients out of a possible twenty-she with 
evidence of hepatitis w ere willing to come for B. S .P . te s ts  and 
review. Four of these had abnormal B, S. P . retention at 45 
minutes. In a control se rie s  of th irteen haemophUic patients 
of the sam e severity  who had received an equivalent number of 
infusions but who had never had hepatitis and had negative Au8E 
antigens, four had abnorm al B. B.P. retention. This would 
indicate an incidence of hepatic Impairment of 30 p er cent in 
haemophilic patients receiving multiple infusions.
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(e) Discussion
ïn the h istory  of blood transfusion it was appreciated 
early  on that Mood and blood products might transm it hepatitis 
(Propert, 1988; Spur ling et a l . , 1946; Brightman and Korns,
1947; Barnet et a l . , 1950; Jam es et a l . , 1950; Rosenthal et a i . , 
1950; W allace, J . , 1961) and it has been shown that the incidence 
of hepatitis increased  linearly  with the number of transfusions 
of Mood up to 6 units (Allen and Sayman, 1062). The A ustralia 
antigen has been found in all the fractions used therapeutically 
in haemophilia and C hristm as disease (Schroeder and Mozen, 1970) 
but the risk  of hepatitis depends on the particu lar fraction used; 
for example the r isk  following fibrinogen may be as much as 35 
tim es that after whole blood (Zuckerman, 1970(a)). By virtue 
of the fact that effective therapy in bleeding d iso rders requ ires 
concentrates of the deficient factor made from  pools of norm al 
plasm a the exposure of an individual patient to the v irus is  higli.
In theory it should be possible to te s t every donor unit 
of blood for the presence of antigen and so reduce the incidence 
of serum  hepatitis, but A lter et al. (1970) have produced evidence 
that this w ill reduce the incidence of serum  hepatitis by no more 
than 25 per cent.
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The incidence of clinical jaundice in our se rie s  was 10 
per cent and th is com pares with a figure of 2 p er cent (Risza 
and Biggs, 1969), 10 per cent (Maycock et a L , 1963; Newcomb 
and Watson, 1963), 14 per cent (Cronberg et a L , 1963) and 30 
per cent (M arder and Sliulman, 1966). It is  thougîit that clinical 
jaundice is only the tip of the iceberg and that up to 100 cases 
of hepatitis may occur for each overt jaundice (Hampers et aL ,
1964). More recent studies however suggest that only 3 - 4  
anicteric cases occur for each ic teric  ease (Mirick et a L , 1965), 
It is  probable that the th irteen  episodes of anicteric hepatitis 
which w ere found fortuitously represen t a g ross underestim ate 
of the incidence in the population at risk . Liver function te s ts  
a re  abnormal for such a short tim e that it would requ ire  twice 
weekly estim ation for sht months to ensure complete screening 
of the patients and this is im practical. In one patient hepatitis 
occurred despite the presence of A ustralia antibody in the plasm a. 
This has been noted before by Holland et al. (1969).
In th ree  of these patients (18,7 per cent) with evidence 
of hepatitis AuBH antigen was found. One of these patients 
(patient 2) has continued to have a positive Au-SH antigen in his
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Mood for two years  and one has developed an AuSH antibody which 
has been p resen t eighteen months. One patient (patient 14) 
developed an AiiSH antibody without having had detectable AuSH 
antigen, a phenomenon reported previously by Zuckermaii (1970(a)). 
This incidence of positive AuSH antigen is low compared with 
the 40 per cent of patients found to be positive by CoBsart et al. 
(1960) and the 82 per cent by Gocke and Kavey (1969) in patients 
with probable serum  hepatitis. It has been suggested that there 
a re  im portant regional variations in the Incidence of AuSH antigen 
(Mathews and MaeKay, 1970) and it has been shown to have a low 
incidence in the West of Scotland (Laiwah et a l . , 1970).
A ustralia antibody was found in 12.8 per cent of haemo» 
phllic patients examined. This is in keeping with the figures of 
12. B per cent found by ICimst and R osier (1970) and of 17 p er cent 
by Sealer and Mufson (1971). Antibody has been detected in as 
many as one-third of haemophilic patients (Blumberg et a l , , 1965; 
Shulman and B arker, 1969). Patients with persistence of AuSH 
antigen have been shown to have biochemical and histological 
evidence of liver impairment (Singleton et a l . , 1971). This was 
seen in both of our patients with persistence of AuSH antigen, one 
had hepato-cellular failure and the other abnormal retention of
B. 8 .P , The meidence of abnormality of B, 8 .P . retention is 
25 per cent in patients with a previous history of hepatitis 
A ustralia antibody and 30.6 per cent in a group of m ultitransfused 
haemophiliacs who had no history of hepatitis and who do not have 
AuBH antibody* There appears to be no study of the long te rm  
hepatic effects of multiple transfusions on liver histology in 
haemophilia although there  have been sporadic ease rep o rts  of 
death from  serum  hepatitis (Newcomb and Watson, 1863).
It is  possible that production of higher purity AHF concen­
tra te s  which contain le ss  fibrinogen may reduce the incidence 
of hepatitis and also some reduction may also resu lt from  exclusion 
of AuBH antigen positive donors. Similarly Judicious use of 
fibrinolytic W iibitors such as aminocaproic acid and tranexam ic 
acid may reduce the haem ostatic requirem ents in selected cases.
This study has shown the high incidence of serum  hepatitis 
associated with patients receiving multiple transfusion,s of pooled 
blood products but there  appears to be a low incidence of AuSH 
antigenaemia. We do not as yet know the rela tive importance 
of the various let erogenic v iruses, but it is  quite possible that 
v irus B is not the only infective agent responsible for post-transfusion
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hepatitiB, It is also possible that there may be other portals 
of entry for infective agents other than transfusion.
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CHAPTER 9 
CHANGES IN PLASMA FIBRINOGEN AND 
ERYTHROCYTE SEDIMENTATION AFTER 
TREATMENT WITH CRYOPRECIPITATE
(a) Introduction
The preparation  of cryoprecipitate involves the cold 
precipitation of various facto rs in Mood plasm a. These consist 
mainly of fibrinogen and antihaemophilic factor with sm aller 
amounts of the other globulins, albumin and some coagulation 
factors (Table 22), The amount of fibrinogen v arie s  from  batch 
to batch but average cryoprecipitate contains about 40 - 50 per 
cent of the fibrinogen from  the starting  plasm a. Brown et al.
(1967) found the levels of clottable protein in cryoprecipitate to 
be eleven tim es that of the starting  plasm a but we have found it 
to foe only 2 - 3  tim es that of plasm a (Forbes et a i . , 1969). As 
the half life of infused fibrinogen is between 4 - 6  days (Madden 
and Gould, 1952; Zetterquist et a i . , 1964) com pared with the 
half life of infused antihaemophilic factor of about ten hours 
(Douglas, 1958; Biggs and Denson, 1968; Abildgaard et a l . , 1964),
110.
the resu lt of cryoprecipitate therapy is a r is e  in the plasm a 
level of fibrinogen. This may reach m assive levels, the highest 
reported  being 2, 500 m g /100 mi (M arder and Shiilman, 1060).
We reco rd  here the changes in plasm a fibrinogen associated with 
cryoprecipitate therapy and the effect on the sedimentation of red  
blood cells.
Fibrinogen and E rythrocyte Sedimentation Bate (EHB)
Fibrinogen and E8R w ere m easured before and after 
therapeutic infusion of various amounts of cryoprecipitate. The 
resu lts  a re  shown in fig. 29 and the differences a re  highly signi­
ficant in both instances (p ( 0.001), Fig, SO shows the re la tion­
ship between the ESK and the fibrinogen levels in a se rie s  of 
fo rty -th ree patients both trea ted  and untreated (r -  0.3255).
Fig, 31 shows the changes in fibrinogen, E8R and AHF levels 
which occurred in one representative patient.
Discussion
The production of very  high levels of plasm a fibrinogen by 
infusion of p lasm a products is usually thought to be a, benign con­
sequence of replacement therapy with only the minor problem s of
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rouleaux form ation and occasional difficulty in crossm atching 
blood (M arder and Shulman, 1966; Bloom et a l . , 1968). There 
a re  however occasional reports of mild haem olysis in the 
recipient (MacMillan et a l . , 1961; Le Quesne et a i , , 1967) and 
a- suggestion that activation of the fibrmolytic enzyme system  
may occur (Shanforom, 1968). The evaluation of elevated fib rin­
ogen levels in the aetiology of haem olysis is extrem ely difficult 
as these patients a re  usually the most severely ill, have had 
m ajor surgery , have bacteria l infections and usually have had 
whole blood transfusions. It has been shown that glycine p re ­
cipitated preparations of AHF contain iso-antibodies to the main 
blood groups (Abildgaard et a l , , I960) but we have been unable 
to show this in cryoprecipitate (Forbes et a i , , 1969). m a recent 
case rep o rt we described a haemophilic boy who developed acute 
in travascular haem olysis when his plasm a fibrinogen was 1.000 mg 
p er cent (Forbes et aL , 1972), The picture in th is patient was 
complicated by concomitant therapy with cephalexin, and prior 
therapy with am piciliin. In re trospect it is  not possible to be 
certain  of the p art played by these various factors. The full 
report of th is patient is in the Appendix 4. It is  unusual, in that
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the plasm a level of cephalexin was extremely low and other 
factors, such as higli blood u rea  and low albumin w ere absent,
(b) Blood group antibodies
It is  well known that patients receiving multiple tra n s ­
fusions of Mood develop antibodies against blood group antigens.
Eleven (8, G p er cent) out of 128 haemophilic patients 
have been found with blood group antibodies (Table 23), The 
commonest antibody was to the Hh system  (eight patients).
Three patients had antibodies to the Kell group. All the patients 
had a m oderate or severe degree of haemophilia or C hristm as 
disease and all had received many transfusions of whole blood, 
plasm a or cryoprecipitate and because of th is it is  not certain 
how ieoimmunisation came about. In one patient anti-D  antibody 
appeared for the f ir s t  tim e after the patient had received a course 
of cryoprecipitate alone. This is  the f irs t documented case of 
accidental production of anti-D  after cryoprecipitate therapy and 
presum ably represents carry over of red  ceils with D antigen 
during preparation* Minute amounts of red cells or red  cell 
stroma can produce Hh-antibodies (Waller, 1949; Wiener, 1949) 
and we have estimated that any single pack of cryoprecipitate may
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contain 0.1 ml of trapped cells. This Individual received 190
packs of cryoprecipitate which may have contained up to 19 ml. 
of red cells. No attem pt has been mad© in the past to give thera^ 
peutic m ateria ls  according to the blood groups of the donors or 
of the recipient as th is had always been considered unnecessary.
The im portance of knowing the iso-antibody status of 
these patients is the avoidance of transfusion of Hh positive or 
Kell positive Mood which might produce acute in travascular 
haem olysis (Wiener and Somi-Gordon, 1947).
(c) Duplication of LDH-1 in a patient receiving 
multiple transfusions
Introduction
The existence of multiple m olecular form s of lactic 
dehydrogenase is well documented and five iso-enzym es have 
been dem onstrated (Yesell and Bearn, 1957; Wieland and 
Phleiderer, 1957). Differences in the concentration of the 
individual iso-enzym es have diagnostic significance in d iseases 
of heart (Cohen et a l . , 1964; Starkweather et a l . , 1966), liver 
Weime and Van M aercke, 1961), striated muscle (Emery, 1965)
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and red  Mood cells (Hess and W alter, 1961). Fujimoto et ai.
(1968) have shown additional bands between IiD Ii-l and -2 and be­
tween LDH-2 and -3 in a patient with oesophageal carcinom a with 
hepatic secondary deposits. They concluded that the bands 
were produced by the tumour cells and represen ted  an altered  
form  of the M subunit, which produced a se t of hybrids with 
the norm al H subunit. We report here the unique observation 
of duplication of LDH-1 after multiple transfusions of plasm a 
products. This is  the f irs t demonstration of heterogeneity of 
LDH iso-enzym es in the population.
Case history
The patient was a severely affected haemophiliac aged 
14 y ears . He sustained a rupture of the left u re te r  with a m assive 
retroperitoneal haematoma as a resu lt of a crushing injury.
Surgery was undertaken under cover of cryoglobulin precipitate, 
which is  a crude concentrate of antiliaemophilic factor made by 
the cold precipitation of human plasm a (Pool et a l . , 1964). This 
therapy was continued for SO days to perm it healing of the wound 
and resorption of the haematoma. Cryoglobulin precipitate from  
1, 500 donors was used in th is patient.
Methods
Electrophoretic separation of lactate dehydrogenase 
(LDH; L -lactate  : NAD oxidorediictase, EC 1 .1 .1 ,2 7 ) iso-enzym es 
was ca rried  out on cellulose acetate and zones of activity w ere 
made visible by incubating the s tr ip s  in contact with (2 g /d i)  agar, 
T r is -buffered to pH 8,4  and incorporating, per litre , 100 mmol 
of lactate, 1.5  mmol of NAD, 66 fimol of phenazine methosulphate, 
500 jiimol of thiazolyl té trazolium  and 6 of sem learbazide 
hydrochloride.
On the fifteenth day after the patient’s adm ission it was 
noted that the fastest anodal m igrating iso-enzyme (LDH-1) 
showed two distinct bands. This splitting of the LDE-1 zone was 
demonstrable until the nineteenth day after adm ission and was 
also shown when hydroxybutyrate or glycerate was substituted 
for lactate. No forniazan dye was produced in this position in 
the specimens affected. Simultaneous eieetropherogram s of 
se ra  obtained on the fourteenth, fifteenth, nineteenth, and twentieth 
days a re  shown in Fig. 32.
During this period the plasm a LDH levels w ere between 
700-1000 TJ/l#re.
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Following a suggestion by P ro fesso r J , H. Wilkinson, 
we progressively  decreased the quantity of serum subjected to 
electrophoresis but a sim ilar splitting of the LDH-2 band, the 
m ost prom inent, could not be dem onstrated.
It is  likely that the additional band was not an artefact, 
but represen ted  an abnorm al H subunit present in one m ore of 
the transfused plasm as and suggests heterogeneity of the LDH. 
iso-enzyme molecule in the population. This is the f irs t dexnon- 
stration of this phenomenon.
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(a) Introduction
Antihaemoplilüe factor (AHF) prepared from  bovine and 
porcine plasma is  of proven value in the management of h aem orr­
hage in haemophilia (Biggs, 1967), It has been effectively used 
in human patients (Macfarlane et a l , , 1954; M acfariane et a l . , 
1967; M acfarlane and Biggs, 1959; Biggs, 1960; Rizza and 
Biggs, 1969), in haemophilie dogs (Sharp and Dike, 1964) and in 
a haemophilic horse (Mossel et aL , 1962). Bovine AHF at con­
centrations of 0. 5 m g /m l produces platelet aggregation both in 
vitro  (Sharp and Bidwell, 1957) and invariably in vivo (Macfariane 
and Biggs, 1959), Thrombocytopenia was also recorded in the 
haemophilic horse trea ted  with bovine AHF (Nossel et a l . , 1962). 
The effect of porcine AHF preparations in vivo and in v itro  is 
not so well defined. Sharp and Bidwell (1967) showed no effect 
on human platelets in v itro  when the porcine preparation was used
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at 0. 5 m g /m l but when the concentration was ra ised  to 5 m g /m l 
platelet aggregation could be produced. Occasional cases of 
transien t thrombocytopenia have been recorded in human haemo- 
phiiic patients during therapeutic adm inistration of porcine AHF 
(Macfarlane et a l . , 1987; E izza and Biggs, 1969).
M aterials and meüiods
Collection of blood: All sam ples were collected by clean
venepuncture from healthy human donors using p lastic  syrm gee. 
Mine volumes of blood was added to one volume of 3. 8 p er cent 
sodium citra te  or 2 p er cent ethylenediam lnetetracetic acid.
All glassw are was siliconised using "Siliclad” (Clay Adams In c ., 
Mew Je rsey , U, S, A. ).
P late le t rich  plasm a: was prepared from anticoagulated
whole blood by centrifugation at 600 g for five minutes at room 
tem perature.
Porcine and bovine aniiphaemopliilic factor; preparations
were purchased from  8. Maw & Son, Barnet, England. The 
contents of each ampoule was dissolved in 50 ml of norm al saline 
and stored  at -20^C. The average weight of dry m ateria l per 
v ial of bovine AHF was 577 mg and of porcine m aterial was 407 mg.
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The dilations re fe rre d  to in the text w ere prepared  from  this 
stock solution. The fibrinogen content of these m ateria ls  was 
(bovine) 576 m g /100 ml and (porcine) 350 m g /100 m i.
The methods used to p repare these anim al products 
a re  essentially those described by Bidwell (1955 (a) and (b)) and 
depend on fractionation with potassium phosphate and sodium 
citra te . This re su lts  in a preparation of AHF between 100 - 
400 fold concentrated with respect to the starting  plasm a.
Adenosine diphosphate (ADP ): Sigma Chemical Company,
St. Louis, M issouri. A stock solution of 100 pg ADP per ml 
was prepared  and kept at -20^C. Dilutions referred to  in the 
tesd were made from  th is.
Collagen: was e^etracted with saline from  human Achilles
tendon.
Animal plasm as (Colorado, U. 8. A. ): w ere purchased from
the Colorado Serum Company and were kept frozen at -20^C.
P lasm a from  a range of prim ates was obtained from  the Laboratory 
for Experim ental Medicine and Surgery in P rim ates  (L. E. M. S. I .P . ) 
New York University Medical Center, New York. Ail sam ples 
w ere obtained deep frozen in 4 per cent sodium citra te .
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Plasm a from  the four animal species which produced 
maidmum platelet aggregation was clotted by addition of 0.025 M 
CaCIg and the serum  incubated at for th ree  hours to remove 
any residual thrombin. P latelet aggregation of the starting  
plasm a was then compared with the incubated serum .
Adenosine: (Sigma Chemical Company Limited, London)
was made up in norm al saline and used at a final concentration 
of 50 fxg/ml of p latelet rich  plasm a.
Celite 512; (Johns-M anville Company, Celite Division,
New York, N .Y .).
S'ephadex G-200 and Bepharose 4B: (Pharm acia, Fine
Chemicals, Uppsala, Sweden) were expanded in barb ita l-saline  
buffer (0.15 M, pH 7.3).
Plasm in : (A.B, Kabi Pharm aceuticals, London) was dissolved
in normal saline immediately before use to the required  concentration. 
Thrombin: (Parke, Davis and Company, Detroit, Michigan,
U. B. A, ) was diluted in barbital saline buffer as required.
Agarose: (BDH Chemicals Limited, Poole, England) was made
up to 0, 9 per cent in barbital buffer pH 8.4, 0.05 M.
Rabbit anti-human fibrinogen antiserum : was purchased
from  Behringwerke A. G.
Bovine and porcine fibrinogen: Koch Light Laboratories
Coinbrook, England, w ere dissolved, as required, in distilled 
w ater to give the reouired  concentration.
Clinical study: Three haemophilic patients w ere given
porcine AHF therapeutically. Two underwent m ajor su rg ery  
and one, with an AHF inhibitor, was bleeding from  the gastro ­
intestinal tract. Standard dosage schedules aa recommended
by the m anufacturera w ere given except In the th ird  patient in 
whom twice the standard dose was eventually given in an attempt 
to overcome the inhibitor and provide a haem ostatic level of 
AHF.
P late le t aggregation; was m easured by the turbidixnetric
method of Born (1962), The apparatus used in th is study con­
sisted  of an E .E , L. titrator connection to a galvanometer 
(E.E.Lo type 20, Evans E lectro-selem um  Limited, England).
A perspex, cuvette was fitted on to a titra to r  above a magnetic 
s t i r r e r  and in the light path from  the photoelectric cell.
Platelet rich plasm a, 2 ml amounts, was added to the cuvette 
together with a sm all s tirr in g  rod. When the s tirr in g  rod was
122.
rotating at a uniform speed, the optical density reading of the 
plasm a sample on the galvanometer scale was adjusted to an a rb it­
ra ry  value of 0.600, The plasm a was agitated for 30 seconds 
to ensure that no change in optical density occurred before addition 
of 0 .1  ml aliquots of aggregating reagent. Changes in liglit 
transm ission , at a wavelength of 492 mp, w ere recorded at 30 
second in tervals over a period of ten minutes from  the addition 
of the te s t m aterial. Control sam ples were handled in an identical 
fashion except that norm al saline replaced the test solution.
P la te let adlxesiveness: was m easured by the glass bead
column nethod as described by Helleni (i960), and modified by 
H irsh et ai., (i960). The glass bead column was made by filling 
a length of vinyl tubing (N T /13, Portland Plastics, Kent) with 
2, S g Bailotini glass beads (0. 57 mm in diam eter) to give a 
column 6 cm in length. The glass beads were held in the column 
by a filter of fine nylon gauze fitted at each end of the column,
2 ml of platelet rich plasma w ere incubated for 10 minutes at 
3‘7^C with 0.1 ml aliquots of porcine o:c bovine AHF then drawn 
into a graduated plastic syringe which was then fitted to an electric» 
ally operated mechanical pump. The plasm a was pushed through 
the column of beads at a constant rate. The apparatus used in
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the study gave a mean contact tim e between plasm a and glass 
of 30 + 1 seconds. P la te le t counts w ere perform ed on the plasm a 
sam ples before and after passage through the column. The 
difference between the two counts was expressed as a percentage 
of the initial p latelet count and th is value taken as an index of 
platelet adliesiveness in the sample. This was repeated in seven 
different plasm a sam ples.
Chandler tube technique: As described by Chandler (1988)
and modified by Cunningham et al. (1968). The transparen t 
vinyl tubing, 12. 3 mm bore, 71 cm in length was made into loops 
by means of a nylon adaptor. The loops were washed in cold 
water and rinsed  in 0. 9 p er cent sodium chloride. C itrated 
platelet rich  plasm a, 5 ml aliquots, was added to the two loops 
and the volume made up to 18 ml with saline. AHF solution or 
saline (0.25 ml) was added to the system and the loops rotated 
on the turntable of a blood cell suspension m ixer (Matburn Limited, 
London) at 28. 5 rpm  In a g lass fronted incubator at 37^0. The 
platelet aggregation was assessed  by the length of tim e taken 
for the appearance of a ’'snowstorm ’’ effect. This was repeated 
on seven different plasm a sam ples.
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Preparation  of rabbit antibody against partially  purified porcine 
AHF; P artia lly  purified porcine AHF prepared  by gel
filtration on Bepharose 4B was concentrated by p re ssu re  dialysis 
on an Amicon using a PM30 membrane. Two ml of concentrated 
AHF, containing approximately 20,000 units of AHF activity and 
5 mg of protein was mixed with 2 ml of Freunds complete adjuvant 
and injected intram uscularly into a white New Zealand rabbit.
The injection of antigen was repeated at three weeks, then one 
week la te r and the animal was bled ten days after the la s t injection. 
The serum  was allowed to clot overnight then heated at 56^C 
for th irty  m inutes. To malsie the antibody monospecific for AHF, 
equal volumes of antibody w ere incubated for one hour with 
purified porcine fibrinogen prepared  by gel filtration. The 
fibrinogen was removed by heating at for th irty  minutes 
and the antibody concentrated by absorbing the w ater with Lyphogel 
(Gelman Instrum ent Company).
P late le t counts: w ere perform ed by the method of Dade (1956)
using formol citra te  as the diluting fluid.
Antiliaemophilic facto r: was assayed by the method of
M argolis (1968) as modified by Breckenridge and Ratnoff (1962).
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Dialyses: w ere performed at 4 €  in cellopliane casings
(Viskiïig Corporation, Chicago, Minois).
Ultracentrifugation; was ca rried  out in a Beckman Model
L ultracentrifnge, the sam ples being spun at 60,000 g for twenty- 
four hours.
Acrilamide gel disc electrophoresis: was perform ed at
pH 9.5  as described by Davis (1964) using a standard ''? p er cent 
gel. The gels w ere stained with 0 . 5 per cent aniline black m 
7 per cent acetic acid.
Immunodiffusion: was carried  out by the method of
Ouchterlony (1962) in 0. 9 per cent agarose in barbital buffer, 
pE 8 .4 , 0 .05 M.
Protein: protein concentration was determined by the
method of Lowry et aL (1951), or estim ated m ore crudely by 
absorption at 280 mjit in a Beckman Model DU spectrophotometer.
Gel filtration of human platelets: was carried out by the
method of Tangen et al. (1971). P latelet rich plasm a (p. r.p . ), 
p repared  as  described previously from  human blood collected 
in ac id -citra te  de^drose anticoagulant, was filte red  on a 1.5 x 30 cm 
column of Bepharose 2B (Pharmacia Fine Chemicals Inc. ).
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The volume of platelet rich  plasm a applied to the column varied 
from  0 .5  - 1.5 ml and the eluting buffer was 0.145 M NaC'l, pH 
7 .4  with 0.005 M T rizm a base containing 5 x 10 ^ IVI Ca CL 
and 0 .1  per cent glucose. P la te le ts  p repared  by this method are 
free of non-absorbed plasm a proteins and aggregate with ADP 
and collagen.
R esults
(fo) Effect of bovine and porcin© AHF on human platelets
1) Platelet aggregation in vivo by porcine AHF: Infusion 
of porcine AHF into haemophilic patients resulted  invariably in 
thrombocytopenia. In the f irs t  two patients (fig, 33) throm bo­
cytopenia was transient and the platelet count returned  to  norm al 
within twenty-four hours. However in patient 3 (fig. 34) severe, 
prolonged, thrombocytopenia was produced with exacerbation
of gastrointestinal bleeding and a rise in blood transfusion req u ire ­
m ents. Mo r is e  in AHF levels could be detected in th is patient.
2) P la te le t aggregation in v itro  by bovine and porcine AHF 
preparations: Bovine and porcine AHF preparations a re
potent platelet aggregating agents in vitro  (fig, 35). Wlien either 
was added to human platelet rich  plasm a, in concentrations
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equivalent to those obtained during therapeutic administration, 
irreversible platelet aggregation occurred within two minutes.
At lower concentrations the effect was less  marked and aggre­
gation became reversible. On a weight for w e i^ t basis the 
bovine material was approximately four times more potent, in 
producing platelèt aggregation than the porcine m aterial.
Platelet aggregation was produced by samples from ten separate 
batches of bovine and porcine AHF preparations.
8) In vitro effect of various animal plasmas on aggregation of 
human platelets: The results are shown in fig. 86. Plasma
from goat, sheep, pig, cow and horse produced aggregation of 
human platelets in vitro. Plasma from a range of primates 
(chimp, rhesus monkey, black ape, baboon, gibbon and squirrel 
monkey) produced very slight, reversible aggregation and plasma 
from a wide range of animals (dog, cat, rat, opposum, rabbit, 
hamster, guinea pig, turkey, pigeon, chicken, paddlefiah and 
lobster) produced no aggregation.
Comparison of the aggregating action of four animal 
plasmas with their sera is  shown in fig. 37. In all four cases
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clotting results in a marked diminution of aggregating ability 
but this did not entirely disappear.
4) Platelet adhesiveness by the method of Hellem: The
mean adhesiveness of the seven control samples using platelet 
rich plasma is 13 per cent  ^ 8 per cent and the seven test samples 
79 per cent Hr  ^per cent. This difference is  highly significant 
(t =: 33, p ( 0.001).
6) Effect on the Chandler tube system: The average time
for the appearance of the "snowstorm" in the seven tests was 
141 seconds with a standard deviation of seventeen seconds.
The "snowstorm" consisted of aggregates of 50 - 100 platelets.
No "snowstorm" appeared in the control tubes and no fibrin 
formation was seen in either tube.
(c) Physical and chemical properties of the platelet
aggregating agent
1) To determine if the aggregating agent was a protein: An
equal volume of 10 per cent trichlorocetic acid (TCA) was added 
to the AHF preparations (one-tenth volume) and the resulting 
precipitate was centrifuged at 3000 rpm for ten minutes. A
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control tube was set up in which an equal volume of saline was 
added to the AHF preparation. Aliquots (0.1 ml) w ere then 
added to platelet rich plasm a in the aggxagometer. This resu lts  
in complete loss of aggregating activity. TCA in th is concen­
tration  had no effect on platelet aggregation.
2) D ialyses: Dialyses of solutions of animal AHF were 
perform ed at 4^C in cellophane casings (Visking Corporation, 
Chicago, Illinois) using at least forty tim es the sample volume 
of barbital saline buffer. After twenty-four hours no significant 
change could be detected in aggregating activity.
3) Absorption: Absorption was perform ed with calcium
phosphate or celite 512, 10 m g /m l of AHF preparation at room 
temperature* The absorbent was removed by centrifugation 
and eluted with 10 per cent sodium chloride. The eluate was 
dialysed overnight against barbital-saline buffer. Aggregating 
activity of the supernatant and the eluate was tested  and the 
activity was shown to rem ain in the supernatant. No activity 
was found in the eluate from  the calcium phosphate or celite.
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4) Effect of tem perature: Aliquots of the AHF p rep ara ­
tions w ere kept for ten minutes in a waterbatli at 40^0, 50^C, 60^C, 
70^C. Any precip itate which form ed was removed by cen tri­
fugation at 800 g for ten minutes. Samples of stock AHF solutions
ow ere also kept at -20 C for two years and at room tem perature 
for one week. The resu lts  a re  shown in fig. 88 (a) and (fo).
These resu lts  indicate progressive destruction of the platelet 
aggregating factor as the tem perature is ra ised , with complete 
destruction of aggregating activity when the preparations w ere 
kept at 70^C for ten minutes.
The aggregating factor is  stable when kept at room 
tem perature for a week and also at -20^C for two y ears .
5) U ltracentrifugation; of the crude animal AHF was
carried  out in a Beckman Model L ultracentrifuge, the sam ples 
being spun at 60,000 g for twenty-four hours. This had no 
effect on the aggregating activity which was presen t to the same 
degree at the top and bottom of the tube.
6) M ilb itors of p latelet aggregation: The effect of collect­
ing the platelet rich  plasm a in 2 p er cent ethylenedramine te tra -  
cetic acid was determ ined and also the effect of preincubation of
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citrated  platelet rich plasma at 3 7 with adenosine and heparin. 
Addition of ethylene diamine te trace tic  acid (E. D, T. A, ) to the 
platelet rich  plasm a resu lted  in Inliibition of aggregation.
Sim ilarly preincubation of platelet rich  plasm a with 
adenosine at a concentration of 50 jitg/ml of plasm a resu lted  in 
inîïibition of aggregation, as did dipyridamole ("Persantin").
Heparin produced no inhibition of aggregation even in 
concentrations of 25 u /m l of plasm a.
7) Effect of ingestion of acetylsalicylic acid ("aspirin", a. s. a. ) 
on bovine and porcine AHF induced platelet aggregation: Four
volunteers w ere given 1,2 g of acetylsalicylic acid after blood 
had been removed for assessm ent of platelet aggregation by animal 
AHF. Samples w ere taken two hours afterw ards and platelet 
aggregation re tested . The aggregating agents tested  w ere collagen 
and crude bovine and crude porcine AHF preparations at a final 
concentration of 2, 5 m g /m l of plasm a.
In ail four experim ents sim ilar findings w ere made. 
Collagen induced aggregation was totally abolished and the secondary 
phase of p latelet aggregation seen with the animal m ateria ls  was 
abolished.
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The resu lts  of one of these four experim ents Is shown 
in fig. 89 (a) and (b).
(d) Purification of the platelet aggregating agents.
Gel filtration of crude porcine or bovine antiliaemophilic factor 
by Bepharose 4)3» 250 mg of crude porcine or bovine AHF
w ere dissolved in 8 ml of barb ita l-saline buffer then sufficient 
sucrose was added to give a  concentration of 10 per cent. This 
was applied to a  column of Bepharose 4B, m easuring 2. 5 x 85 cm, 
equilibrated in barbital-saline buffer. The protein was washed 
through the column with barb ita l-saline buffer and the effluent 
collected in 8 ml aliquots. This was then examined for protein 
concentration, aggregating activity, antihaemophilic factor 
activity, and for the presence of fibrinogen by addition of thrombin 
(10 /m l) and calcium chloride, 0,025 M.
The re su lts  a re  shown in figs, 40 (a) and (b).
Two protein peaks w ere easily and consistently separated. 
The m ajor peak contained fibrinogen as evidenced by the appear­
ance of fibrin on the addition of thrombin and calcium. These 
tubes contained no platelet aggregating activity or AHF activity.
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Poiyacrilam ide disc gel electrophoresis of th is peali shows a 
single line (fig, 41, left).
The sm aller protein pealc, preceding the fibrinogen 
peak, contains all the platelet aggregating activity and the AEF 
activity (figs. 42 (a) and (b)). Mo fibrin could be detected in the 
peak tube on addition of thrombin but polyacrilamide disc gel 
electrophoresis of a  concentrate (x 100) showed a line in the 
fibrinogen position (fig. 41, right) but no other line suggesting 
the presence of AHF was found. This is probably due to the 
inability of the large AHF molecule to enter the separating gel, 
a finding reported  previously for human AHF by Kaas et al.
(1969). Injection of th is peak into a rabbit confirm s the presence 
of an impurity which can be readily removed by absorption of 
the antibody with purified fibrinogen (fig. 43).
The aggregating activity in the peals tube was about one- 
th ird  that of the starting  m aterial as was the level of AHF activity. 
This rep resen ts  a 100 fold increase m  purity of the aggregating 
protein.
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Does the purified fraction produce the same pattern of p la telet 
aggregation as the crude AHF ? P late le t aggregation was
tested  using both crude porcine AHF and the purified fraction.
A volume of 0.1  m l of aggregating agent was added to 2 m l of 
platelet rich  plasm a.
The resu lts  of th is experiment a re  shown in fig. 44,
A sim ila r pattern of aggregation is produced by the 
crude and the purified m aterial. At a critical concentration a 
foiphasic reaction is  seen in both preparations.
Aggregation of human platelets at 87^C and 24^C (room tem ­
perature) Purified  bovine AHF (200 |ig /m l) was added to
s tir re d  platelet rich  human plasma both at 37^C and at 24^C 
(room temperature) in an attempt to see if the pattern  of aggre­
gation of p la telets was different.
The results a re  shown in fig. 45, Sim ilar patterns of 
irrev ers ib le  p latelet aggregation a re  found at an AHF concentration 
of 10 p.g/ml but at 5 fig /m l the biphasic pattern is  lost when aggre­
gation is  ca rried  out at room tem perature. Sim ilarly at 2 ^tg/ml 
slight reversib le  aggregation occurs at 37^C but not at 24^C.
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Association of the platelet aggregating activity with antiiiaemo- 
phiiic factor
1) Is the aggregating activity associated with AHF activity? 
Samples of purified porcine and bovine AHF were diluted with 
barb ita l-saline  buffer to provide a  concentration of aggregating 
activity which produced rapid, irrev ers ib le  aggregation of p la te­
le ts in human platelet rich plasm a. This m aterial was then 
incubated with one-tenth volume of plasm a from  a haemophiliac 
with a  potent AHF inliibitor and as a control, one-tenth volume 
of plasm a from  a haemophiliac without an inhibitor. Plate le t 
aggregation and AHF assays w ere m easured at zero tim e and after 
incubation for sixty minutes.
In two separate experiments the antihaemophilic factor 
activity of the purified porcine or bovine fraction was totally 
destroyed without any change in the platelet aggregating activity. 
The starting  level of AHF in one experiment was 2. 80 u n its /m l 
and in the other 1.0 units per ml. The results of one experiment 
a re  shown in fig. 46.
136.
2} Association of aggregating activity with the antihaemophilic 
factor molecule P artia lly  purified porcine AHF was p re ­
pared by gel filtration as already described, A fraction was 
chosen which produced rapid irrev ersib le  p latelet aggregation.
Equal volumes of th is fraction were incubated with one-tenth 
volume of the monospecific anti-AHF antibody or control rabbit 
serum  for th irty  minutes at room tem perature. The tubes w ere 
then spun at 3000 g for th irty  minutes and tested  for platelet 
aggregating activity, AHF activity was assayed at the beginning 
and end of the incubation period.
The resu lts  a re  shown in fig. 47. Ineubation of the 
partia lly  purified AHF with a monospecific antibody to AHF 
resu lts  In total rem oval of the aggregating activity. No apparent 
change was noted in control tube. Addition of the antibody also 
resulted  in total loss of AHF activity. The assay level of AHF 
in the control tube was unchanged at 2. 3 u /m l  and in the antibody 
tube was 0.01 u /  ml.
3) Association of aggregating activity with fibrinogen ïn
a sim ilar experiment to that described above the use of a mono- 
specific antifibrmogen antibody had no effect on platelet aggregation.
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(e) Aggregation of human platelets by com m ercial 
bovine and porcine fibrinogen preparations 
Commercial preparations of both bovine and porcine 
fibrinogen were obtained from  Koch-Light Laboratories. Both 
preparations w ere made up in saline to concentrations of 400 mg 
per cent and 800 mg p er cent.
At concentrations of both 4 m g/m l and 8 m g /m l bovine 
fibrinogen produced platelet aggregation. Porcine fibrinogen 
at a concentration of 8 |Ltg/ml produced only slight aggregation 
(fig. 48).
Gel filtration of bovine and porcine fibrinogen preparations and 
Bepharose 4B 250 mg of com m ercial bovine or porcine
fibrinogen in 5 m l of saline w ere filtered through Bepharose 4B
equilibrated with barb ita l-saline . Aliquots of G ml w ere collected 
and analysed for protein, fibrinogen, antihaemophilic factor 
and aggregating activity.
Ab shown ill fig. 49 (a) and (b) a pattern sim ila r to  that 
produced by filtration  of com m ercial animal AHF was obtained. 
There were at least two protein peaks. The f irs t peak contained 
a ll the platelet aggregating activity as well as the AHF activity.
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No thrombin elottable m aterial was present in th is fraction.
The second, la rg e r peak contained fibrinogen as evidenced 
by the production of fibrin  by thrombin. No platelet aggre­
gating activity or significant levels of AHF were found in th is 
fraction.
To determ ine if gel-filtered  p latelets were aggregated by p u ri­
fied bovine and porcine AEF Gel filtered  p latelets (2 ml)
were substituted for platelet rich  plasm a in the Born system  and 
0 .1 ml of the purified AHF fractions added. Irrev e rsib le  aggre­
gation of p la te le ts occurred at the concentrations shown in fig.
50.
Effect of incubation of human plasm in with purified AHF p rep ar­
ations Preparations of purified bovine AHF (200 jug/mi) and
purified porcine AHF (350 jbtg/ml) w ere incubated with purified 
human plasm in 1 u /m l  and 0,25 u /m l  respectively. Appropriate 
controls w ere set up with norm al saline. Samples were assayed 
for AHF activity and aggregating activity at various tim e in tervals 
as shown in figs. 51 (a) and (fo). In the experiment using bovine 
AHF the preincubation sample of AHF activity assayed at 430 per 
cent and produced rapid  irrev ers ib le  aggregation. By fifteen 
minutes no activity could be detected using the assay; platelet 
aggregating activity had been substantially reduced.
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In the second experiment using porcine AHF with plasm in 
at a lower concentration (0.25 u /m l)  the starting level of AHF 
activity was 840 per cent but by fifteen minutes of incubation no 
activity was detectable. However it was only after 120 minutes 
of incubation that a significant reduction in platelet aggregation 
was obtained. Total loss of aggregating activity was found after 
sixteen hours of incubation.
To determine if animal platelets are aggregated by porcine or 
bovine AHF P late le t rich plasm a was obtained from  a 
wide range of animals by drawing the blood directly  into one- 
tenth volume of sodium citra te  (0.14 M). Species examined 
included, pig, horse, cow, goat, rabbit, mouse, ra t, dog, and 
guinea pig.
Ho aggregation of p latelets of any species except the 
guinea pig was found with either bovine or porcine AHF.
The resu lts  of aggregation of guinea pig p la telets by 
crude bovine and porcine AHF is shown in figs. 52 (a) and (b).
(£) Discussion
Both bovine and porcine AHF preparations cause aggre­
gation of human platelets in vivo and in vitro . This action Is
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in trinsic  to the native plasm a from  which the AHF is prepared 
and is  also found in the plasm a of goat, sheep and horse. 
Aggregating activity is  found at low levels in prim ates but is 
absent from many other m am m als and all fish and fowl tested.
The aggregating activity is precipitated by ten per 
cent trich lo racetic  acid and is  inactivated by heating at 60^C 
for ten m inutes. It is  not absorbed by oolite 512 or calcium 
phosphate and is  therefore not rela ted  to the contact or vitam in 
K dependent coagulation factors. Aggregation was not inhibited 
by heparin which isihibits thrombin induced platelet aggregation 
(Clayton and C ross, 1963).
The pattern of platelet aggregation is  temperature 
dependent and is biphasic, aggregation starting on addition of 
the crude AHF preparation  without the delay seen with collagen 
(Zucker and B orelli, 1962; Ilovig, 1963). Identical patterns 
of p latelet aggregation a re  produced by crude and partia lly  purified 
AHF. The reaction is  dependent on calcium ions and is  blocked 
by preincubation of the platelet rich  plasm a with adenosine, a 
competitive Inhibitor of endogenous ADI  ^ re lease . The second 
phase of aggregation can be blocked by prior ingestion of acetyl-
salicylic acid which Is thought to produce inhibition of re lease  
of endogenous p latelet ADP (Ziicker and Peterson , 1968), The 
aggregating activity is also destroyed by incubation with plasm in.
Gel filtration  of the crude AHF preparations shov/s that 
two m ajor protein fractions a re  present. The la rg est fraction 
is fibrinogen which gives a single line on polyacrilamid© disc 
gel electrophoresis. The sm aller of the two fractions contains 
coincidental peaks of AHF and aggregating activity. This m aterial 
is  not pure and disc gel electrophoresis of a concentrated sample 
yielded a line in the sam e position as fibrinogen. Antibodies 
produced against th is fraction contained two lines on immuno­
diffusion plates.
The possibility existed that the aggregating activity was 
either AHF or a high m olecular weight polymer of fibrinogen.
In an attem pt to destroy AHF activity, sam ples of the purified 
anim al AHF w ere incubated with a potent iniiibitor obtained from 
a patient with haemophilia. Despite total loss of AHF activity 
as m easured in the coagulation assay system  no changes resulted  
in platelet aggregation. In unpublished experiments we have 
shown that these inhibitors do not alter the level of AHF like antigen
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in plasm a (Forbes and Prentice, 1972). However addition of 
a potent monospecific antibody against AHF resulted  in rapid 
loss of platelet aggregating and AHF activity. Addition of an 
antifibrinogen antibody had no effect on aggregation of p latelets 
or AHF activity. This suggests that the aggregating activity 
is due to  a property of the AH’F molecule ra th er than the active 
site or sites which participate in the coagulation cascade.
The disappearance of the aggregating agent from  animal 
plasm as when they are  clotted, or from  crude porcine and bovine 
AHF on the addition of sm all amounts of thrombin probably 
reflec ts  destruction of the AHF molecule during the clotting process 
or loss from  absorption onto fibrin, AHF activity has not been 
detected in serum .
The finding of agglutinins to human p latelets in animal 
plasm as is not new. Le Koy et al. (i960), Brinkhous et al,
(1965) and Mason and Head (1967) described an activity present 
in the fibrinogen fraction of various animal species which they 
called thrombocyte agglutinating activity (TAg). Solum (1968) 
showed that highly purified bovine platelet fibrinogen aggregated
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human p la telets, however, some of the aggregating activity 
rem ained despite the rem oval of all thrombin elottable m aterial. 
Bovine fibrinogen prepared  com m ercially has been 
used as a p latelet aggregating agent by Caen et al, (1966 (a) and 
(b)), in patients with throm basthenia whose p latelets w ere not 
aggregated by ADP, adrenaline, noradrenaline, 5-hydroxytrypt- 
amine, thrombin, purified collagen, crude connective tissue or 
human fibrinogen. Bovine fibrinogen at a concentration of 1, 5 
m g /m l produced aggregation in five of the six cases tested.
These authors also showed that the aggregating activity could be 
destroyed on Incubation with plasm in and the reaction did not 
consume complement. This reagent is now used to define certain  
platelet abnorm alities eg. Thrombasthenia, Bernard-Soulier 
Giant P late le t Syndrome (Council on Throm bosis, A. H, Â ., 1972), 
Gel filtration on Sepiiarose 4B of commercially available 
p reparations of bovine and porcine fibrinogen shows that there are  
two protein peaks which are identical with those obtained after 
gel filtration of com m ercial AHF preparations and it has been 
shown that the platelet aggregating m aterial is contained within the 
AHF peak and is  not rela ted  to the fibrinogen fraction.
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The mechanism by which partially  purified animal AHF 
aggregate human platelets is unknown. As the reaction is foi- 
phasic and is blocked by p rio r  ingestion of acety l-salicy lic acid 
th is would suggest active transport of the m aterial through the 
platelet membrane. Falcao et al, (1007) using electron m icro­
scopy claim ed to have shown the presence of a cementing sub­
stance between the p latelets and no change in the external m em branes 
of platelets aggregated by bovine fibrinogen preparations. We 
have been unable to confirm this using purified AHF and gel- 
filtered  p latelets. It is  possible that the appearances described 
by these authors were a resu lt of non-specific trapping of plasm a 
protein.
Infusion of anim al AHF preparations into haemophilic 
patients gives r ise  to thrombocytopenia which is transien t and 
is  re la ted  to the dose given. Thrombocytopenia is probably due 
to trapping of large platelet aggregates in the cap illaries a 
phenomenon which is  sim ilar to the retention of p latelet aggregates 
in the Hellem glass bead columns. Bleeding as a re su lt of the 
low platelet count has been occasionally documented (Biggs and 
M acfarlane, 1959; Hall et a l , , 1962; Hisza and Biggs, 1969),
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despite a norm al or high level of AHF. In one of our patients 
(case 3) there  was no r is e  in the plasm a level of AHF due to 
inactivation by inliibitor but there  was evidence of increased  
gastrointestinal blood loss with a r ise  in blood transfusion 
requirem ents and a fall in haemoglobin which corresponded to 
the thrombocytopenic episode.
All th ree  of the patients esqierienced pain along the line 
of the vein through which the AHF solution was adm inistered and 
also suffered throm bosis in the veins at the infusion site . This 
tlirombogenic effect has been recorded previously (Biggs, 1960), 
and may foe due to adiierence of platelet aggregates to the endo­
thelium  of the vein with production of platelet throm bi. This 
phenomenon has been observed by Berm an and Fulton (1961) 
and M ustard et al. (1962) while infusing other p latelet aggre­
gating agents. Such platelet throm bi may stim ulate formation 
of fibrin with resu ltan t occlusion of the vessel.
Examination of a blood film in one of our patients during 
infusion of porcine AHF showed multiple platelet aggregates con­
sisting of 30 - 50 p latelets, m easuring 100 - 200 jii in diam eter.
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Such platelet aggregates could have pathological consequences 
but this has not been proven In man. However, in experim ental 
situations, a sim ilar p icture can be produced by infusion of 
adenosine diphosphate intravenously. T ransient thrombocyto­
penia has been produced by th is means in humans (Davey and 
Lander, 1964), ra ts  (Nordoy and Chandler, 1964), cats (Born 
and C ross, 1963), swine (Mustard et a l . , 1964; Murphy et a l , , 
1964) and in rabbits (Eegoli and Clark, 1963). In experim ental 
anim als, platelet aggregates induced by ADP, can foe seen block­
ing capillaries in the lung (Nordoy and Chandler, 1964) where 
they may produce irrev ers ib le  tissue  changes even though the 
platelet thrombus itse lf is transien t. M ustard et al. (1964) 
produced m yocardial infarction in swine by infusion of ADP ; 
and in the ra t, infusion of ADP may result in resp ira to ry  a r re s t  
with platelet throm bi in the pulmonary capillaries, a reaction 
that can be produced under experimental conditions by the injection 
of other embolising partic les (De Takats, 1939), In the rabbit, 
if platelet aggregates a re  form ed within the renal circulation, 
focal acute glom erulonephritis is produced with a rea s  of cortical
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necrosis (Glymi et a l . , 1966). In these experiments fibrin 
thrombi were found in the  renal a r te rie s  and glomerular capil­
la rie s  twenty-four hours after ADP infusion. This finding was 
in terpreted by the authors as indicating that the fibrin  throm bi 
w ere secondary to the platelet aggregates occluding blood flow, 
hi the original toxicity studies by Sharp and Bidwell 
(1957) injection of AHF preparations into rabbits produced no 
histological changes of note. This was probably because rabbit 
p la telets a re  not aggregated by bovine or porcine AHF preparations. 
This is  in keeping with the finding of Le Roy et al, (1960) that 
there  is m arked in terspecies differences to a range of aggregating 
agents. A wide range of escperimental anim als (dog, pig, cow, 
horse, sheep, rat, rabbit) have been examined and no effect 
of porcine or bovine AHF has been shown on their platelets. The 
only animal p la telets which give the same reaction to AHF as the 
human is  the guinea pig. This confirms the observations of 
Sinakos and Caen (1967) who used a crude bovine fibrinogen p re ­
paration to produce platelet aggregation.
Despite wide usage of these preparations the re  has been 
no clinical evidence of pulmonary or myocardial complications
148*
in patiente receiving bovine or porcine AHF. In one case (Wardle, 
1967), pro teinuria developed during a course of bovine AHF 
which also produced thrombocytopenia. P ro te inu ria  and bio­
chemical evidence of renal damage was present in th is patient 
three months la te r . In a case described by Goudemand et al. 
(1968) the patient developed a reversib le  episode of glom erulo­
nephritis. The cause of th is was obscure but it was suggested 
by the authors that it represen ted  an immune reaction.
It is  certain that many haemophiliacs owe their lives 
to the use of animal aiitihaemophiiie factor, however, as more 
potent concentrates of human material become available the use 
of animal products will diminish but they s till re ta in  great in terest 
as platelet aggregating agents in which ro le they seem  to have 
unique actions.
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of Mood group antibodies and the effects of elevation of the plasm a 
fibrinogen are  discussed.
Animal AHF preparations have been used for some years 
in the management of haemophilia. In Chapter 10 a re  the studies 
carried  out both la vivo and in vitro into the mechanism of platelet 
aggregation by preparations of animal AHF. I present evidence 
that the aggregating agent is the AHF molecule itself and not 
fibrinogen as had been thought previously. This work includes 
investigation of the physical and chemical characteristics of the 
aggregating agent as well as studies of inhibitors of the reaction.
4*'
products,- From  this study it is clear that patienta with haemo­
philia may safely have teeth extracted after sm all doses of plasm a 
concentrate and tranexamic acid.
Patients with haemophilia and other bleeding disorders 
are  well Mown to have behaviour disturbances and on occasion 
florid psychiatric symptoms. One reflection of s tre ss  may be 
the high incidence of peptic ulceration. This often presents as 
gastro"intestinal bleeding and was one of the commonest causes 
of death* Chapter 6 is a review of the episodes of gastro-m testm al 
bleeding seen in this unit in the past ten years and covers one 
hundred and seven separate episodes of bleeding. In this Ï have 
confirmed that peptic ulcer occurs in over 50 per cent of these 
patients and may be symptomless. The hasards of conservative 
management and the complications of surgery are  described.
The keystone of the modern treatm ent of haemophilia is 
replacement of the deficient activity by infusion of plasm a or 
plasm a concentrate. This exposes the haemophiliac to various 
additional hazards, of which serum  hepatitis is the most important. 
In this section is described the incidence of both clinical jaundice 
and anicteric hepatitis, as well as the incidence of positivity of 
Australia (AuSIi) antigen and antibody. In addition the incidence
3.
therapy with plasm a products the clinical signs in the acute 
haem arthrosis resolve rapidly but the radioactive scan rem ains 
abnormal. This suggests that the mechanism for production 
of pam (perhaps kinin generation) is different from  that producing 
continuation of liyperaemia in the synovium.
Haematomata of muscle are  usually situated peripherally 
and present no clinical diagnostic problem. Chapter 4 is con­
cerned with attem pts to diagnose early occult muscle bleeding 
by estimation of serum  enzymes which a re  liberated from  damaged 
muscle. The use of ultrasonography in the localisation and 
quantitation of peripheral haematomata is also investigated and 
new methods of investigation of chronic haematomata (pseudo™ 
tumours) a re  described.
The commonest elective surgical procedure in the haemo­
philia is dental extraction. In recent years the availability of 
potent concentrates of plasm a products have overcome the problems 
of excess bleeding from  the e^itraction site but have introduced the 
hazards of production of serum  hepatitis or AHF inhibitors.
Chapter 5 is the report of a  carefully controlled, double-blind 
tr ia l of tranexamic acid, a fibrinolytic inhibitor, in the reduction 
of post-extraction bleeding and of the requirements of plasm a
2,
Perhaps the greatest cause of morbidity in haemophilia 
is recurren t bleeding into the joints of the severely affected 
patients. From  studies both in the human and in the animal it 
would seem that a  vicious circle is set up in which bleeding 
produces hypertrophy of the synovial villi and produces synovial 
hyperaemia; this in turn increases the chances of further bleeding 
and eventually bone and cartilage changes occur. It seem s 
lüceiy that if therapy is to be successful then it must be given 
early before cartilage or bone changes have occurred, It is 
known that plasm a infusion will produce dramatic re lief of the 
symptoms of acute haem arthrosis but as yet there is  no evidence 
that it significantly a lte rs  the pathological processes in the Joints.
I have attempted to use the new techniques of radioactive joint 
scanning with technetium, and thermography in an attempt to define 
the early changes in the knee joints of haemophilie patients with 
acute and chronic joint disease and also with no apparent Joint 
disease. These two techniques probably m easure slightly different 
aspects of joint inflammation but both a re  more sensitive than 
clinical examination and detect changes before they are  apparent 
radiologically. Both methods a re  easily repeatable and offer a 
method of assessing resolution of acute haem arthroses. Following
îî
The Haemophilias: Clmieal and Laboratory Investigations
Bummary of M.D. Thesis submitted by Dr. Charles D. Forbes
The clinical features of haemorrhagic disease have been 
recognised for alm ost 1,500 years but it is  only in the last fifty 
years that significant advances have been made in their diagnosis 
and treatment.
/  i
The advances of most importance concern the under- ^
L
standing of the normal coagulation and haemostatic mechanisms.
It has become apparent in recent years that the ’’Bleeding Syndromes' 
consist of a large number of different diseases, each with its own 
specific protein abnormality. In th is thesis I look at the haemorr- 
hagic problem s of patients with haemophilia and Christm as disease.
In these two diseases the clinical episodes of bleeding a re  identical 
although they are  due to deficient activities of different proteins.
The thesis consists of three sections. In the f irs t is  the 
detailed historical introduction to the ’’Haemophilias” and the 
current concepts of the clotting mechanism, l i  the second section 
there are  five chapters dealing with different clinical facets of 
bleeding in these patients and in the th ird  section is described the 
complications and side effects of therapy with plasma products of 
human and animal origin.
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THE INTRINSIC CLOTTING 
MECHANISM
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Fig. 1 Diagram matic representation of the ’’w aterfall” or ’’cascade” 
theory of blood coagulation as put forward originally by 
MacfaiTane (1964) and Davie and Ratnoff (1964). The original 
sequence of events has been modified slightly in the light of 
modern knowledge.
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Fig. 2 Representative colour scan of haemophilia knee joints obtained 
twenty-five minutes after the intravenous injection of 5 me. of 
99mxc. Colour coding is so arranged that there is a gradation 
from deep red, red, orange, yellow, purple, blue, green, brown 
which corresponds to diminishing amounts of radio-activity. 
There is no isotope uptake in the right knee which has never been 
the site of a haemarthrosis and was clinically and radiologically 
normal. It has been given a score of 0. The left knee has a 
score of 2.
'Fig. 3 Representative colour scan of a patient with severe haemo­
philia with an acute haemarthrosis in the right knee joint 
(patient 1). This scan has been given a score of 3 using our 
scoring technioue which depends on the width, depth, degree 
or isotope uptake with or without irregular localisation of 
the isotope. The left knee has a score of 0.
Fig. 4 Representative colour scan of a patient with severe haemo­
philia and chronic knee joint disease (patient 10). The scan 
of the right knee has been graded 2 on the basis of the 
isotope uptake. The left knee has a score of 0.
Fig. 5 Representative colour scan of a patient with severe haemo­
philia showing bilateral abnormalities in the knee joints 
(patient 5). The right knee joint has been given a score of 
1 and the left knee a score of 3.
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Fig, 0 Relation between the clinical ’signs* score and the radio­
active scan abnorm alities in acute haemophilie haem arthrosis. 
There is  a  good correlation between the scan abnormality and 
the ’signs* score. For comparison the other joint of the 
patient is shown. All these joints w ere the site  of freqnent 
previous bleeding episodes and all had evidence, both clinical 
and radiological, of chronic haemophilie arthropathy.
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Fig, T Relation between the clinical, ’signs* score and the rad io ­
active scan in chronic haemophilie joint disease. There is 
a  poor correlation between the clinical ’signs* score and 
the abnormality of the scan.
\Fig. 8 Thermograph of the knee joints of a patient with severe
haemophilia with an acute haemoarthrosis in the right knee 
joint. This has been given a score of 3. There is irregular 
emission of infra-red energy from this joint and the swelling 
of the joint and wasting of the quadriceps can be seen. The 
left knee is normal.
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Fig. 9 Thermograph of the knees of a patient (patient 9) with
severe haemophilia and chronic arthropathy of the knees. 
Both joints are abnormal, the right knee has been given a 
score of 2 and the left a score of 1. There is irregular 
emission of infra-red energy from both knees. This may 
be due, in part, to abnormal venous plexuses around the 
disorganised joint.
\Fig. 10 Thermograph of the knees from a patient (patient 13) with
mild haemophilia who has never bled into the knee joints and 
who has no clinical abnormalities. There is abnormal 
infra-red emission from both knees and this has been given 
a score of 1.
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Fig. 11 Thermograph of the knees from a patient (patient 1) with 
severe haemophilia who has an acute haemarthrosis of the 
right knee. The left Imee appears normal and has been 
given a score of 0. The right kneo has a score of 3. The 
use of isotherm lines to determine the difference in temperature 
between these two joints is shown in the next figure.
Fig. 12 Demonstration of the use of iso-therms to determine the
difference in temperature between knee joints. As can be 
seen there is an acute haemarthrosis of the right knee joint; 
each of these pictures represents a step of 1°C and there is  
a 5°C difference between the two joints.
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Fig. 13 Relation between the clinical *signB* sco res and thermography 
sco res in aeate and chronic haemophilie arthropathy and in 
patients with no joint disease*
$ « rep resen ts  acute haem arthrosis
o - rep resen ts  chronic joint d isease
3E - no apparent joint disease
Acute joint disease - 5 patients
0)
Ou(/)
£a
UiO
E
Q) # #
»
J_
2 3
scan score
?Fig. 14 Comparison of therm ographs and radioactive scans in acute
liaemarthrosiB. The opposite Joint, which has chronic d isease, 
is shown for comparison. There is a good correlation 
between the scans and therm ographs in the acute Joints.
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‘ig. 16 Comparison of therm ographs and radioactive scans in chronic
haemophilic Joint disease. There is a poor correlation between 
the scans and the therm ographs. It is possible that the scan 
and therm ograph m easure different aspects of joint inflammation 
in this situation (see tesd).
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Fig. 18 Distribution of creatine kinase activity in forty «one patients 
with haemophilia or C hristm as disease who had no evidence 
of m uscle disease or m uscle bleeding. There is no significant 
difference between th is group of patients and the norm al levels 
reported  by MacQueen et al. (1972).
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Fig, 17 Representative figure to show the changes in creatine kinase
and lactate dehydrogenase after muscle bleeding in a patient who 
developed a m assive muscle haematoma after an intram uscular 
injection (patient 2). The peak activity of CK in th is patient 
occurred at 96 hours. Peak LBH activity occurred on day 10.
E lectrophoresis and examination of isoenzymes showed a 
pattern 1 ) 2 ) 3 ) 5 ) 4  suggesting that the increase in LDB 
resu lted  from  breakdown of red  blood cells within the haematoma.
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Fig. 18 Pattern of elevation of CK and LDH in a patient with severe
C hristm as disease who presented with loin pain of undetermined 
aetiology.
Fig. 19 (a) Ultrasonograph (1. 5 MHz, - 20) of thigh in patient 2. 
Longitudinal section of lateral aspect of thigh showing the 
extent of the haematoma (35 x 6 cms). The position of the 
femur is shown by the arrow. There are reflecting echoes 
within the haematoma.
Fig. 19 (b) Ultrasonograph (1. 5 MHz, - 20) of thigh in patient 2.
Cross section of thigh 6. 5 inches above the patella to show 
the large transdonic space filled by the haematoma (15 x 
20 cms). The position of the femur is shown by the arrow.
Fig. 20 (a) and (b) Ultrasonographs of the thigh in patient 5 showing 
the presence of a large haematoma (cross section 5 x 6  cms) 
in the posterior compartment of the thigh extending from the 
knee into the buttock. Fig. 20 (a) is taken at 16 cms above the 
patella and 20 (b) at 10 cms above the patella. Both figures 
show transverse sections of the thigh and were taken at 2. 5 
MHz, - 20.
Fig. 21 Ultrasonograph of calf in patient 3. Scan taken with patient 
lying on face so that posterior surface of calf is uppermost. 
Central mark indicates the site of cutaneous bruising where 
the patient was kicked while playing football. The foot lies  
to the right of the picture. The cross section of the haema­
toma measures 1 5 x 5  cms. Scan taken at 2. 5 MHz (-30). 
Arrow points to the haematoma.
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Fig 22 Plain X-ray of the pelvis in a patient with bilateral pseudo­
tumours. There is erosion of the blade of the ilium on the 
left side. Continuous with this area of bone destruction 
there is a soft tissue mass within which are areas of cal­
cification. There are osteosclerotic areas in the ilium.
Fig. 23 (a) Intravenous pyelogram of patient with bilateral pelvic 
pseudotumours showing displacement of the left ureter and 
bladder. The left ureter is held in fixed dilatation by the 
pseudotumour.
yFig. 23 (b) Barium meal and follow through showing displacement 
of both large and small bowel by a large mass in the left 
pelvis and a smaller mass in the right side.
Fig, 24 Ultrasonograph of the lower abdomen (2. 5 MHz, - 10) In the
patient with bilateral pelvic pseudotumours. This is a trans­
verse section of the abdomen 1 inch below the umbilicus showing 
two discrete lesions, measuring 7 . 5 x 5  cms on the right and 
10 X 7. 5 cms on the left. The margins of the lesions are 
indistinct and they contain reflecting echoes.
SYMPHYSIS PUBIS
Fig. 25 Photoscan of pelvis after injection of 87 M strontium showing 
a large round volume of abnormal uptake in the right pelvis 
and an elongated volume of abnormal uptake extending 
laterally and superiorly in the left pelvis. These areas 
correspond to the sides of the pseudotumour.
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Fig. 26 Factor TOÏ replacem ent given alter dental extraction to patients 
receiving tranexam ie acid or placebo. In the treated group only 
two patients required to have additional replacement therapy 
and in the placebo group eleven required an average of 620 units 
of factor Vin.
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Fig. 27 Changes in the erythrocyte sedimentation rate and fibrinogen 
levels in the tranexamie acid treated and placebo groups.
The significant rise in EI^ R and fibrinogen is  a reflection of 
the volume of plasma concentrate infused.
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Fig 28 Urokinase sensitivity te s ts  and eiiglobnlm lysis tim e estimations 
before and after treatment with tranexamie acid and in the 
placebo group. Depression of urokinase sensitivity indicates 
that the plasm a level of tranexam ie acid was sufficient to 
inhibit fibrinolysis. In both groups there was a fall in the 
euglobulin lysis tim e indicating accelerated lysis but the 
differences were not significant (P = 0,1).
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Fig, 29 Erythrocyte sedimentation ra te  and fibrinogen levels before 
and after cryopreclpitate infusion in eight patients. ïn both 
te s ts  there a re  significant differences pre and post-infusion 
(P = (0.001).
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Fig. 30 Shows the relationship between fibrinogen and erythrocyte 
sedimentation ra te  (r ~ 0. 3355). With a r is e  in plasm a 
fibrinogen there is a corresponding r is e  in the E8E until it 
reaches a level which approximates to the packed ceil volume, 
at which point no change in the EBE occurs with a further r ise  
in fibrinogen level.
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Fig. 31 Serial estim ations of erythrocyte sedimentation ra te , plasm a 
fibrinogen and factor YÏIÏ levels in one representative patient 
who received multiple infusions of eryoprecipitate during 
surgery. The amount of cryoprecipitate given is indicated 
at the top of the slide. The peak lovel of fibrinogen and EBB 
occurred on day 4,
Fig. 32 Cellulose acetate electrophoresis of LDH iso-engym es. 1, 
day 14; 2, day 15; 3, day 19; 4, day 20. Zones of activity 
w ere made visible by incubating the s tr ip s  In contact with 
agar, t r i s -buffered to pH 8,4 and incorporating, per litre ,
100 m. mol of lactate, 1. 6 ra, mol of HAD, 66 ji mol of phena^ine 
methosulphate, 500 p mol of thiazolyl tétrazolium  and 6 /i mol of 
semicarfoazitie hydrochloride. This figure has been retouched 
to bring out the bands m ore clearly. The original photograph 
may be seen in our a rtic le  in Clinical Chemistry (1971), 17, 948.
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Fig. 88 Effect o b  the platelet comits of infusion of 8,000 unit doses (R l) 
of porcine AMF in two patients with haemophilia. Thrombo­
cytopenia was noted 10 minutes after the injection and exam­
ination of peripheral Mood film s at th is tim e showed the 
presence of circulating platelet clumps of 80-50 platelets. By 
12 hours the num bers of platelets had risen  to approach the p re ­
treatm ent level. Giving two doses of 8,000 units within the 
space of 12 hours resulted  in severe prolonged thrombocyto­
penia and in patient % (above) resulted  in a decision to discon­
tinue therapy with miimal m aterial.
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Fig, 34 Effect on platelet count, haemoglobin and the blood transfusion 
requirem ents of the infusion of porcine AHF. 8,000 units were 
given for the f irs t two days and 16,000 units w ere given for the 
next th ree  days. Severe thrombocytopenia produced an 
increase in gastrointestinal blood loss with a fall in haemoglobin 
despite a  r is e  in the ra te  of blood transfusion. This patient 
had a high titre  inhibitor and did not have a r is e  in plasm a AHF 
after the porcine infusions.
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[■'ig, 35 Aggregation of human platelets by different concentrations of 
com m ercial porcine and bovine AHF preparations, m this 
system  a fall in optical density indicates platelet aggregation. 
Irrev ersib le  aggregation of platelets was produced by bovine 
AHF at a concentration of 50 fxgfinl and by porcine AHF at 
200 iJig/mL This would suggest that bovine AHF has, weight 
for weight, about four tim es the aggregating^activity of porcine 
AHF preparations. At certain  concentrations platelet 
aggregation is reversib le .
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Fig* 36 Aggregation of human platelets by various mammalian plasm as. 
Aliquots of 0 .1  ml of animal plasm a w ere added to 2 ml of 
human platelet rich plasm a. Rapid irrev e rs ib le  aggregation 
was produced by sheep and goat plasm a and reversible 
platelet aggregation by cow, pig and horse plasm a.
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Fig. 37 Comparison of plasma and sernm from various animal plasmas.
in the aggregation of human platelets. Serum was obtained by 
clotting the plasma samples with the addition of calcium chloride 
(0,035 M) and then incubated at 37^C for three hours to remove 
any residual thrombin. Clotting of the plasma resulted in 
diminution of the aggregating activity in all cases, suggesting 
that the aggregating activity lay in the fibrinogen fraction or 
some closely related fraction.
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Fig. 38 P rogressive Inhibition of the platelet aggregating agent with 
r is e  in temperature. The effect on porcine AHF is shown.
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Fig. 39 (a) and (b) The effect of mgeation of acetylsalicylic acid on 
aggregation of human platelets by AHF preparation showing 
Inhibition of the second phase of aggregation after the ingestion 
of aspirin , (a) is  porcine AEF, (b) is  bovine AHF.
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Fig. 40 (a) Gel filtration of the commercial preparations of porcine 
AHF on 8epharose 4B. This shows that there are two main 
protein peaks. The second peal: coneiets of fibrinogen alone. 
The first contains all the AHF activity and the aggregating 
agent which have coincidental peaks of activity.
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Fig, 40 (b) Gel filtration of bovine AHF on Sepharose 4B
Fig. 41 Polyacrüimide disc gel electrophoresis of a preparation of 
porcine AHF prepared by gel filtration and then concentrated 
X 100 by pressure dialysis is shown on the r i^ t .  There is 
a faint band which lies in the same position as the purified 
porcine fibrinogen (left).
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Fig 42 (a) Aggregation of human platelet rich  plasm a by sam ples
of eliiate from  the Sepharose 4B columns shown in Fig. 40 (a). 
This shows that aggregating activity is found only in the 
sam ples of eluate from the f irs t protein peaks i. e. the AHF, 
immunodiffusion.
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îTig. 42 (b) Aggregation of human platelet rich  plasm a by sam ples 
of eluate from  column shown m  fig. 40 (b).
Fig. 43 Immunodiffusion slide with antibody in the central wells and 
doubling dilutions of crude porcine AHF in the peripheral 
w ells. On the left is the crude rabbit antibody and this shows 
two lines against crude AHF and on the right, the antibody, 
which has been adsorbed with purified fibrinogen, shows a 
single line against the crude AHF preparation. This anti­
body preparation gives no lines against purified fibrinogen.
It also rapidly destroys AHF activity when incubated with 
AHF at 3 7 0 c .
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Fig. 44 Comparison of platelet aggregation between the purified 
porcine AHF m aterial and the impure AHF. The pattern 
of platelet aggregation is  sim ilar with both preparations.
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Fig. 45 Comparison of aggregation of human platelets by purified 
AEF at and at 37%. It is apparent that at 37 C the 
pattern of platelet aggregation is  different at some con­
centrations of AEF^ from that at room temperature. Using 
a concentration of 5 of purified porcine AEF there is
a secondary phase of platelet aggregation which is  irreversible 
whereae at 34% the aggregation is reversible.
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Fig 46 Aggregation oi human platelets by porcine AHF before and 
after incubation with a spontaneous iiiMbitor from  a haemo­
philiac patient. The starting  level of AHF activity was 
2. 8 u n its /m l. This AHF activity was totally destroyed when 
incubated with the inlitibitor. No change occurred in the 
aggregating activity.
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Fig. 4'? Loss of aggregating activity after incubation of a  monospecific 
rabbit antibody against AHF, with a purified fraction of porcine 
AHF. There is complete loss of AHF activity and of 
aggregating activity after incubation. There was no loss of 
aggregating activity when normal rabbit serum  was used as a 
control.
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Fig*48 Aggregation of human platelets by com m ercial preparations 
of bovine and porcine fibrinogen. The pattern  of aggregation 
Is sim ilar to that produced by AHF preparations. The 
aggregating activity in bovine fibrinogen seem s to be between 
2 - 4  tim es greater than the porcine flbrogen.
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Fig. 49 (i) Gel filtra tioa of porcine fibrinogen on Sepbarose 4B, 
The pattern of separation is identical to that produced from 
the commercial ABF preparations. Platelet aggregating 
activity is  localised to the peaks of AHF activity which 
contaminates these preparations.
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Fig. 49 (b) Gel filtration of bovine fibrinogen on Sepharose 4B,
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Fig. 50 Aggregation of gel filtered  human ipdateiets by purified bovine 
and porcm e AHF, Comparison with previous figures will 
show that production of irreversib le  p latelet aggregation 
requ ires a much higher concentration of the aggregating 
agent when "washed" platelets are  used.
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Fig. 51 (a) The effect of iBcabatioii of plasm in on aggregation 
produced by porcine AHF, There is p rogressive loss of 
ÀHF activity and also of the aggregating activity.
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Ig . 51 (b) The effect of incubation of plasm in on aggregation 
produced by bovine AHF. There le p rogressive loss of 
AHF activity and also of the aggregating activity.
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Fig, 52 (a) Aggregation of guinea pig platelets by porcine AHF
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Fig. 5% (b) Aggregation of guinea pig platelete by bovine AHF.
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TABLE 2 Serial radioactive scan scores m a patient 
with a resolving acute haem arthroeis of 
left knee (Patient mo. 4)
Date ’Signs’ score 
Right Left
Scam score 
Right Left
1) Acute haemarthrosis
10,12. 3 f  : 11* 1 : 3
2) 22;12.70 3 : 0 1 : 3
3) 14; 1.71 3 : 0 1 : 3
4) 18; 3; 71 3 : 0 1 : 2
S) Acute Im em arthrosis
13; 4.71 3 : 11* 1 : 3
Shows the rapid clinical response to  AHF therapy with
re tu rn  of the ’signs’ score to aero  within 48 hours with
only gradual improvement of the scan over twelve weeks. 
P ro g ress  complicated by a recurrence of the acute 
haem artîirosis in the left knee..
Denotes Joint with acute haem arthroaio
The right iaiee joint is  the site  of degenerative changes 
both clinically and radiologically
TABLE 8 Radioactive scan sco res  in two patients, 
before and after an acute haem arthrosls
’S igns’ score Scan sco re
Right Left Bight Left
Patient 2. 2 8 .1 0 .7 0 4 : 4 1 1
Acute haem arthrosis  
8 .6 .7 1 4 : 12* 1 : 3
P a tie n ts . 1 0 ,1 1 .7 0 4 : 4 1 : 1
Acute haem arthrosis 
2 0 .5 . 71 4 I 12* 1 : 3
Both patients had sev ere  haemophilia witli m ultiple  
previous episodes of bleeding into the knee joints and 
chronic arthritic changes a s  judged clin ically  and radio- 
log ica lly . Both have a baseline abnormality in the  
radioactive scan s which is  due to the chronic arthritis  
and both show a change in ’s ig n s’ and scan sc o re s  with 
the onset of the acute haem arthrosis.
Acute haem arthrosis
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TABLE 8 Clinical and radioactive scan sco res in patients
with chronic liaemophilic joint d isease
Patient
number
Age Severity Incidence of 
bleeding score
* Signs’ score Scan score
Eight Left Eight Left Eight Left
9 34 Severe 1 8 0 4 2 : 3
10 36 Moder­
ate
2 ; 0 4 : 0 2 : 0
11 31 M oder­
ate
1 ; 0 1 : 0 2 : 2
13 19 Severe 3 : 8 1 2 8 : 3
13 13 Severe 3 : 8 0 1 3 : 3
14 48 M oder­
ate
2 : 2 2 2 3 : 1
15 34 Severe 3 : 3 2 : 4 2 : 2
16 43 Severe 3 3 2 : 3 3 : 1
17 61 Severe 3 2 6 6 3 : 1
180 33 Moder­
ate
5* 0£i 0 2 0 1 1 1
19 38 Severe 3 : 3 3 : 4 2 : 1
30 14 Severe 1 : 3 3 3 2 : 2
31 39 Severe 2 : 3 0 : 4 0 : 3
33 19 Severe 2 : 3 3 : 5 8 : 3
33* 13 Severe 2 : 0 3 0 3 : 3
Ail patients in th is group had evidence clinically of chronic haemopMilc 
joint d isease in one or both knee joints.
Patient had C hristm as disease
TABLE 6 Eadioacüve scan scores in patients with haemophilia
fout no apparent joint disease
Patient
number
Age Severity Incidence of
bleeding score
Eight Left
’Signs’
Right
score
Left
Scan score 
Right Left
24 49 Mild 0 : 0 0 : 0 0 ; 0
26 16 Mild 0 0 0 : 0 0 ; 0
26 50 Mild 0 : 0 0 : 0 0 ; 0
27 11 Mild 0 : 0 0 : 0 2 ; 2
28 11 Mild 0 0 0 : 0 3 c 3
29 14 Mild 0 : 0 0 : 0 3 : 3
30 35 Mild 0 : 0 0 0 0 0 0
31 52 Moder­
ate
0 : 0 0 : 0 0 0 0
32 31 Mild 0 : 0 0 0 0 . 0
83 14 Mild 0 : 0 0 : 0 0 ; 0
34 16 Mild 0 : 0 0 : 0 0 0 0
35 34 Mild 0 : 0 0 0 0 ; 0
None of the patients in th is group had sustained previous bleeding 
into the knee joints and none had clinical evidence of a rth ritis . 
Radiology of all these joints showed no abnormality.
isi®
O  jî^ j
“  i ' -
y  .il
i?y O
• rH ta? "{«)
.n  q  w  
Q i cd Pa 
cd
H  © o  
cd
ufil
p" q
î j i
B  13 "gG a§
0N
%
W)
,q
m0  , II
i “ i
Eh K
©8
0
m1
%
•'It^
M
«M
1%;
§
y
m
*CQ %
S^lJ
I
W
S
iT ^%  cd O ©
1 ^
Eh
O  .. eo  (M o  0*3
0* oa • •  sa
eo  T"“i
C» (%3 eg o  eo
CD 09 G% ea
m e*^ eg ?=!
CQ G--3 m
M eg o
F“) S)-) cg
v=i
ü> O
©
foj
I
Q) 0
I Ê
©Sg
GQ
eg
«g
o
CD
i(-
W
(sg
'^ 4
■pH
co  eg  vH c-g ee> eg
p * 0 * o« # * • •
cg eg e^  m eg
v“t o  eg  -iH m  o
o  r-4 50  eg  eg  M
(# CD eo eg
M vH 50 ÇV3 cg
T-l O t‘o3 W3 O
O  v-t eg  «O GO ^
©
»§
m
0)•^ lo)
Cd
Q)
X iq
§
©I©I©I iI
eg t“"3 co v^i¥“3 eg GQ (a 00¥«=i egeg
O  m
o  GO
o  ¥“■} vH
o  o  o
o  o
o  o  o
o  C ) o
■rj %# T)(Viw) fwt («aI
*f«l *pHl #P*:1
W  Irj
l^ 'À f"-| f'.--J
CO GO oj^=5 ¥*H
vi eg 60
s
Lfù CD C" m O)
«
"W
o  vH
TatpJ -rM
eg m <^ 1
©
w
ao
II
o
%
I
I
x s
U
1
I“M
cd
P i
«S3 V=1 eg
GO ¥“4 ¥"=! M
•y3=; CD CD V=4
eg %“4 eg eg •s^ l
Q) 0
S
:ë
II
^  g
s i
Q
{
l!) ffl q M
S g
M «S
1 
'i ^W
g
t»i=j
so
EH
P4
O
I
©
I
i0
'ë
1
I
t3
I6
3
<4
do
g
© cS
I CGIi
I
"i &-M P
■§TJ
'dII
I:dcd
Pi
CO ©
CO
e g
3T"1 8
- r | l O
© © LQ
d J GO
vH v"4 f
- r | CD
v H eg
E^* O  eg ¥=4
L'“ eg 
eg idG O eg
I
I
i
a  s
"3
II
CO
o©
S
o
I jI#0 Xf-21
l l
Ê „S
©pH
p=4
p
.3
to
©
I
r=4
<4
xi
|j  g
i l
ÆI a) 
© ©
IIrtaj plu*| 
0 %II
Is«Î*;J ^
II
% Cd
Ëta "Hli
II[s; il
© ÇQ
3  p
Eh d oo
Ts 3
§  S ’ 
3  aII
■1É
o 3  
m BM
ë  â
I»! ^
a
%) El) 
| q 9
■B IW 0  GÏ, B:■II
• s
# §li-g '53
©
i
ô
b!U 4)
■a .8
a  ® o
fl
"8 g
I  im S
â
| l  ,% ’0
& I
■ K
ïlII
I
■|
0r=4
o
I•f*î
y©
w
i  a0 Cd
E l acd 0@4 0-# >1 A Eh
y
*!«î0
a
;ShEh
y
-Î'U?0
m
g
%
0IHH
1
w hI I
ig' ife**
I0
y
Iu
«3
I
© 0 ©}> >
© m mm m cod d cd
g S '%4
I
i
@
«
II
pstti fOdi pt»s.|
MM r»^ j p=H0 ra d
a  a  am m m
S 'â
3  "ti
S S
piC}E'i H
"W
g0 â3EH
3  
oLj'*P»1 T*n$J3 41
&
'SI
3  3
m ,2 q ,a
# sM Pi
© O  O  €0 O  O €> O
. .......... .
û> © (!)
N U
0 © CD
> î> >
CD 0 CD
m CQ m
-g
©
q
g;
m o © 0 ) CD
^'î N
(ij 0 CD (D CD
t> > > !> l>
S m m m GO
I
mçH LC3 BiO CD T") eg <=^1 Sjj GO o¥=“1 w 01 sg 01 GO cg ¥^8 êg
•fH M GO 01 KO ÇP l> 00 03 Cj
ggm
ImI
ü
XIâ
I4dp.,
I
3
m
01
I
I
IB:
"S*0I
<1
CO Oa
H 0A M
Q)q a>
3 md CÎ© pS*t
•X” •X- *;(• if if
o o 01 o  o o to O uo ©
o eg b-» G<i oo vH to eg
vH o 01 01  eo 01 GO eg 01 GO
eg v'™!
O
O0*1
toEr-lO
CCOGO
00 CD0)3
vH
CDsH
eq
¥H
eg
ovH
lO
eqT"!
¥h eg GO 01 to  GO &* 00 Oa O','H
01
lO
M
eg
M
Q
3
I1
2
B
63
<3>
O
d
■ sâ
Ji
§ '3
^  §. "M
8 r**Hcd
| l m yrP  O
TVUSLE 12 Clinical details of patients under going ultra- 
sonography of muscle haematomata
Patient Disease Severity Age Haematoma 
Site Size
1 Haemophilia Severe 37 Calf M assive
2 Haemophilia Severe 16 T h i^ MCaseive
3 Haemophilia Severe 23 Calf Moderate
4 Haemophilia Severe 22 Buttock Massive
5 Circulating
anticoagulant - 58 Thigh M assive
6 C hristm as
disease Severe 25 Calf Moderate
7 Haemophilia Severe 14 Thigh Moderate
Clinical data of patiente receiving AMCA 
or placebo
PI^GEBO AMCA
Number of episodes of ezctraction 16 16
Number of patients 14 14
Number with haemophilia 9 11
Number with Christm as disease 8 8
Level of plasm a factor (mean, 
p e r cent) 
(range)
4. G 
(0 " 22)
5
(0 - 28)
Clinical severity; Severe 7 8
Moderate 6 5
Mild 1 1
Patients a re  equally divided between the te s t and placebo groups 
with regard  to number of episodes of extraction, disease, severity  
and assay of levels of coagulation factors.
TABLE 14 R esults m  the AMCA trea ted  and placebo 
groups after dental extraction
PLACEBO AMCA
Number of roo ts extracted (mean) 5. § 
(range) (2-12)
6.9
(2-22)
Blood loss per patient (ml) (mean) 84.1 
(range) (4-823)
61.2
(1-749)
Blood lost p er root extracted 
(ml)
(mean) 15.3 
(range) (0, 5-64)
8.9
(0. 5-38. 6)
Units of replacem ent therapy 
per root extracted (units)
(mean) 617 
(ran g e)(0-15,800)
30 and 68 
in two 
patients
Fall in haemoglobin (Gms 
p er 100 mi)
(mean) 1.4 0 .3
F ail in haem atocrit (per cent) (mean) 5,0 0 .9
Haemophilic patients trea ted  with AMCA show a significant reduction 
in Mood loss (0.01 ( p ( 0.025) and a Mglily significant (p ( 0.001) 
reduction in p lasm a requirem ents.
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TABLE Comparison of the grade of defect 
in the two groups of haemophilic 
patients with gastrointestinal bleeding
Grade of defect Severe Moderate m id
Patien ts without IIX: 3-Î- 1
dyspepsia
P atien ts with 4 4
dyspepsia
* Include 2 with C hristm as disease 
-Î- liciiide 1 with Christm as d isease
# Include t  with Christm as d isease
There Is a significant difference In the distribution of 
the severity  of the d isease in the two groups of patients 
= p (  0 .05 >0.02).
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TABLE 22 Levels of coagulation factors in 
1 unit (approximately 20 ml) of 
cryo'precipitate
F actor Level (Mean + S. D. )
II 48 -f 19 per cent
¥ 65 -f 9 p er cent
DC 52 4 6 p e r cent
v m 180 'f 79 units p er pack
Fibrinogen 557 4 21 m g /100 ml
Plasminogen 2,8  + 0,25 c ,u . /m l
Plasminogen activator Nil
This shows the wide variation in level of AHF (F¥ÏÏÏ) 
in Individual packs of cryoprecipitate and th is is  one 
of the m ajor disadvantages of its use. Fibrinogen is 
precipitated simultaneously with AHF and is  the m ajor 
protein constituent. During long continued adm in­
istra tion  of cryoprecipitate a state of hyperfibrino- 
genaemia appears due to the relatively long survival 
in the circulation.
TABLE 23 Incideace of Mood group antibodies m
128 patients with haemophilia and 
C hristm as disease
Number of patients Antibody
3 Anti « K
4 Anti - D
2 j u ü i -  C + D + C
1 Anti » C
1 Anti “ E
A ll patients except one had received multiple blood 
transfusions as well as plasm a products before 
detection of the antibody. One patient developed an 
anti ■« D after infusion of cryoprecipitate alone.
APPSNDSS:
ADDITIONAL METHODS
j&PPI&NIEK 3
(1) Fibrinogen assay
The method described is  that of Ratnoff and Mengie 
(1051) as modified by A lkjaersig (1960). In this assay fibrin- 
ogen is clotted with thrombin; the fibrin so form ed is hydrolysed 
with ,sodium hyclroxicle and the tyrosine re leased  is  estim ated 
colourimetrlcaliy. A constant proportion of tyrosine in the 
fibrinogen molecule is assum ed (1:11.7).
ïn a 15 ml te s t tube a re  placed "0 .2  mP* glass beads 
(diam eter 0.15 mm), 6 .0 ml saline, 0 .1 ml thrombin solution,
100 N, Ï. E. units/m l, 0.2 ml, 2.5  per cent calcium chloride 
and 0 .2 ml plasm a. The tube is  shaken but not inverted and the 
fibrin is  caught up on the g lass beads. After standing for one 
hour at 4^C the tube is shaken again and centrifuged for 10 minutes 
at 2,000 r .  p. m. The glass beads and adherent fibrin a re  washed 
th ree tim es with saline. After final centrifugation and décant­
ation of the washing fluid, 0.4  ml 10 per cent sodium hydroxide 
is added and the tube boiled in a w ater bath for 20 minutes.
A fter cooling to room tem perature, 0 .6  ml 5 p er cent tr ich lo r­
acetic acid, 2 m l 0. 5 H sodium hydroxide and 0 .6  ml dilute (1:2)
A3.
Folin Ciocalteu reagent a re  added. After standing for 15 mimiteB 
for colour development, optical density at 650 m/i is  read  
against a reagent blank. Readings a re  converted to fibrinogen 
concentration, m g /100 ml, from  a standarded tyrosine curve.
A lkjaersig, H. (I960) in N. L H, Conference on Thrombo­
lytic Agents, eds. Roberts, E . R . , Geraty, J. D ., University of 
North Carolina P ress, Chapel Hill, p. 316
Eatnoff, O. D ., Menzie , G. (1951) 816, Journal of Laboratory
mid Clinical Medicine
(2) Plasminogen assay
The method used was the caseinolytic assay of Remmert 
and Cohen (1949) as modified by Alkjaersig et al. (1959). Anti- 
plasmin is f irs t  destroyed by incubating the plasm a with acid.
The acid is neutralised with alkali and buffer, and streptokinase 
is then added to convert the plasminogen to plasmin. The plasmin 
so produced is  assayed by a casetnolytic technique, the amount 
of tyrosine released from  the casern being a m easure of the 
amount of plasmin present.
The casein solution used is  prepared by boiling for 20 
minutes 25 gm casein ("Eammarsten" quality, Nutritional Bio-
A3.
Chemicals Corporation, Cleveland, Ohio) in 500 ml phosphate 
buffer, 0.1 M olar, pH 7. 6. The solution is filtered while hot 
and after cooling, the pH is  readjusted to 7.6,
To 0 .5 ml plasm a is  added 0. 5 ml 1 /S  M hydrochloric 
acid. After standing for 15 minutes at room tem perature to 
destroy antiplasm in 0. 5 ml 1 /6  N sodium hydroxide is added, 
followed by 1. 0 ml phosphate buffer, 0 .1 Molar, pH 7. S, 0. 5 ml 
streptokinase solution 2,000 units/m l, (V aridase-Lederie), and 
2 .0  m l 5 per cent casein solution. After addition of casein 
the assay mixture ia incubated at 37^C for 62 m inutes. At 2 
minutes and 62 minutes 2 ml aliquots a re  taken and to each is  
added 2 ml 10 per cent trichloracetic acid. After centrifugation 
(2,000 r .p .  m. for 10 minutes) 1 ml of the supernatant is  added 
to 5 ml 0. § H sodium hydroxide and 1.5 ml 5 per cent tr ich lo r­
acetic acid, followed by 1. 5 ml dilute (1:2) Folin Cioealteu reagent. 
After standing for 15 minutes for colour development, the optical 
density of the 62 minute sample is  read  at 650 with the 2 
minute sample as blank. Tyrosine release is  read  off a standard 
curve, one casein unit equals 180 mg tyrosine re leased  in one hour.
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A ikjaersig, N ., F letcher, A .P . and Sherry, S. (1959) Journal 
of Clinical Investigation, 38, 1086
Rem m ert, L. F. and Cohen, P. (1949) Journal of Biological 
Chemistry, liU , 431
(3) EugloWlin ly sis
The fraction of plasm a which p recip itates in dilute solutions 
at pH 5.8 (the euglobulin fraction) contains plasminogen activator, 
plasminogen and fibrinogen, but antiplasm in is largely in the 
supernatant (Maefarlane and P illing, 1946). If the euglofoulin 
precipitate is  resuspended and clotted with thrombin, much shorter 
lysis tim es a re  found than with the whole plasm a from  which the 
euglobulin precip itate was prepared  (for a norm al plasma, hours 
instead of days). The technique is  therefore m ore convenient 
than whole plasm a clot lysis tim e determination.
Method
The method used was that of Sherry et al. (1959), The 
test is  set up within 30 minutes of withdrawal of the sample, which 
is  stored at 4^C. To 7 ,4  ml acetic acid, pH 5.3, is  added 0. 6 ml 
plasm a. After standing 10 misiutes at 4^C, the precip itate is 
centrifuged down at 2 ,000 r .  p. m. for 10 minutes in a refrigera ted
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centrifuge. The supernatant is  poured off, the precip itate is 
dissolved in 0 .7  ml barbiton© buffer in 0 .9 per cent saline 
7 .4 , and clotted with 0.1 ml thrombin, 10 N. Ï. H. u n its /m l.
Time for complete clot lysis at 3 7 is  noted.
Calculation of re su lts
Results a re  expressed in arbitrary units. It has been 
shown by Sherry and A lkjaersig (1957) that in fibrinolytic assays, 
activity is  a  d’irec t function of the reciprocal of the ly sis  tim e, 
and accordingly a logarithm ic plot of lysis tim es against units 
of activity shows a linear relationship. Euglobulin ly sis  tim es 
are  expressed in te rm s of a rb itra ry  units of activity derived from  
such a plot. A lysiB tim e of 30 minutes is  assigned an activity 
of one unit, and the values for other lysis tim es a re  obtained by 
dividing the ly sis  tim es observed into 30. Norm al euglobulin 
lysis tim es a re  over 800 minutes (i. e. lees than 0 .1  unit) and if 
lysis has not talten place the te s t is  discontinued at 300 minutes, 
the resu lt being presented as ’l e s s  than 0,1 unit” .
M aefarlane, H.G, and Pilling, J . (1946), Lancet, 2,
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Sherry, 8. and AH^jaersig, N. (1957) Throm bosis et D iathesis 
liaeiBorrhagie (Sfcuttg. ), 264
Sherry, S ., Lindem eyer, B . I . , Fletcher, A.P. aaid A lkjaersig, N. 
(1959) Journal of Clinical Investigation, 38, 810
(4) Urokinase sensitivity test
The te s t wao performed according to the method of McMicoi 
and Douglas (1964). 0 .2  ml of plasma, 0.32 ml of urokinase
(500 jj,/m l), 0 .1 ml of throm bin (20 /i/m l) a re  added together 
in a 10 X 75 mm glass tube and allowed to clot. The tim e taken 
for dissolution of the clot is  recorded. The tim e is  then converted 
to arbitrary units, 1 unit of activity being equivalent to 10 minutes,
2 units a re  equivalent to 5 minutes and I  unit being equivalent to 
20 minutes.
McHicoi, G.P, and Douglas, A. S. (1Û64) i n ’Recent Advances in 
Clinical Pathology’, edited by Dyke, 8. C.
(5) A ssays for antiliaemophilic factor and C hristm as factor
The method described is  that of M argolis (1958) as 
modified by Brockenridge and Ratnoff (1962).
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(a) P rep are  a kaolin-phosphoUpid mixture by mixing 5 ml 
phospholipid with 50 mgm kaolin in a mechanical homogeniser. 
Using a 1 ml glass or plastic pipette, immediately pipette 0. Î ml 
of the kaolin ■'-phospholipid m bdure into as many 10 x 75 m m  
disposable glass tubes as will be needed. To do th is, draw 1 ml 
of the rnM ure into the pipette and fill no more than six tubes;
if the kaolin se ttle s , re - f il l  the pipette. Carefully re-m ix  the 
kaoiiii-phospholipid m ixture before each pipetting to ensure an 
even distribution of reagent in all tubes.
(b) P lace the kaolin-phospholipid tubes in an ice-w ater bath.
(c) Using an 0 .2  ml silicon-coated or p lastic pipette, pipette 
0.1 ml of substra te  plasm a into each of two kaolin-pliospholipid 
tubes, tap gently to mix, transfer to the 37^C bath and set the 
interval tim er to ring at 8 minutes,
(d) After 8 m inutes, p repare a 1:20 dilution of the plasm a to 
be tested  by mixing 0 .1  ml of plasm a with 1.9 ml barb ita l-saline 
buffer in a cellu lose-n itrate or thin-walled polypropylene tube, 
kept in the ice bath, using a 0.2 ml silicone pipette to transfer 
the plasm a. Invert the tube over parafilm  to mix.
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(e) At 8 m inutes, tran sfe r with a p lastic or silicone-coated 
pipette, 0 .1  ml of diluted plasm a to each substrate-kaolm -G liddex 
tube and immediately add 0 .1  ml 0,025 M calcium chloride, 
using 0,2 ml glass pipettes. S tart the stop watches with each 
addition of calcium  chloride. Mix immediately, and then let the 
tubes stand at 3'7^C until the watches read  30 seconds. Then 
mix gently and til t  the tubes continually until the clotting occurs. 
The tubes a re  tilted  by rotating the w rist; they should foe held 
one beside the other, in such a way that the degree of rotation
is the sam e in both tubes. The end-point is usually sharp, a 
firm  clot appearing suddenly; stop the appropriate watch as 
soon as a clot is  noted. Record the clotting time to the nearest 
tenth second.
(f) Xf the plasm a of the subject under te s t is  m ore than 2 seconds 
different from the "control” plasm a, repeat the assay  with the 
plasm a with the shorter clotting tim e, diluted 1:40; th is  should 
be a fresh dilution, ra th e r than a se ria l dilution of the 1:20.
Repeat the process until the clotting time is longer than that of the 
other plasm a.
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(g) To determine the "per cent activity” of the plasm a with the 
longer clotting tim e, plot the clotting tim es of the plasm a which 
has been calibrated on log-log paper and read  the activity of the 
other by interpolation,
(h) A standard frozen pooled plasm a may be used for the 
calibration curve. In th is case, a fresh normal plasm a should 
also be tested  at a concentration of 1:20.
(6) E rythrocyte sedimentation rate (E.8.R. )
The method used is that of Westergren (1921). Venous 
Mood is  rediluted with 3 .8  per cent trisodium citrate in the 
proportion of 1 p a rt of c itra te  to 4 p arts  of blood. The sample 
is then drawn up in the W estergren tube' to the 200 mm m ark.
The tube is  placed exactly vertical and left undisturbed for 60 
minutes. The height of the c lear plasma above the upper lim it 
of the column of sedimenting red cells is  then read  to the nearest 
millimetre. This figure in m illimetres per hour is  the E. 8 .E . 
W estergren, A. (1921) Acta m edica Scandinavica, 54, 247
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APPENDIX 4
ADDITIONAL CASE HISTORY
A case of m travasciiiar haemolysis occurring 
during cephalexin therapy and associated with
massive elevation of the plasm a fibrinogen
We describe here the case of a haemophilic boy who 
developed acute intravascuiar haemolysis while recovering from  
rep a ir  of a ruptured ureter. At th is tim e his fibrinogen level 
was 1000 m g /100 ml and he was taking cephalexin. The cause 
of the haemolysis has not been clearly  defined.
Cas© history
The patient was a severely affected haemophiliac with 
no antihaemophilic factor (AHF) activity detectable in the plasm a. 
He sustained a rupture of the ureter, multiple frac tu res  of rib s  
and large haematom ata of head, arm s and legs as the re su lt of 
a crushing injury. This was associated with intra,peritoneal 
bleeding and a fall in haemoglobin from 15 to 6 .2 /1 0 0  ml.
Surgery to the u re te r  was undertaken under cover of cryoglobulin 
precipitate, prepared  by cold precipitation of human plasma (Pool 
et a l . , 1964). Four units of donor Mood were transfused to
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bring the haemoglobin to 12 G /100 ml. No serological abnor­
malities w ere detected at the tim e of perform ing the matching 
tea ts . The infusions of cryopreclpltate w ere continued for 
thirty-tw o days to allow complete healing of the u re te r , skin 
incision and the drainage tube tracks. On the sM h  postoperative 
day the patient developed haem aturla and a haematoma of the thigh 
at the site of an in tram uscular injection when the AHF activity 
of the plasm a fell below the haem ostatic level. This was the 
only tim e the patient had any evidence of bleeding during the 
postoperative period.
During anaesthesia the patient asp irated  gastric  content 
and developed a pneumonitis of the left lower lobe and collapse 
of the right upper lobe. This was trea ted  with ampicillin, 1 0 /  
day for nine days, then with cephalexin, 2 G /d ay  for thirteen days.
Blood urea  was elevated to 50 m g /100 m l immediately 
after surgery  but rapidly fell to norm al and at the tim e cephalexin 
was adm inistered ranged from  20 ™ 25 m g /100 ml.
Nine days after the s ta rt of cephalexin therapy the patienth 
plasm a was noted to be brown in colour and the following resu lts  
suggestive of acute in travascular haemolysis w ere obtained;
methaemalbumin 2, 34 m g /100 ml, plasm a haemoglobin 6 m g /100 ml, 
reticulocyte count 5 p er cent, to tal bilirubin 1. 6 m g /100 ml.
Direct broad spectrum antihuman globulin (Coombs’) te s t using a 
stanclarîl slide technique was negative and the osmotic fragility  
of the red blood celle was normal. Haemolyeie increased  and 
maximum values were seen on the thirteenth day of cephalexin 
therapy when the reticulocyte count was 13 per cent, the methaem- 
albumin 3.47 m g /100 ml and the plasm a haemoglobin 8. 9 m g /100 ml. 
The serum complement level was normal. The ma^dmum serum  
level of cephalexin obtained during this tim e was of 10 /ig /m l, 
th ree hours after an oral dose of 500 mg and this occurred on 
the twenty-third postoperative day. Serum proteins w ere slightly 
elevated, the to tal being 8 .7 G/lOO ml with an albumin of 4 .6  G /
100 ml (55 p er cent) and globulin of 4 .1  G /100 m l. Electro- 
phoresis of plasm a proteins showed elevation of the gammaglobulin 
fraction to 2 .4 G /100 ml (25.4 p er cent), p-globulin 8, 5 per cent,
I globulin 8 per cent and oLg globulin 3 .1 per cent w ere 
within norm al lim its. Plasma fibrinogen was grossly elevated at 
1067 m g /100 ml.
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Since it is  reported (Kosakai and Miyakawa, 1970) that 
the direct antiglobnlin test on the red blood ce lls of patients 
receiving cephalosporins varies, depending upon the particular 
drug given and the particular antihuman globulinreagents and 
technique employed, it was decided to attempt to enhance the 
sensitivity of the method by using a two-stage method modified 
from that of Cohen and Nelken (1964). The patient’s  thrice 
washed red blood corpuscles, collected soon after cessation  
of cephalexin therapy, were incubated at room temperature with 
goat antihuman serum, washed to remove free serum and followed 
by a rabbit antigoat serum on a slide. Careful attention was given 
to finding the optimal dilutions for the rabbit antigoat and goat 
antihuman sera. The patient’s  cells tested by th is technique 
gave a positive reaction, control sensitised and unsensitised cells  
reacting satisfactorily. No Irregular blood group antibodies 
were detected in the patient’s serum. Direct antiglobulin reactions 
were performed using specific goat antihuman IgG immunoglobulin 
and anti-B . C component of complement with negative results.
This is  in agreement with Molthan et al. (1967) who reported the
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coating on the cells of their patients to be non-specific protein 
in nature.
Cephalexin was stopped at this time and thereafter the 
levels of plasma haemoglobin, metliaemalbnmin and the reticulo­
cyte count fell and haemoglobin level rose to normal.
Discussion
All members of the cephalosporin group of drugs are 
Imown to bind normal plasma proteins to red cells in vitro and 
so produce a positive direct anti-globulin test (Kosakai and 
Miyakawa, 1970; Mine et a l . , 1970). The antiglobulin reaction 
is  dependent on the type of antiserum used and hi in vitro experi- 
ments the incidence of positive te s ts  rises with the concentration 
of the drug,
Molthan et al. (1967) reported positive direct Coombs’ 
tests in 75 per cent of patients receiving ceplialothin. This 
finding was confirmed by Gralnick et al. (1967) who showed that 
40 per cent of patients on cephalotliin developed a positive Coombs’ 
test. In these series, patients with impaired renal function had
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a high incidence of positive tests probably because of the h i^  
blood cephalothin concentrations and because aaotaemic red 
cells were more easily sensitised. The incidence of positive 
tests was also higher in patients with hypoalbuminaemia.
A similar result was reported by York and Landes 
(1968) and Foord (1970) in patients receiving cephaloridine.
In the latter study involving sixty-five patients, the overall 
incidence of positive Coombs’ tests was 15 per cent but all the 
positive tests occurred in tlie group of patients receiving over 
4 G of cephaloridine/day. This gave an incidence of 26 per 
cent in this group. Perkins et al. (1967) reported similar 
observations in patients receiving cephalothin or cephaloridine. 
Girdwood (1971) reviewing the notificatione to the Safety of Drugs 
Committee cites eight «samples.
At least five cases of positive Coombs’ tests have been 
recorded after cephalexin therapy. Two cases are quoted by 
Foord (1970), one of these being in a monkey and one case by 
Pass et al. (1970). Also Erikssen et al. (1970) report that two
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out of five patients on cephalexin developed a positive Coombs’ 
te s t as determined by a ’tube* technique although the slide test 
was negative.
Positive Coombs’ te s ts  in patients on cephalosporins have 
been regarded as laboratory curiosities and of no significance 
with regard  to haemolytic anaemia; however, two cases of acute 
haemolysis have been described (Kaplan et a i . , 1968; Foord, 1971), 
The f irs t patient received cephaloridine and the second cephalexin. 
Both patients had, however, received penicillin therapy prior to 
the cephalosporin and. both had im paired renal function. The 
Incidence of cross-sensitisa tion  reactions between penicillin and 
cephalosporins is  probably between 10 and 15 per cent (Ky et a i . , 
1970) but v aries widely according to the c rite ria  chosen.
The case presented here is  complicated by the p rio r 
adm inistration of am pieillin, the elevation of the gammaglobulin 
and the high fibrinogen level, but renal function, plasm a albumin 
and the plasm a level of cephalexin were all within normal lim its. 
During the whole of this haemolytic episode and for ten days th e re ­
after, the patient received cryoglobulin precipitate and had no 
evidence of bleeding.
